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Validation of a novel surveillance paradigm for ventilator-associated
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Peter MC Klein Klouwenberg1,2*, Maaike SM van Mourik1, David SY Ong1,2,
Janneke Horn3, Marcus J Schultz3, Olaf L Cremer2, Marc JM Bonten1,4
1Department of Medical Microbiology, University Medical Center Utrecht, the
Netherlands; 2Department of Intensive Care, University Medical Center
Utrecht, the Netherlands; 3Department of Intensive Care Medicine, Academic
Medical Center, University of Amsterdam, the Netherlands; 4Julius Center for
Health Sciences and Primary Care, University Medical Center Utrecht,
the Netherlands
Critical Care 2013, 17(Suppl 4):P1; doi:10.1186/cc12902
Background: Reliable surveillance methods are indispensable for
benchmarking of healthcare-associated infection rates. The National
Healthcare Safety Network (NHSN) recently introduced surveillance of
ventilator-associated events (VAE), including ventilator-associated
conditions (VAC) [1]. This new algorithm is amenable to automated
implementation and strives for more consistent interpretation. We assess
the feasibility and reliability of automated implementation.
Materials and methods: Retrospective analysis of an ICU cohort with
prospective assessment of ventilator-associated pneumonia (VAP) in two
academic medical centers (January 2011 to June 2012). The algorithm
was electronically implemented as specified by the NHSN using minute-
to-minute ventilator data. Two minor modifications were developed to
improve stability and comparability with manual surveillance (10th
percentile and intermittent ventilation). Concordance was assessed
between the algorithms and prospective surveillance. Attributable
mortality of VAC was estimated by multivariable competing-risk survival
analysis.
Results: Two thousand and eighty patients contributed 2,296 episodes of
mechanical ventilation (MV). VAC incidence was 10.0/1,000 MV days.
Prospective surveillance identified 8 VAP cases/1,000 MV days. The
original VAC algorithm detected 32% (38/115) of patients affected by
VAP; positive predictive value was 25% (38/152). Using the 10th
percentile identified the same number of VAC cases, but only 116 were
identical. VAC incidence was 24.9/1,000 MV days with the intermittent
ventilation modification. Concordance between the original algorithm and
the modified versions was suboptimal. Estimates of attributable mortality
varied by implementation: original VAC subdistribution hazard ratio
(sdHR) = 4.33, 10th percentile sdHR = 6.26 and intermittent ventilation
sdHR = 2.40.
Conclusions: Concordance between manual VAP surveillance and the
VAE algorithm was poor. Although electronic implementation of the VAE
algorithm was feasible, small variations considerably altered the events
detected and their effect on mortality. Using the current specifications,
comparability across institutions using different electronic or manual
implementations remains questionable.
Reference
1. NHSN: The National Healthcare Safety Network Device-associated
Module: Ventilator-associated Event Protocol. Atlanta, GA: Centers for
Disease Control and Prevention 2013.
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Acute kidney injury decreases long-term survival over a
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Adam Linder1*, Adeera Levin2, Keith Walley1, James A Russell1, John H Boyd1
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Background: We hypothesized that one single episode of acute kidney
injury (AKI) reduces long-term survival compared with no acute kidney
injury (No AKI) following recovery from critical illness.
Materials and methods: A prospective cohort of 2,010 patients admitted
to the ICU between 2000 and 2009 at a provincial referral hospital was
followed to determine whether AKI influences long-term survival.
Results: Of the 1,844 eligible patients, 18.4% had AKI stage 1, 12.1% had
stage 2, 26.5% had stage 3, and 43.0% had No AKI, using the KDIGO
classification. The mean and median follow-up time was 8.1 and
8.7 years. The 28-day, 1-year, 5-year and 10-year survival rates were
59.6%, 44.9%, 37.4%, and 33.4%, in patients with any AKI (stage 1, stage
2, stage 3), which was significantly worse compared with the critically ill
patients with no AKI at any time (P < 0.01). The adjusted 10-year
mortality risk associated with AKI was 1.44 (95% CI = 1.2 to 1.7) among
28-day survivors. Patients who had mild AKI (stage 1) had significantly
worse survival at 28 days, 1 year, 3 years, 5 years and 10 years compared
with No AKI (P < 0.01) (Figure 1A). Patients with sepsis and AKI who
survived 28 days had significantly poorer 5-year and 10-year survival
compared with nonseptic AKI (P < 0.01) (Figure 1B).
Conclusions: Patients with one episode of mild (stage 1) AKI have
significantly lower survival rates over 10 years than critically ill patients
without AKI. The causes and mechanisms of this association warrant
further careful study. Close medical follow-up of these patients may be
warranted and mechanistic research required understanding how AKI
influences distant events.
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Heparin-binding protein improves prediction of severe sepsis in the
emergency department
Adam Linder1*, Ryan Arnold2, Marco Zindovic1, Igor Zindovic1,
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Background: The early identification of risk of developing severe sepsis
in patients with suspected infection remains a difficult challenge. We
hypothesized that an elevated plasma level of heparin-binding protein
(HBP), a neutrophil-secreted mediator of vascular leakage, would be a
predictor of delayed clinical deterioration and progressive organ
dysfunction in emergency department (ED) sepsis patients.
Materials and methods: A prospective, multicenter study in Sweden and
the US was conducted of 763 patients presenting to an ED with a
suspected infection and signs of systemic inflammation. Based on
recorded clinical and laboratory parameters and final diagnoses, patients
were classified into various groups depending on the severity of the
infection and inflammatory response. Plasma levels of HBP were measured
and compared with levels of other standard sepsis biomarkers including
procalcitonin, lactate, WBC, and C-reactive protein.
Results: The final diagnoses were severe sepsis with organ failure in
338 patients, nonsevere sepsis without organ failure in 340 patients, and
no infection in 85 patients. One-hundred and forty-three patients (19%)
presented without signs of severe sepsis, but developed delayed
circulatory failure and/or organ dysfunction within 72 hours of enrolment.
In this patient group, an elevated HBP level could predict the delayed
Figure 1(abstract P2) A: Bar chart showing that patients with AKI of any stage had significantly poorer mean survival rates compared to
control patients with no AKI, at 28-days, 90-days, 1-year, 3-years, 5-years and 10-years after enrolment. B: Unadjusted Kaplan-Meier curves
showing the10-year survival from ICU admission for patients classified as having any stage of AKI according to the KDIGO classification using serum
creatinine. Time is calculated from 28 days after admission (28-day survivors). Mantel-Cox Log Rank showed a significant difference in mortality between
the two curves with or without AKI.
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development of severe sepsis with an AUC value of 0.86. Elevated HBP
levels (>30 ng/ml) were found in 80% of the patients and elevated
procalcitonin levels (>0.5 ng/ml) were detected in 59%, 10.5 hours
(median) before developing severe sepsis.
Conclusions: Detection of elevated plasma-HBP levels may help to
provide an early risk-stratification of patients with suspected infections in
the ED. An elevated HBP level was independently able to predict delayed
clinical deterioration to overt shock or severe sepsis with organ failure.
Acknowledgements: This project was supported in part by Axis-Shield
Diagnostics and the Swedish Government Funds for Clinical Research
(ALF), the University Hospital, Lund, Sweden.
Clinical trial number: ClinicalTrials.gov NCT01392508 (the IMPRESSED
study).
Potential conflicts of interests: AL, BC, and PÅ are listed as inventors on
a patent filed by Hansa Medical AB.
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Critical Care 2013, 17(Suppl 4):P4; doi:10.1186/cc12905
Background: Sepsis is the principal cause of mortality in intensive
therapy units (ITUs) around the world [1]. Several international
organizations created in 2002 the Surviving Sepsis Campaign (SSC),
targeting the reduction of sepsis mortality in 25% during 5 years [2]. The
Fundação Hospitalar do Estado de Minas Gerais (FHEMIG), Brazil, was
incorporated in this campaign with eight hospitals (four general hospitals,
one trauma hospital, one oncologic center, one infectious diseases center,
one maternity hospital). The aim of this study is to evaluate the impact of
using the SSC sepsis protocol in severe sepsis and sepsis shock lethality
in the FHEMIG net hospitals.
Materials and methods: This is a retrospective cohort study based on
eight ITU public hospitals. The inclusion criteria were patients with severe
sepsis and sepsis shock according to the SSC protocol, from January 2010
to December 2012, aged older than 18 years, which had a final outcome
of hospital discharge or death. The sepsis lethality was compared
annually from 2010 to 2012. Since 2010, the implementation of educative
and managerial measures was based on the SSC guidelines: auditing of
medical charts; education in sepsis care; issue of booklet and posters
about sepsis; inclusion of sepsis information in the medical residence
program; and collaboration of hospital directors in monitoring and giving
information of the sepsis guideline. The study was approved by the
Institutional Ethical and Research Committee. Data were collected and
analyzed on EPIINFO software, using ANOVA test for comparisons with
precision of 95%.
Results: In the period of 3 years, 1,698 severe sepsis and sepsis shock
patients were registered and 1,152 (67.84%) died. We verified a reduction
of 12% (P = 0.0073) on lethality global. Hospitals 2 and 6 had a significant
reduction on lethality, of 35% (P < 0.0001) and 17% (P = 0.0073)
respectively (Table 1).
Conclusions: The sepsis lethality is still high in this institution (64.1%),
compared with the Public Hospitals in Brazil (59.6%) and the world rate
(30.8%) [3]. After the adoption of managerial measures based on the SSC
protocol, there was a significantly reduction in lethality, but only one
hospital reached the target reduction of 25% on lethality. This
heterogeneity could be explained by different engagements of the
professional board and directory and different patient’s profiles. The sepsis
mortality is a major challenge in the world [4], and application of the SSC
protocol led to a significant reduction in sepsis lethality.
Acknowledgements: The authors would like to acknowledge the
assistance of the staff and local protocol team of the participant hospitals:
Hospital João XXIII, Hospital Alberto Cavalcanti, Hospital Geral de
Barbacena, Hospital Júlia Kubitschek, Hospital Eduardo de Menezes,
Maternidade Odete Valadares, Hospital Regional João Penido and Hospital
Regional Antônio Dias.
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Passive immunotherapy of extended peritonitis as abdominal sepsis
prevention
Olexandr Butyrsky*, Viktor Starosek
Department of Surgical Diseases, Crimean State Medical University,
Simferopol, Ukraine
Critical Care 2013, 17(Suppl 4):P5; doi:10.1186/cc12906
Background: The outcome of extended peritonitis is determined by
many factors including antimicrobial defense. Microbial invasion, surgery,
and intensive therapy cause secondary immunity deficiency associated
with septic complication incidence and post-surgery lethality. The great
importance in initialization and supporting these processes belongs to
Escherichia coli endotoxin that participates in digestive tract immunity
and general immunoresistance.
Table 1(abstract P4) Severe sepsis and sepsis shock death in the eight FHEMIG hospitals, from 2010 to 2012
Hospital 2010 2011 2012 P value
Number of
patients
Death
(n)
Death
(%)
Number of
patients
Death
(n)
Death
(%)
Number of
patients
Death
(n)
Death
(%)
ANOVA
1 103 62 60.2 120 66 55 94 47 50 0.3578
2 59 52 88.1 114 87 76.3 110 63 57.3 0.0001
3 24 22 91.7 33 26 78.8 34 32 94.1 0.1292
4 68 57 83.8 71 63 88.7 68 54 79.4 0.3270
5 64 50 78.1 63 51 81 76 59 77.6 0.8821
6 94 75 79.8 92 54 58.7 115 76 66.1 0.0070
7 39 31 79.5 56 40 71.4 65 53 81.5 0.3954
8 49 15 30.6 38 10 26.3 49 7 14.3 0.1476
Total 500 364 72.8 587 397 67.6 611 391 64.1 0.0074
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Materials and methods: Thirty-two patients ages 15 to 86 (male:female =
24:8) treated for extended peritonitis were investigated. Blood was sampled
after admission and in 5 days to determine anti-lipopolysaccharide
antibodies of different classes (anti-LPS-IgA, anti-LPS-IgG, anti-LPS-IgM,
respectively) by hard-phase immunoenzyme analysis. The control group
included 10 healthy donors (opt.un.): anti-LPS-IgA - 0.348 ± 0.053, anti-LPS-
IgM - 0.162 ± 0.01, anti-LPS-IgG - 0.333 ± 0.051.
Results: Patients with high levels of anti-endotoxin immunity were 15.6%
(n = 5) (Table 1); after surgery they had rapid recovery, normalization of
peristalsis and laboratory parameters by the 5th day. Patients of low
immunity level were 84.4% (n = 27); they had a long complicated recovery
period. In group I for standard treatment within 5 days one noticed
evident shifts of all parameters that witnesses its sufficiency. In group II the
parameters are not increased evidently, which testifies to necessity of
additional immunocorrection. Low immunity level patients were
introduced to 3 ml sandoglobulin H on the 5th day after surgery that was
associated with a sharp increase of anti-LPS antibody titer (Table 2).
Growth of anti-LPS antibody titer was associated with positive dynamics of
the post-surgery period.
Conclusions: The majority of peritonitis patients have decreased
competent anti-LPS antibodies, which determines the severity of the post-
surgery period. Low immunity level patients need passive nonspecific
immunotherapy that stimulates protective functions, blocks mechanisms
of inflammation progress, and prevents abdominal sepsis.
P6
Efficacy of specific immunotherapy of abdominal sepsis
Olexandr Butyrsky1*, Iryna Butyrsky2
1Department of Surgical Diseases, Crimean State Medical University,
Simferopol, Ukraine; 2Department of Hygiene, Crimean State Medical
University, Simferopol, Ukraine
Critical Care 2013, 17(Suppl 4):P6; doi:10.1186/cc12907
Background: According to the 2004 WHO Annual Report, abdominal
sepsis (AS) is one of the most dangerous diseases of the 21st century. But
the issue of its treatment including immunotherapy is very far from being
completely solved. Our aim was the demonstration of specific
immunotherapy efficacy in AS.
Materials and methods: We investigated activity of immunogenesis
(production of specific antibodies) in AS in 50 patients under impact of
hyperimmune plasma infusion obtained from the donors who recently
endured acute inflammatory abdominal diseases. The control group was
made up of 10 healthy people.
Results: Our investigations demonstrated that the donors’ titer of specific
antibodies is evidently more according to indexes of anti-Escherichia coli,
anti-Pseudomonas aeruginosa, anti-Staphylococcus aureus, anti-bacteroids,
anti-peptococci immunity. Introducing hyperimmune plasma obtained
from such donors evidently increases specific antibody titer in AS patients
(Table 1).
Our results demonstrated that the titer of specific antibodies to AS main
agents in the dead patients was evidently lower in comparison with the
control group and in recovered people. This trend is observed 7 to
10 days after surgery. For example, at admission the titer of anti-S. aureus
antibodies in dead patients was 11% lower in comparison with the
control group, and the titer of anti-E. coli antibodies 19% lower in
comparison with control group and 32% lower in comparison with
recovered patients; 7 to 10 days after surgery in dead patients in
comparison with recovered patients, the titer of anti-S. aureus antibodies
was lower by 22%, and the titer of anti-E. coli antibodies by 47%.
Conclusions: Introducing hyperimmune plasma (specific immunotherapy)
increases titer of specific antibodies, and increased concentration of
specific antibodies improves forecast of survival in AS.
P7
Characteristics and outcomes of patients with culture negative septic
shock compared with patients with culture positive septic shock: a
retrospective cohort study
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Yazdan Mirzanejad4, Dennis Maki5, Yaseen Arabi6, Steven Lapinsky7,
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Table 1(abstract P5) Indexes of anti-endotoxin immunity in extended peritonitis
Before treatment, opt.un. 5th day of treatment, opt.un.
High immunity level patients (group I, n = 5)
Anti-LPS-IgA 0.276 ± 0.004 (p1 > 0.05) 0.452 ± 0.02 (p2 < 0.001)
Anti-LPS-IgM 0.210 ± 0.03 (p1 < 0.01) 0.286 ± 0.04 (p2 < 0.05)
Anti-LPS-IgG 0.121 ± 0.01 (p1 < 0.01) 0.184 ± 0.02 (p2 < 0.01)
Low immunity level patients (group II, n = 27)
Anti-LPS-IgA 0.084 ± 0.007 (p1 < 0.001, p3 < 0.001) 0.154 ± 0.015 (p2 < 0.01)
Anti-LPS-IgM 0.202 ± 0.02 (p1 < 0.05, p3 > 0.05) 0.213 ± 0.01 (p2 > 0.05)
Anti-LPS-IgG 0.069 ± 0.008 (p1 < 0.01, p3 < 0.001) 0.083 ± 0.007 (p2 > 0.05)
p1, evidence between donors and day of admission; p2, evidence between day of admission and the 5th day; p3, evidence between patients of different
immunity level.
Table 2(abstract P5) Dynamics of anti-LPS-antibodies in
low immunity level patients with peritonitis after
sandoglobulin H injection
Before injection, opt.un. After injection, opt.un.
Anti-LPS-IgA 0.154 ± 0.015 0.342 ± 0.02*
Anti-LPS-IgM 0.213 ± 0.01 0.284 ± 0.02*
Anti-LPS-IgG 0.083 ± 0.007 0.186 ± 0.04*
*P < 0.001.
Table 1(abstract P6) Dynamics of specific antibody titer
in AS patients after hyperimmune plasma introduction
Before introducing,
units/l
After introducing,
units/l
Anti-E. coli (n = 10) 3.27 ± 0.23 4.15 ± 0.31*
Anti-P. aeruginosa (n = 10) 3.15 ± 0.41 3.94 ± 0.21*
Anti-S. aureus (n = 10) 3.06 ± 0.31 4.02 ± 0.45*
Anti-bacteroids (n = 10) 3.56 ± 0.28 4.36 ± 0.35*
Anti-peptococci (n = 10) 3.76 ± 0.39 4.51 ± 0.32*
*Parameters change evidently (P < 0.05).
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Critical Care 2013, 17(Suppl 4):P7; doi:10.1186/cc12908
Background: Previous studies have identified that nearly 30% of patients
with severe sepsis and septic shock lack a definitive microbial etiology.
The characteristics and outcomes of culture negative septic shock are not
well defined despite large epidemiologic studies on septic shock
Materials and methods: Retrospective nested cohort study of 2,651
patients with culture-negative septic shock and 6,019 culture-positive
septic shock patients derived from a trinational, 8,760-patient database of
patients with septic shock between 1989 and 2008.
Results: In total, 30.6% of cases of septic shock cases were identified as
culture-negative within the database. Patients with culture-negative septic
shock (CNSS) experienced similar ICU mortality as did those with culture-
positive septic shock (CPSS) (41.7% vs. 40.5% P = 0.276) and identical
overall hospital mortality (51.9% vs. 51.9% P = 0.976). Severity of illness
was similar between CNSS and CPSS (median APACHE II 25 (IQR 6 to 54) vs.
25 (IQR 4 to 70) respectively). Initial and 6-hour lactate levels were also
similar among CNSS and CPSS patients (mean 4.4 vs. 4.1, P = 0.237 and
mean 4.0 vs. 4.1, P = 0.221 respectively). Interestingly CNSS patients were
significantly more likely to be hypothermic than CPSS patients (temperature
<36°C 18.9% vs. 15.3%, P < 0.0001). CNSS patients presented significantly
more often from the community (63.3% vs. 58.0%, P < 0.0001), where
patients with CPSS presented more often with nosocomial infections (36.7%
vs. 42.0%, P < 0.0001). Gastrointestinal and respiratory tract infections were
the predominant sources of infection in both groups. However, CNSS
patients with respiratory tract infections experienced lower mortality than
their CPSS counterparts (49.6% vs. 56.3%, P = 0.008) but similar mortality
rates with gastrointestinal infections (61.0% vs. 58.2%, P = 0.289) (Tables 1
and 2).
Similar to our previous findings, we identified by the second hour after
onset of persistent/recurrent hypotension that the in-hospital mortality
rate was significantly increased relative to receiving therapy within the first
hour (odds ratio, 1.62; 95% CI, 1.21 to 2.15; P < 0.001) in the CPSS group.
Following increasing delays in the administration of appropriate
antimicrobial therapy over the first 6 hours after the onset of hypotension,
patients in both groups experienced nearly congruent, significant increases
in hospital mortality; at 6 hours the CNSS group (odds ratio, 2.87; 95% CI,
Table 1(abstract P7) Comparison of variables of
culture-positive and culture-negative septic shock
Variable
Sex 0.3725
Female 2,565 (42.6) 1,157 (43.6)
Male 3,454 (57.4) 1,494 (56.4)
Age <0.0001
Mean 62.0 (16.1) 63.9 (16.3)
Median 64.0 67.0
Range 16 to 102 16 to 101
Admit source 0.0567
Surgery 86 (3.2) 53 (4.3)
ER 2,245 (84.1) 990 (80.5)
Medical 334 (12.5) 180 (14.7)
TxER 3 (0.1) 3 (0.2)
TxICU 2 (0.1) 2 (0.2)
TxWard 0 (0) 1 (0.1)
Survival
15 3,785 (62.9) 1,598 (60.3) 0.0213
30 3,275 (54.4) 1,399 (52.8) 0.1585
90 2,906 (48.3) 1,283 (48.4) 0.9204
ICU 3,583 (59.5) 1,545 (58.3) 0.2760
Overall 2,895 (48.1) 1,276 (48.1) 0.9760
ICU LOS <0.0001
Missing (%) 0 0
Mean 11.0 (13.4) 9.8 (13.7)
Median 7.0 6.0
Range 1.0 to 215.0 1.0 to 314.0
Table 1(abstract P7): Comparison of variables of culture--
positive and culture-negative septic shock (Continued)
Hospital LOS <0.0001
Missing (%) 0 0
Mean 26.3 (34.1) 23.1 (31.1)
Median 15.0 12.2
Range 0.5 to 370.0 0.3 to 314.0
APACHE 0.4450
Missing (%) 375 (6.2) 179 (6.8)
Mean 25.7 (8.1) 25.7 (8.3)
Median 25.0 25.0
Range 4 to 70 6 to 54
Days to extubation 0.2414
Mean 6.5 (9.5) 6.2 (9.2)
Median 4.0 3.0
Range 0.0 to 117.0 0.0 to 100.0
Days on pressors 0.1927
Missing (%) 1,878 892
Mean 3.6 (3.7) 3.3 (3.2)
Median 3.0 2.0
Range 0.0 to 54.0 0.0 to 34.0
Temperature <0.0001
Mean 37.6 (1.7) 37.4 (1.7)
Median 38.0 36.2
Range 27.3 to 42.7 30.4 to 42.7
<36°C 869 (15.3) 473 (18.9) <0.0001
>38°C 2,707 (47.7) 1,075 (42.9) <0.0001
>38.3°C 2,264 (39.9) 878 (35.0) <0.0001
Infection source <0.0001
Community 3,491 (58.0) 1,677 (63.3)
Nosocomial 2,528 (42.0) 974 (36.7)
Lactate - baseline 0.2377
Missing (%) 5,328 (88.5) 2,328 (87.8)
Mean 4.3 (3.8) 4.4 (4.5)
Median 3.1 2.8
Range 0.3 to 26.4 0.3 to 26.7
Lactate - 6 hours 0.2214
Missing (%) 5,132 (85.3) 2,204 (83.1)
Mean 4.1 (3.7) 4.0 (3.8)
Median 2.8 2.6
Range 0.1 to 25.8 0.4 to 23.1
Lactate - 24 hours 0.4919
Missing (%) 5,164 (85.8) 2,236 (84.3)
Mean 3.7 (4.1) 4.1 (5.0)
Median 2.4 2.3
Range 0.3 to 54.4 0.2 to 37.6
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1.72 to 4.78; P < 0.0001) and the CPSS group (odds ratio, 3.44; 95% CI, 2.17
to 5.48; P < 0.0001) (Figure 1). Survival differences between these time
intervals are not significantly different in patients with CNSS and CPSS.
Conclusions: Patients with CNSS behave similarly to CPSS patients in
nearly all respects. As with bacterial septic shock, early appropriate
antimicrobial therapy appears to improve mortality. Earlier recognition of
infection is the most obvious effective strategy to improve hospital
survival. Optimal duration of therapy is not well defined among patients
with CNSS. In addition to early, appropriate antimicrobial therapy, use of
de-escalation strategies such as serial procalcitonin levels may be useful
to determine the length of empiric broad-spectrum antimicrobial use in
this population.
P8
SRT2379, a small-molecule SIRT1 activator, fails to reduce cytokine
release in a human endotoxemia model
Maryse A Wiewel1*, Anne Jan van der Meer1, Jonathan Haddad2,
Eric W Jacobson2, George P Vlasuk2, Tom van der Poll1
1Center for Experimental and Molecular Medicine, Academic Medical Center,
University of Amsterdam, the Netherlands; 2Sirtris, A GSK Company,
Cambridge, MA, USA
Critical Care 2013, 17(Suppl 4):P8; doi:10.1186/cc12909
Background: SRT2379 is a selective small-molecule activator of the
NAD+-dependent deacetylase, Sirtuin 1 (SIRT1), which has broad anti-
inflammatory effects in cell cultures and rodents. The aim of the current
Table 2(abstract P7) Comparison of major sites of
infection
Culture-
positive
Culture-
negative
P
value
Respiratory infection
n (%) 2,172 (63.9) 1,228 (36.1)
ICU LOS (median, IQR) 8.0 (4, 16) 6.7 (3, 12.8) <.0001
Hospital LOS (median,
IQR)
16.0 (6, 32) 13.0 (5, 26) 0.0024
15-day survival (n, %) 1,344 (61.9) 782 (63.7) 0.4761
Hospital survival (n, %) 949 (43.7) 619 (50.4) 0.0086
APACHE (mean, SD) 26.4 (8.0) 25.4 (8.0) <.0001
Gastrointestinal
infection
n (%) 1,476 (58.9) 1,030 (41.1)
ICU LOS (median, IQR) 6.5 (3, 13) 5.0 (3, 11) 0.0153
Hospital LOS (median,
IQR)
15 (5.7, 33) 11.1 (3, 29) 0.0059
15-day survival (n, %) 877 (59.4) 542 (52.6) 0.0002
Hospital survival (n, %) 617 (41.8) 402 (39.0) 0.2892
APACHE (mean, SD) 25.5 (8.2) 26.1 (8.5) 0.1180
Figure 1(abstract P7) Odds ratio of death by antibiotic delay in culture-positive and culture-negative septic shock.
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study (EUDRACT # 2011-002266-20) was to determine the effect of
SRT2379 on the inflammatory responses in normal healthy male subjects
after exposure to LPS.
Materials and methods: This single-blind, placebo-controlled study
consisted of four treatment arms (n = 8 per arm): (1) oral SRT2379 50 mg;
(2) oral SRT2379 250 mg; (3) oral SRT2379 1000 mg; and (4) placebo. All
subjects received a single dose of study drug on day 1 followed by
intravenous LPS 4 hours later. Laboratory parameters of inflammation
along with assessment of clinical signs, safety assessments, and
pharmacokinetic measurements were recorded at baseline and after LPS
administration.
Results: SRT2379 was well tolerated. Adverse events were similar across all
treatment groups and were predominantly as expected with LPS
administration. Pharmacokinetic exposures increased in a dose-dependent
manner. SRT2379 did not significantly impact cytokine release as
compared with placebo: TNFa (183.52, 177.57, 123.84 vs. 195.30 pg/ml for
groups 1, 2, 3 vs. group 4, respectively, P > 0.05), IL-6 (195.25, 237.51,
180.26 vs. 250.08 pg/ml, respectively, P > 0.05), IL-17 (3.88, 2.59, 6.42 vs. 8.09
pg/ml, respectively, P > 0.05), IL-8 (126.11, 105.25, 110.56 vs. 108.77 pg/ml,
respectively, P > 0.05), and IL-10 (12.61, 13.03, 40.40 vs. 11.90 pg/ml,
respectively, P > 0.05). SRT2379 also had no impact on vital signs, leukocyte
counts, or coagulation activation markers compared with placebo.
Conclusions: Although SRT2379 suppresses inflammatory markers in
preclinical experiments, we were unable to demonstrate a similar impact in
this human model of endotoxemia. This may be due to potency or exposure
issues, with the compound. SRT2379 terminated for further clinical
development. More promising candidates are being identified for future
clinical exploration.
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Background: One of the perspective directions for the improvement of
surgical patients’ treatment results is a multimodal approach in
perioperative management including wide administration of regional
anesthesia, early enteral feeding and modification of infusion therapy. The
goal of this study is the assessment of the multimodal approach effect on
antiendotoxin immunity and systemic inflammation after major abdominal
surgery.
Materials and methods: Open nonrandomized research. In the control
group (n = 52), perioperative management was carried out with
perioperative starvation, total intravenous anesthesia and analgesia on the
basis of opiates. In the multimodal approach group (n = 40) we used a
thoracic epidural analgesia in combination with early enteral feeding and
preoperative infusion of HES 130/0.42 of 15 ml/kg body weight. In vein
blood tests we analyzed C-reactive protein (CRP) and antibodies to
lipopolysaccharide of Escherichia coli by IgM (anti-LPS-IgM) class. Data are
submitted in the form of the median and 95% CI. The Mann-Whitney U
criterion is used for comparisons between groups.
Results: The median maintenance of CRP was 135.7 mkg/ml (95% CI =
153.5 to 249.5) in the control group for 3 days after operation but in the
multimodal approach group was significantly lower - 89.0 mkg/ml (95%
CI = 56.9 to 212.4; P < 0.05). The median anti-LPS-IgM level was 0.087 MU
(95% CI, 0.084 to 0.226) in the control group in the same time but in the
multimodal approach group was significantly higher - 0.181 MU (95% CI,
0.153 to 0.241; P < 0.001). The obtained data can mean that the expressed
system inflammatory reaction has negative impact on the postoperative
period. Reduced antiendotoxin immunity increases terms of hospitalization
as an independent factor. This also increases the number of complications
and lethality in surgery.
Conclusions: The multimodal approach that includes thoracic epidural
analgesia, early enteral feeding and preoperative infusion of HES 130/0.42
after volume abdominal operations prevents exhaustion of antiendotoxin
immunity and system inflammatory reaction.
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Background: Septicemia is a systemic disease caused by the spread of
microorganisms and their toxins in the blood. These bloodstream
infections are a major cause of morbidity and mortality in children in
developing country [1-4]. It has been confirmed by culture that is
associated with clinical manifestation and systemic response [5-7]. It is
crucial to continuously monitor any change in the local patterns of
infection and susceptibility to various antibiotics. The aim of this study was
to determine the bacteriological profile and antimicrobial sensitivity
patterns among children suspected of having septicemia.
Materials and methods: A cross-sectional study involved about 201
pediatric patients (≤12 years) was conducted from October 2011 to February
2012 at Tikur Anbessa Specialized Hospital and Yekatit 12 Hospital’s
pediatric units after the proposal of this study was approved by National
Ethics Review Committee. Standard procedure was followed for blood
sample collection. Samples were incubated in the BACTEC 9050 System,
followed by isolate identifications based on standard microbiological
procedures and testing for their susceptibility to antimicrobial agents using
the disc diffusion method. Data were analyzed using the SPSS version
19 software package.
Results: Out of 201 study subjects, 110 (54.7%) were male. The majority
(147, 73.1%) of them were neonates (≤28 days). The mean length of
hospitalization was 11.24 days. Out of the 201 tested blood samples,
blood cultures were positive in 56 (27.9%) cases (Figure 1). Gram-negative
and Gram-positive bacteria constituted 51.8% and 46.4%, respectively.
The most frequent pathogen found was Staphylococcus aureus (23.2%),
followed by Serratia marcescens (21.4%), CoNS (19.6%), Klebsiella spp.
(16%), Salmonella spp. (5.4%) and Enterobacter cloacae (3.6%) (Figure 2).
The majority of bacterial isolates showed high resistance to ampicillin,
penicillin, co-trimoxazole, gentamicin and tetracycline. Ciprofloxacin and
nalidixic acid were the most effective antimicrobial agents for Gram-
negative bacteria, while vancomycin and clindamycin for Gram-positive
bacteria (Table 1). Deaths occurred in 25 (12.4%) children, out of which
13 (23.2%) had bacteremia.
Conclusions: The present study revealed that both Gram-positive and
Gram-negative bacteria were responsible for bloodstream infections
and the majority of the isolates were multidrug resistant. S. aureus and
S. marcescens were the most common isolated bacteria from blood
cultures. The alarmingly higher percentages of multidrug-resistant isolates
urge us to take infection prevention measures and to conduct other large
studies for appropriate empiric antibiotic choice.
Acknowledgements: The authors would like to acknowledge the
technical support provided by the members of the Departments of
Microbiology and Pediatrics of Tikur Anbessa Specialized and Yekatit 12
Hospitals. They also thank Mr Yoseph Kenea for his excellence statistic
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Figure 1(abstract P11) Distribution of 56 blood culture isolates by age interval and gender.
Figure 2(abstract P11) Distribution of blood culture isolates in children with suspected of having sepsis.
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Background: After recent studies of the BMBF (SepNet), sepsis causes about
150 deaths per day in Germany, making it the third leading cause of death in
Germany. In acute sepsis, rapid diagnosis and rapid medication is crucial. Both
as a reliable parameter for diagnosis of sepsis and for guiding the antibiotic
therapy, procalcitonin (PCT) is a very sensitive available biomarker [1] and is
recommended in the current guidelines [2] to be quantified under sepsis
suspicion. Although there are a couple of commercially available fast analytical
devices for the quantification of PCT, none of these devices completely fulfill all
requirements for a point-of-care testing (POCT) device which are: bedside
testing; no sample preparation (whole blood testing); simple handling with
ready-to-use and single-use cartridges; and short turnaround time between
analysis and medical treatment in the clinical necessary concentration range.
Whereas most devices fulfill the latter requirements they are still too big for
bedside testing or cannot handle whole blood.
Materials and methods: Based on newly developed monoclonal antibodies
(mAbs) [3], a fast and sensitive immunoassay for the quantification of PCT in
whole blood was developed and transferred to a commercially developed
(not available on market) POCT device (respons®IQ) from pes diagno-
sesysteme GmbH.
Results: With the new developed mAbs the achieved limit of detection for
PCT in plasma and whole blood is 0.04 ng/ml and 0.05 ng/ml respectively,
which is within the clinical necessary range (<0.05 ng/ml). The now
established assay shows high reproducibility within 9 minutes, independent
of different plasma samples due to the selection of suitable additive
compounds. In a first set of leftover patient samples, the PCT-POCT assay
showed good correlation (R2 = 0.988, n = 14, m = 2) with the state-of-the-art
technology Kryptor (BRAHMs) (D Rascher, M Rieger, HMGU, AMP,
unpublished data). Moreover, in cooperation with Dr A Geerlof (HMGU),
human recombinant PCT (hrPCT) was produced in two biological and clinical
relevant forms (amino acids 1 to 116 and 3 to 116) in high amounts and
high purity (A Geerlof, D Rascher, M Rieger, unpublished data). This hrPCT
will replace expensive (5 k$/mg) and batch-to-batch varying commercial
available hrPCTs as standard reference material.
Conclusions: The assay shown here for the quantification of PCT fulfils all
requirements for POCT. Within 9 minutes, PCT can be quantified near the
patient’s bed in whole blood without sample preparation.
Acknowledgements: The authors thank Dr A Geerlof (HMGU) for
producing recombinant PCT, Dr E Kremmer (HMGu) for producing the
mAbs and Dr P Miethe from the Forschungszentrum für Medizintechnik
und Biotechnologie (fzmb GmbH) for the delivery of the patient plasma
samples.
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Background: Pentoxifylline, a xanthine derivative, has raised new interest
in neonatal research due to its immunomodulatory functions and its
potential role in reducing mortality from sepsis. Two small studies on a
per-protocol analysis have shown promising results. This larger trial on an
intention-to-treat basis will determine whether the use of pentoxifylline
as an adjunctive therapy for sepsis in preterm neonates (≤36 weeks)
weighing <1,500 g will truly result in a reduction in the all-cause
mortality.
Materials and methods: Preterm infants ≤1,500 g with suspected
infection admitted to the NICU of a large tertiary, training, government
hospital were eligible for inclusion in the study. After informed consent,
Table 1(abstract P11) Antimicrobial resistance pattern of bacteria isolated from blood culture
Antimicrobial
drugs
Resistance proportion of bacterial isolates (R%)
S. aureus
(n = 13)
S. marcescens
(n = 12)
CoNS
(n = 11)
Klebsiella spp.
(n = 9)
Salmonella spp.
(n = 3)
E. cloacae
(n = 2)
Other GNBa
(n = 3)
Other GPBb
(n = 2)
Penicillin 92.3 ND 81.8 ND ND ND ND 100
Ampicillin 84.6 100 100 100 100 100 100 100
Clindamycin 0 ND 0 ND ND ND ND 0
Erythromycin 30.8 ND 54.5 ND ND ND ND 0
Chloramph. 7.7 25 36.4 44.4 100 0 100 50
Ciprofloxacin 30.8 0 18.2 44.4 0 0 0 0
Vancomycin 15.4 ND 18.2 ND ND ND ND 0
Cefoxitin 38.5 33.3 54.5 0 0 0 66.7 50
Gentamycin 30.8 91.7 36.4 100 100 0 100 50
Tetracycline 53.8 91.7 45.5 55.5 100 100 66.7 100
SXT 61.5 91.7 81.8 77.8 100 100 66.7 0
Ceftriaxone 46.2 16.7 27.3 100 100 100 100 50
Nalidixic acid ND 0 ND 44.4 0 0 0 ND
ND, not done; SXT, sulphamethaxozol/trimethoprim. aGram-negative bacteria (Acinetobacter baumanii, Escherichia coli, and Pseudomonas leutole). bGram-positive
bacteria (Enterococcus spp. and Streptococcus. spp.).
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they were randomized to receive either pentoxifylline at a dose of
6 mg/kg/hour or placebo. Patients with major congenital malformations,
congenital infections and severe hemorrhage were excluded from the
study. Pentoxifylline was administered as a 6 ml infusion for 6 hours for
6 days. The control group received normal saline in the same manner as
the pentoxifylline infusion. Patients, parents and physicians (outcome
assessors) were blinded to the treatment assignments. The primary
outcome was analyzed on an intention to treat basis. The primary
outcome measured in the study is the occurrence of all-cause mortality
between the two groups. Secondary outcomes measured include
mortality from sepsis, adverse drug reactions and length of hospital stay.
Results: A total of 312 neonates are included in this interim analysis: 156
in the pentoxifylline group and 156 in the control group. Baseline
characteristics were comparable between the two groups. In this analysis,
there is no difference in the occurrence of death among patients in the
pentoxifylline group versus the placebo group (RR: 1.08 (0.83, 1.41)).
There is no statistical difference in the risk of death from septic shock
(RR: 1.03 (0.67, 1.59), P = 1.0). There was also no significant difference in
the length of hospital stay in the two groups (36 days in treatment group vs.
35 days in control group, P = 0.910). No significant adverse drug reactions
were noted with pentoxifylline use.
Conclusions: Pentoxifylline as an adjunct therapy for sepsis did not show
a decrease in the all-cause mortality. There is also no difference in the
occurrence of death from sepsis and length of hospital stay. No adverse
drug reactions were noted with pentoxifylline.
Acknowledgements: The authors thank the neonatology fellows of the
Philippine General Hospital and Ms Carmi Pitajen, RN, research assistant.
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Background: Sepsis is a serious clinical condition with a considerable
morbidity and mortality. Procalcitonin (PCT) is a good biomarker for early
diagnosis and infection monitoring. A semi-quantitative PCT assay can be
performed at the bedside and has good diagnostic value [1,2]. The
present study aimed to investigate the effect of a semi-quantitative PCT
test on the empirical antibiotic initiation time, the appropriateness of
empirical antibiotics and mortality in septic patients.
Materials and methods: The study design was a randomized diagnostic
trial, which was also a pragmatic trial. Septic patients more than 18 years
old with and without signs of organ hypoperfusion or dysfunction who
were admitted to Cipto Mangunkusomo Hospital emergency department in
the internal medicine unit were eligible. Subjects were randomly assigned
to either a semi-quantitative PCT-examined group (study group) or a
control group. Semi-quantitative PCT test results will be informed to the
physicians taking care of the patients. The primary outcome was 14-day
mortality. Secondary outcomes were the time of initiation and appropria-
teness of empirical antibiotics. A Tropical Infection Consultant will assess the
appropriateness of empirical antibiotics based on Pedoman Umum
Penggunaan Antibiotik Departemen Kesehatan Republik Indonesia.
Results: Two hundred and five patients met the inclusion criteria. Ninety-
five of 100 subjects from the study group and 102 of 105 subjects from
the control group were included in the analysis (Figure 1). Both groups
have equal baseline characteristics (Table 1). The mortality risk was lower
in the study group (RR 0.53; 95% CI 0.36 to 0.77). The study group had
greater probability to have a first dose of empirical antibiotic in less than
6 hours compared with the control group (RR 2.48; 95% CI 1.88 to 3.26).
No effect was seen in appropriateness of empirical antibiotics between
groups (RR 0.99; 95% CI 0.92 to 1.08) (Table 2).
Conclusions: Semi-quantitative PCT examination affects the empirical
antibiotic initiation time and mortality in septic patients, but not the
appropriateness of empirical antibiotics.
Figure 1(abstract P15) Enrollment of patients and completion of the study.
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Background: Sepsis is a complex disease with an initial proinflammatory
profile triggered by an infection process, which is typically followed by a
compensatory anti-inflammatory response, leading to immunosuppression.
There are few cases in literature relating sepsis with opportunistic infections,
such as strongyloidiasis, which may lead to severe clinical consequences
due to hyperinfection. Human strongyloidiasis is a neglected tropical disease
of major worldwide distribution, affecting millions of people. Despite of the
fact that infection with Strongyloides stercoralis is usually self-limited and
with low morbidity in immunocompetent individuals, it may become lethal
in cases of immunosuppression, such as AIDS, corticosteroid treatment and
transplantation. Our aim in this work was to investigate the presence of
S. stercoralis antigens and anti-parasitic IgG in sepsis patients in a highly
endemic area of strongyloidiasis.
Materials and methods: Serum samples from 27 individuals with
strongyloidiasis and 27 healthy subjects were used as positive and
negative controls, respectively, according to their parasitological
analyses. Additionally, 27 sepsis patients were also investigated. We
have used ELISA tests to detect S. stercoralis antigens and IgG anti-
S. stercoralis in all three groups. The cutoff value was determined by the
ROC curves obtained by Prism 5.0 software.
Results: IgG anti-S. stercoralis was detected in six patients; five under
septic shock and one with sepsis. Among them, four were positive for the
parasite antigen-antibody immune complex; three under septic shock and
one with sepsis, demonstrating that 15% of sepsis patients were infected
by the parasite, which may have significantly contributed with the
hyperinfection presented by septic-shock patients (10%).
Conclusions: There are only two reports of an association between
S. stercoralis infection and immunosuppression, which led to lethal sepsis
cases. However, our preliminary analysis through antigen-antibody
Table 1(abstract P15) Baseline characteristics of the patients
Characteristic Semi-quantitative PCT-examined group, n (%) Control group, n (%)
Age
>60 years 28 (29.5) 23 (22.5)
≤60 years 67 (70.5) 79 (77.5)
Mean age (years) 51.4 ± 15.7 48.6 ± 46.0
Sex
Male 42 (44.2) 40 (39.2)
Female 53 (55.8) 62 (60.8)
Sepsis severity
Sepsis 57 (60.0) 54 (52.9)
Severe sepsis and septic shock 38 (40.0) 48 (47.1)
Comorbidity
Without comorbidities 20 (21.1) 20 (19.6)
With comorbidities 75 (78.9) 82 (80.4)
Source of infection
One source 82 (86.3) 86 (84.3)
≥2 sources 13 (13.7) 16 (15.7)
14-day mortality 26 (27.4) 53 (52.0)
Table 2(abstract P15) Effect of semi-quantitative procalcitonin assay on adequacy of empirical antibiotics and
mortality in septic patients
Outcomes Semi-quantitative PCT assay, n (%) RR (95% CI) P value
Examined Not examined
Empirical antibiotic initiation time
≤6 hours 83 (87.4) 36 (35.3) 2.48 (1.88 to 3.26) <0.001
>6 hours 12 (12.6) 66 (64.7)
Appropriateness of empirical antibiotics
Appropriate 88 (92.6) 95 (93.1) 0.99 (0.92 to 1.08) 0.890
Inappropriate 7 (7.4) 7 (6.9)
14-day mortality
Yes 26 (27.4) 53 (52.0) 0.53 (0.36 to 0.77) <0.001
No 69 (72.6) 49 (48.0)
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immune complex demonstrated that this parasitic infection might be
more common in sepsis than expected. The correct diagnosis of the
causal infection in sepsis may support the correct therapeutic choice,
which is fundamental to avoid the continuous spread of specific
pathogen/parasite triggers that will eventually lead to hyperinfection, and
consequently to severe sepsis.
Acknowledgements: The authors would like to thank the patients and
their families for the direct collaboration in this work, the medical staff
from the ICU of the university hospital for providing the biological
samples and the clinical parameters, and financial support by CNPq,
CAPES, and FAPEMIG.
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Background: More than 50% of all septic patients admitted to intensive
care departments derive from intermediate care units (INCU). Biomarkers
represent the most promising tool for early diagnosis of sepsis; but their
accuracy in INCU has been largely disregarded [1]. Moreover, given the
complexity of the septic pathophysiology, a panel of biomarkers could
be more effective than a single one. For this reason we tested acute
phase protein, cell surface, vasotonous related, coagulation system, and
tissue hypoxia markers in early ruling in/out of sepsis in patients suffering
from systemic inflammatory response syndrome (SIRS) [2-5].
Materials and methods: This prospective observational study included
all SIRS [5] patients newly admitted to a medical ward from February to
May 2012. Cases were diagnosed as sepsis or non-infective SIRS by
clinical examination, cultures of the biological fluid, and imaging during a
7-day follow-up. Investigators were blinded to biomarker results. Survivors
at 7 and 30 days were also assessed. Samples for procalcitonin (PCT),
presepsin (sCD14-ST), pro-adrenomedullin (PRO-ADM), fibrin degradation
products (FDP) and lactate were collected within 4 hours of admission.
Their role in predicting diagnosis and survival, alone or in combination,
have been investigated by receiver operating characteristic (ROC) curve,
Youden index, relative risk and binary logistic regression.
Results: Among the 60 sepsis patients (microbiological and clinical
sepsis), the most common sites of infection were the lung (67%), urinary
tract (17%), abdomen (5%), and skin (8%). The sepsis group had
significantly higher levels of PCT, sCD14-ST and FDP than the non-
infective SIRS group. The area under the ROC was 0.80, 0.78, and 0.67 for
FDP, PCT, and sCD14-ST respectively. Main results are reported in Table 1:
the combination of FDP and PCT detected correctly 10 more cases,
leaving misdiagnosed only nine out of 80 patients. ROC curves are
reported in Figure 1. sCD14-ST (cutoff 1.317 ng/ml, OR 12.2 (95% CI 2.6 to
55.5) P = 0.0002) and lactate (cutoff 20 mg/dl OR 11.9 (95% CI 2.23 to
62.5) P = 0.001) were comparable in predicting 7-day survival. Mortality
at 30 days was significantly higher in patients with PRO-ADM level
≥4.09 nmol/l (OR 26 (95% CI 4.8 to 143) P = 0.000002). The Kaplan-Meier
curves for PRO-ADM are reported in Figure 2.
Conclusions: In intermediate care setting patients, the combination of FDP
and PCT could be useful for an early discrimination of sepsis from non-
infective SIRS. PRO-ADM, sCD14-ST, and lactate should be considered as
early indicators of more intensive ward care and precocious ICU admission.
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Background: Sepsis still represents the leading cause of mortality among
children and its etiology changes according to age, immune status and
geographic location [1-4]. Prevention of this disease has key role in
reducing morbidity and mortality and includes development and
application of vaccines [5-7]. In 2010, pneumococcal and meningococcal
C vaccines were introduced in the basic immunization schedule in Brazil.
The application of these may already be influencing the etiologic profile
of sepsis in childhood [7]. The evaluation of this profile, as well as the
clinical manifestations and course of sepsis in the post vaccine, becomes
essential for better clinical decision and effective therapeutic approach in
hospitalized patients. The objective was to determine clinical
manifestations, etiology and outcome of sepsis in patients admitted to a
pediatric ICU.
Materials and methods: A retrospective cohort study, by collecting data
from medical records of patients diagnosed with sepsis admitted to the
pediatric ICU of Hospital Municipal Dr. Mario Gatti, Campinas, SP, from
January 2011 to December 2012. The variables studied were: age, sex,
vaccination schedule, etiologic agent identified in cultures and clinical
outcome.
Results: Eighty-seven patients were included in the study (56 male,
31 female) with a mean hospital stay of 8.16 days, vasoactive drug use of
2.82 days and 5.33 days of mechanical ventilation. In total, 57/87 cultures
were negative. Among the positive, the majority (21/30) was collected
less than 48 hours after admission and the most frequent etiologies were:
Gram-negative bacteria (10), Staphylococcus aureus (7) and Neisseria
meningitidis (4). Two cultures were positive for Streptococus pyogenes and
only one for Streptococcus pneumoniae. Twenty-four (16.1%) patients died.
Table 1(abstract P17)
Biomarker Cutoff Sensitivity Specificity PPV NPV PLR NLR Accuracy
PRO-ADM 0.2 nmol/l 83 37 80 41 1.3 0.5 72
PCT 0.1 ng/ml 80 74 90 54 3.0 0.2 78
sCD14-ST 0.407 ng/ml 90 50 84 62 1.8 0.2 80
FDP 180 ng/ml 80 70 89 53 2.6 0.2 77
FDP + PCT 180 + 0.1 ng/ml 95 68 90 81 3 0.075 88
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Mortality was higher in patients with incomplete immunization (P =
0.047). Among the cases with meningococcal etiology, 3/4 were not
vaccinated.
Conclusions: The clinical group of patients diagnosed with sepsis
showed short time of hospitalization, use of vasoactive drugs and
mechanical ventilation. Mortality was high and higher in the group of
patients with incomplete immunization. Among the causative agents, it
was predominantly Gram-negative bacteria and S. aureus, no vaccine-
preventable etiologies.
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Figure 1(abstract P17) ROC curves of PCT, FDP, sCD-14ST, and the
combination of FDP + PCT. Solid thick line, PCT; dashed line, FDP;
dotted line, PCT+FDP; dot-dash line, sCD-14ST; thin solid line, reference
line.
Figure 2(abstract P17) Thirty-day survival curve (Kaplan-Meier) according to PRO-ADM levels.
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Introduction: The project ‘HUPE against sepsis’ seeks to emphasize the
importance of early recognition of sepsis, in order to accelerate the
implementation of measures associated with decreased mortality for
severe sepsis. It is therefore important that the professionals involved in
healthcare are attentive to quick detection of signs and symptoms
associated with the condition. The objective was to identify the
difficulties for the implementation of the protocol advocated by the
Surviving Sepsis Campaign and adopted by the project ‘HUPE against
sepsis’.
Materials and methods: The study was conducted in clinical medical
and surgical wards, DIP, general duty, cardiac and ICUs of the Pedro
Ernesto University Hospital (HUPE), totaling 11 inpatient units. In January
2013, a questionnaire was applied to doctors, nurses and nurse
technicians, including effective, contractors and residents. This instrument
contained closed questions, professional profile and was related to the
topic in question.
Results: Fifty-one professionals participated in the study: 22 (43%)
medical staff and 29 (57%) nurses. Of these, 12 were medical residents,
and eight were nursing residents, all in the first year (approximately 78%
of workers investigated). Most physicians (55%), 38% of nurses and
40% of nurses claimed to have greatest difficulty administering the first
dose of antibiotics within up to 1 hour after the diagnosis. About 45% of
doctors and 31% of nurses also reported difficulty in the distribution of
materials to acquire the sepsis kit (which contains materials for deep
venous puncture, invasive hemodynamic monitoring and collecting blood
cultures). Physicians (41%) and nurses (40%) still reported as a problem
going to the pharmacy to get the first dose of the antibiotic. Other
limiting factors were also appointed: obtaining the vesical catheterization
of delay (for hourly diuresis control); rapid identification of severe sepsis;
printed data record of the protocol; samples of blood culture for aerobic;
and peripheral venous access puncture.
Conclusion: The difficulties pointed out by the professionals investigated
are common and include factors that prevent the correct and early
implementation of the protocol, be they of institutional and/or
professional responsibility. Seeking solutions to the problems raised allows
a targeting of future actions to be developed, among them the constant
updating and training of professionals involved in assistance for the
inpatients investigated. This allows, also, the search for better institutional
infrastructure appropriate to meeting the demands of the patient with
severe sepsis.
P20
Early prediction of SIRS and sepsis development via chemiluminescent
analysis
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Background: Neutrophils as a part of nonspecific immunity factors play a
crucial role in antimicrobial resistance. Reactive oxygen species (ROS) are
an important compound of the neutrophils’ microbicidal action. Analysis
of neutrophils’ ROS production could provide valuable data on a
phagocyte link of immunity [1]. A chemiluminescent (CL) assay being
highly sensitive allows evaluating oxidative output of the cells in
dynamics. Many studies on neutrophil CL in humans with different
diseases have been published [2,3]. However, the results often vary
between authors because of the lack of standardized method of CL
analysis. So we have developed a methodology of neutrophils’ CL
analysis according to the principles of evidence-based medicine.
Materials and methods: One hundred and twenty healthy donors and
17 ICU patients with second-third-degree burns participated in this study.
We held an assay on the 1st, 8th and 15th day after injury and later; 37
observations in total. To dilute blood samples we used Hank’s balanced
salt saline (HBSS) with glucose, pH 7.4. Luminol (Sigma-Aldrich) was
dissolved in double-distilled water at 1 mM. N-formyl-methionyl-leucyl-
phenylalanine (FMLP; Sigma-Aldrich) and 4-phorbol-12-myristate-13-acetate
(PMA; Sigma-Aldrich) were diluted in dimethyl sulfoxide (MP Biomedicals,
LLC) to make stock solutions that were dissolved in HBSS on the day of
experiment. CL was evaluated by means of a chemiluminometer Lum-12
(Department of Biophysics, Moscow State University) [4].
Results: We substantiate an optimal experiment design in the context of
obtaining the highest intensity of analytic signal and reproducible
findings. Thus we have developed a method for evaluation of a
neutrophil function, based on a step-by-step stimulation of the cells by
PMA and FMLP. Using our approach, we investigated the distributions of
CL characteristics for the population of 80 healthy donors. We obtained
reproducible kinetic profiles with intensive flash and absent glow phase
of emission in all of the samples. Profiles of ICU patients’ samples showed
high intensity of both flash and glow phase of emission (Figure 1).
Insufficient glow phase indicated subsequent development of severe
septic complications.
Figure 1(abstract P20) Kinetics of CL response in ICU patient and donor.
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Conclusions: As a result we suggest a reliable and replicable method for
the evaluation of a neutrophil function. Investigation of the glow phase
of the emission is promising to forecast risks of septic complications; we
constructed a range of values of adjusted CL glow amplitude at different
neutrophil counts that indicates a low probability of SIRS and septic
complications that could be useful for correction of intensive treatment
tactics.
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Background: Bacteremia is a common clinical condition with an incidence
of approximately 140 to 160 per 100,000 person-years. Since sepsis is a
time-critical diagnosis, identification of emergency department (ED)
patients at risk of bacteremia is therefore a priority. The study objective
was to validate a previously published clinical decision rule for predicting a
positive blood culture in ED patients with suspected infection based on
minor criteria, major criteria and a total score [1].
Materials and methods: This was a retrospective matched cohort study,
set in a large urban academic tertiary ED at Aarhus University Hospital,
Aarhus, Denmark with approximately 56,000 patient visits annually. Adult
ED patients with blood cultures obtained from 1 January through
31 December 2011. ED patients with blood culture-confirmed bacteremia
were matched 1:3 to patients with negative cultures. The outcome was
true bacteremia. Features of the clinical history, co-morbid illnesses,
physical observations and laboratory tests were used to evaluate the
performance of the clinical decision rule including calculation of the total
score (Table 1). We report operating characteristics and the summary
c-statistic for the decision rule.
Results: Among 1,526 patients, 105 (6.9%) patients were classified with
true bacteremia. The sensitivity of the prediction rule was 94% (95%
confidence interval (CI) 88 to 98%) and specificity 48% (95% CI 42 to
53%). Positive and negative predictive values were 37% (95% CI 32 to
44%) and 96% (95% CI 92 to 99%), respectively. The area under the
receiver-operating characteristics curve was 0.83 ± 0.02 standard error
(Figure 1).
Conclusions: The clinical decision rule performed well in our ED setting
and is likely to be a useful supplement to clinical judgment.
Acknowledgements: The CONSIDER Sepsis Network is a collaboration of
clinical researchers with an interest in sepsis at Aarhus University
Hospital, Aarhus, Denmark.
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Background: Conscious assessment for organ dysfunction in infected
patients is not uniformly performed since the prognostic performance of
organ dysfunction has not been validated. We hypothesize that the
number of organ dysfunctions is a prognostic marker in emergency
department (ED) patients with suspected infection and that an increasing
number of organ dysfunctions correlates with in-hospital mortality.
Materials and methods: A prospective observational study of adult
(18+ years) ED patients with suspected infection presenting to one of
two urban, academic medical center EDs. The inclusion criterion was
clinically suspected infection at ED presentation. At Beth Israel Deaconess
Medical Center (BIDMC), Boston, USA, consecutive patients were enrolled
over a 1-year period (internal validation set) and at Aarhus University Hospital
(AUH), Aarhus, Denmark, a case-control study was performed (external
validation set). Laboratory and clinical data were collected at enrollment
to assess organ dysfunction. Primary outcome was in-hospital mortality.
Table 1(abstract P23) Decision rule
Major criteria Minor criteria (1 point each)
Suspected endocarditis (3 points) Age >65 years
Temperature >39.4°C (103.0°F) (3 points) Temperature 38.3 to 39.3°C
Indwelling vascular catheter (2 points) Chills
Vomiting
Hypotension (systolic blood pressure <90 mmHg)
White blood cell count >18,000 cells/mm3
Bands >5% (in our setting, immature cells >0.5%)
Platelets <150,000 cells/mm3
Creatinine >2.0 mg/dl (177 µl/l)
A blood culture is indicated by the rule if at least one major criterion or two minor criteria are present. Otherwise, cultures may be omitted. Points used to
calculate the total score.
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Figure 1(abstract P23) Receiver operating characteristics curve (ROC) for external validation of the bacteremia prediction rule, calculated using
the total score.
Figure 1(abstract P24)
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Logistic regression was performed to determine the independent mortality
odds.
Results: Four thousand, nine hundred and fifty-two patients were
enrolled at BIDMC and 483 patients at AUH. Overall mortality rates were
4% and 11% with mean ages of 58 ± 21 and 69 ± 16 years, respectively.
The mortality rate increased with increasing number of organ
dysfunctions: BIDMC: 0 organ dysfunctions, 0.6% mortality; 1 dysfunction,
3.3%; 2 dysfunctions, 7.8%; 3 dysfunctions, 15.9%; and ≥4 dysfunctions,
34.3%; and AUH: 2.2%, 6.7%, 17%, 41%, and 57% mortality (Figure 1). The
number of organ dysfunctions remained an independent predictor after
adjustment for age and Charlson Index (Table 1). The AUCs for the
models were 0.82 and 0.87, respectively (Figure 2). The effect of specific
types of organ dysfunction on mortality was largest for respiratory
dysfunction (OR 3.57 (95% CI 2.5 to 5.1)) in the internal and for
hematologic dysfunction (OR 33.57 (8.56 to 127.3)) in the external
validation set (Table 2).
Conclusions: Using readily available criteria in the ED to assess the
number of organ dysfunctions is a reliable tool in predicting in-hospital
mortality in both validation sets and could assist in risk prognostication
and aid with earlier, targeted therapy.
P25
Lactate levels in emergency department patients across all causes of
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Background: Physiologic instability (PI) is a common, critical problem in the
emergency department (ED) [1,2], and can have different underlying causes.
The ability to determine the underlying cause of instability is paramount for
early treatment and risk stratification [3]. Lactate has been shown to have
prognostic value in some categories of unstable patients [4,5]. The objective
of this study was to investigate how serum lactate concentrations differ
across categories of PI and the association of lactate concentrations with
clinical deterioration for each category.
Materials and methods: A prospective observational study of adult
patients with PI at a university ED. PI was defined as lactate ≥4 mmol/l, or
>5 minutes of heart rate (HR) ≥130, or respiratory rate (RR) ≥24, or shock
index ≥1, or systolic blood pressure ≤90 mmHg. We excluded patients with
no lactate measurements, isolated atrial tachycardia, seizure, intoxication,
psychiatric agitation, or tachycardia due to pain. A physician retrospectively
Table 1(abstract P24) Effect of number of organ dysfunctions on in-hospital mortality adjusted for age
and Charlson Comorbidity score
Number of organ dysfunctions Internal validation set in-hospital mortality External validation set in-hospital mortality
1 4.5 (2.3 to 8.6) 3.1 (0.9 to 10.4)
2 9.3 (4.8 to 18.1) 7.3 (2.1 to 24.7)
3 18.0 (8.8 to 36.9) 33.6 (8.56 to 127.3)
4 50.5 (22.0 to 115.8) 45.0 (8.56 to 236.2)
5 39.0 (8.9 to 170.7) 285.9 (16.9 to 483.2)
Data presented as OR (95% CI).
Figure 2(abstract P24)
Table 2(abstract P24) Effect of organ dysfunctions on
mortality adjusted for age and Charlson Index
Variable Internal in-hospital
mortality
External in-hospital
mortality
Hematologic 3.4 (2.2 to 5.2) 29.0 (7.1 to 116.9)
Respiratory 3.6 (2.5 to 5.1) 1.4 (0.8 to 2.6)
Cardiovascular 3.2 (0.9 to 11.5) 18.5 (7.3 to 46.8)
Metabolic 3.0 (2.2 to 4.0) 6.7 (2.9 to 11.2)
Neurologic 2.4 (1.7 to 3.4) 8.9 (4.7 to 17.1)
Renal 2.1 (1.4 to 3.0) 5.4 (2.7 to 10.9)
Hepatologic 2.2 (1.4 to 3.4) 4.5 (1.1 to 18.2)
Data presented as OR (95% CI).
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Figure 1(abstract P25) Lactate levels across groups of physiological instability.
Figure 2(abstract P25) Levels of lactate across groups of physiologic instability stratified by deterioration. no/yes = deterioration present or not.
(*) Significant differences between groups (p < 0.05).
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categorized PI cause. Categories were defined as septic, cardiogenic,
hemorrhagic, hypovolemic, or other. The primary outcome was deterio-
ration, defined as: acute renal failure (elevated creatinine to ≥2× baseline
levels), intubation, vasopressors, or in-hospital mortality.
Results: We identified 1,156 patients with PI and excluded 324. Of the
remaining, 304 did not have lactate measurements, leaving 528 for the
analysis: 302 septic, 46 cardiogenic, 29 hemorrhagic, 57 hypovolemic, and
94 with another cause of instability. The differences in lactate levels
between groups were not statistically significant (Figure 1). The lactate
levels were statistically different between patients who deteriorated when
compared with patients who did not deteriorate in the sepsis group (3.05
mmol/l vs. 1.91 mmol/l, P < 0.0001) and the other group (2.89 mmol/l vs.
1.94 mmol/l, P = 0.002). No statistically significant differences were
demonstrated for the cardiogenic, the hemorrhagic or the hypovolemic
groups (Figure 2).
Conclusions: Lactate levels were not significantly different between the
five groups with PI. However, in patients in the sepsis or other group,
elevated lactate predicted deterioration. This was not demonstrated for
the other causes of PI. This study suggests that in unstable patients
lactate has the same likelihood of elevation between different causes of
instability, but it may not have the same prognostic value for
deterioration across underlying causes.
Acknowledgements: CONSIDER Sepsis Network is a collaboration of
clinical researchers with an interest in sepsis at Aarhus University
Hospital, Aarhus, Denmark.
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Background: Sepsis is the main cause of death in ICUs all over the world.
Early detection of the pathogen is essential for appropriate antimicrobial
treatment.
Materials and methods: To evaluate the reduction in time of
antimicrobial adjustment therapy in patients with sepsis comparing a
rapid molecular test (SeptiFast®) with conventional blood cultures, a
randomized controlled clinical trial was conducted between October 2012
and May 2013 in a cardiology hospital. Adult patients staying more than
48 hours in hospital with clinical suspicion of sepsis were included in the
study. Blood samples were collected for cultures (BacT/ALERT®) and
Septifast® test immediately prior to initiation of antibiotic therapy.
Patients were allocated into two groups. In the Intervention Group (GI),
Septifast® results were communicated to the medical researcher and
antimicrobials were adjusted. In the Control Group (GII), Septifast® results
were not informed and therapy adjustment was based on the blood
culture. Registered in Clinical trials.gov (NCT 01450358).
Results: Forty-six patients were included, 17 in GI and 29 in GII. Key data
are shown in Table 1. In GI therapy adjustment was done in 580 minutes
compared with 3,007 minutes in GII (P = 0.004).
Conclusions: The rapid molecular test (SeptiFast®) reduced the time for
adjustment of antibiotic treatment in comparison with conventional
blood cultures in critically ill sepsis patients.
Table 1(abstract P26) Distribution of characteristics in the two groups
Intervention group (n= 17) Control group (n= 29) P
value
Age (years) 63 (46 to 75) 66 (39 to 85) 0.340
Gender (female) 5 (30%) 10 (34%) 0.999
Hospital stay (mean, days) 32 (9 to 118) 31 (3 to 112) 0.632
APACHE II (mean) 17 (8 to 29) 17 (8 to 29) 0.730
Ejection fraction <40% 8 (47%) 17 (58%) 0.545
Receiving antibiotics prior to study 11 (65%) 11 (38%) 0.126
Septic shock 9 (53%) 16 (55%) 0.999
Patients with adjustment therapy
based on SeptiFast®
6 (35%) -
Patients with adjustment therapy
based on blood culture
- 7 (21%)
Mean time (minutes) of adjustment
therapy
580 3,007 0.004
Pathogens detected in SeptiFast® P. aeruginosa (2), K. pneumonia/oxytoca (1), E. aerogenes/cloacae (1),
S. marcescens (1), A. baumanii (1)
-
Pathogens detected in blood culture - S. aureus (4), K. pneumonia (2),
M. morganii (1)
28-day mortality 9 (53%) 17 (59%) 0.765
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Background: Biomarkers were assessed during neutropenic fever in
hematopoietic stem cell transplantation (HSCT). The objective was to
assess serum values of C-reactive protein (CRP), procalcitonin (PCT) and
IL-6 to identify infection in HSCT and risk factors for death.
Materials and methods: Prospective study with 296 patients submitted
to autologous or allogeneic HSCT. PCT, CRP and IL-6 dosed at the
following moments: afebrile neutropenia, fever, 24 hours upon fever,
72 hours upon fever and long-lasting fever. Patients were classified into
groups (I, afebrile; II, fever of unknown origin; and III, clinically or
microbiologically proven fever). ROC curves, sensitivity, specificity, and
multivariate analysis were used to evaluate factors associated with death.
Results: One hundred and ninety patients had fever. Mean and median
values of IL-6 at fever onset in group I with regard to group II (P = 0.013)
presented significantly higher values. Levels of CRP in group I differed
significantly from those found in group III (P < 0.05). Groups differed in
levels of IL-6 and CRP at fever onset. Group II presented IL-6 and CRP
concentrations significantly lower than group III. Cutoff values of PCT:
fever onset, 24 hours upon fever, 72 hours of fever, and long-standing
fever were: 0.32; 0.47; 0.46 and 0.35 µg/l. At fever onset, sensitivity was
52.3 and specificity 52.6 for infection diagnosis. Best cutoff values of CRP
for fever onset, 24 hours upon fever, 72 hours upon fever and long-
standing fever were: 79, 120, 108 and 72 mg/l. At fever onset, sensitivity
was 55.4 and specificity was 55.1. Best cutoff values of IL-6 for fever
onset, 24 hours upon fever, 72 hours upon fever and long-standing fever
were: 34, 32, 16 and 9 pg/ml. At fever onset, sensitivity and specificity
were: 59.8 and 59.7. In the autologous’ group, IL-6 presents significant
values at initial moments. Independent risk factors identified in the
multivariate analysis were: related donor, unrelated donor, Gram-negative
infection, DHL ≥390 (UI/l), urea ≥25 (mg/dl) and CRP ≥120 (mg/l).
Conclusions: IL-6 and CRP are associated with the early diagnosis of
clinically or microbiologically confirmed infection in post-HSCT febrile
neutropenia. The association of the three biomarkers did not present any
advantage, nor did it improve diagnostic accuracy. IL-6 was the only
biomarker significantly associated at an early stage with infection when
assessed only in patients submitted to autologous HSCT. The independent
variables associated with death were: allogeneic transplantation, Gram-
negative infection, DHL ≥390 UI/l at fever onset and urea ≥25 mg/dl at
fever onset and CRP ≥120 mg/l.
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Background: Pneumonia is the most frequent source of infection in
cancer patients and accounts for 50% of all cases of septic shock.
Frequently cancer patients attend a hospital for several treatments and
an event of pneumonia in this scenario is called healthcare-associated
pneumonia (HCAP) by current ATS/IDSA guidelines. The aims of this study
were to describe a population of cancer patients with severe pneumonia
(not acquired in the hospital setting) who required ICU admission;
identify predictors of hospital mortality; and classify the study population
based on ATS CAP/HCAP definitions providing a comparison of clinical
data, microbiologic variables and outcomes between the two groups.
Materials and methods: A prospective cohort study was performed from
2002 to 2011 at Instituto Nacional de Cancer and Hospital Sirio-Libanes,
Brazil. Adult patients (>18 years) with a definite diagnosis of cancer and
presenting with pneumonia (not acquired in the hospital setting) were
evaluated at ICU admission. Demographic, clinical and laboratory data
were collected during the first day of ICU including the CURB-65, the
SAPS II, the SOFA score, comorbidities, Performance Status and cancer-
related and treatment-related data.
Results: A total of 268 patients were admitted to the ICU with pneumonia
and classified as CAP (n = 109/40.7%) and HCAP (n = 159/59.3%). There
were 187 (69.8%) patients with solid tumors and 81 (30.2%) patients with
hematological malignancies. One hundred and sixty-seven (62.3%) patients
had septic shock at ICU admission. ICU and hospital mortality rates were
45.5% and 67.9%. When we compared CAP and HCAP populations, we
observed similar characteristics and outcomes in both groups. As expected,
higher severity of illness, organ failures, need for life-sustaining therapies
and failure of NIV were associated with increased mortality. In a multivariate
analysis, mechanical ventilation in the ICU (OR 2.52 (1.19 to 5.32)), dialysis in
the ICU (OR 3.86 (1.23 to 12.10)) and higher severity of illness (SAPS2 per
point OR 1.03 (1.01 to 1.05)) were associated with increased hospital
mortality whereas successful noninvasive ventilation was associated with
lower mortality (OR 0.32 (0.13 to 0.77)). The model showed good
discrimination (AROC 0.832).
Conclusions: We believe that cancer patients are a distinct group of
patients with pneumonia regardless of HCAP or CAP classification. They
have specific characteristics and predictors of outcome, and treatment
should be based on their clinical characteristics and local microbiologic
profiles.
P29
Sepsis-associated brain dysfunction in critically ill patients
Cristiane Damiani Tomasi1*, Franciele Vuolo1, Larissa de Souza Constantino1,
Dhébora Mozena Dall’Igna1, Eduardo Mazon1, Renato Mafioleti1,
João Quevedo1, Cristiane Ritter11, Antonio Teixeira2, Felipe Dal-Pizzol1
1Laboratório de Fisiopatologia Experimental and Instituto Nacional de
Ciência e Tecnologia Translacional em Medicina, Programa de Pós-
Graduação em Ciências da Saúde, Unidade Acadêmica de Ciências da
Saúde, Universidade do Extremo Sul Catarinense, 88806-000, Criciúma, SC,
Brazil; 2Departamento de Bioquímica e Imunologia, Instituto de Ciências
Biológicas da UFMG, Belo Horizonte, MG, Brazil
Critical Care 2013, 17(Suppl 4):P29; doi:10.1186/cc12929
Background: Delirium is a common occurrence in critically ill patients
and is associated with an increase in morbidity and mortality [1]. Some
evidence suggests that septic patients with delirium may differ from a
general critically ill population. In a subgroup analysis of the MENDS
study, a benefit of dexmedetomidine sedation over lorazepam was only
evident in septic patients [2]. The aim of our study was investigate the
relationship between systemic inflammation and the development of
delirium in septic and nonseptic critically ill patients.
Materials and methods: We performed a cohort study in a 20-bed mixed
ICU that included consecutive patients admitted for more than 24 hours.
Delirium was diagnosed using the Confusion Assessment Method for the
Intensive Care Unit (CAM-ICU). Coma was defined as a Richmond Agitation
Sedation Scale (RASS) score of -4 or -5. Blood samples were collected
within 12 hours of enrollment for determination of TNFa, soluble TNF
receptor (STNFR)-1 and STNFR-2, IL-1b, IL-6, IL-10 and adiponectin.
Results: Seventy-eight patients were included in the study: 26 nonseptic/
nondelirium (control), 13 nonseptic/delirium (delirium), 21 septic/
nondelirium (septic) and 18 septic/delirium (sepsis-associated delirium
(SAD)). From all analyzed biomarkers only STNFR1, STNFR2 and adiponectin
were independently associated with delirium occurrence, but none of these
biomarkers had a significant interaction with sepsis. In contrast, there was
significantly interaction between sepsis and IL-1b suggesting that this
cytokine is differently modulated when comparing septic and nonseptic
patients with delirium.
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Conclusions: The association between IL-1b and delirium is different in
septic versus nonseptic patients, suggesting that mechanisms which drive
SAD may differ from that of nonseptic ICU delirium.
Acknowledgements: This work was funded by the NENASC project
(PRONEX program CNPq/FAPESC); INCT-TM; PROCAD Sepse - CAPES and
FAPEMIG.
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Background: Despites advances in treatment, tuberculosis (TB) remains a
global health threat and is the leading co-infection among Brazilian HIV-
infected patients [1-4]. Mortality of TB in the presence of sepsis and
shock septic can be as high as 67%, with respiratory failure being the
leading cause of ICU admission [2,3,5]. Clinical factors that enhance
mortality among HIV-TB patients are yet to be explored.
Materials and methods: We retrospectively accessed data of HIV/AIDS
critically ill patients from January 2007 until May 2012, at a referral infectious
diseases hospital. All patients admitted to the ICU with laboratory-confirmed
TB were included in the analysis. Demographic and clinical data were
categorized for survivors and nonsurvivors and the results were displayed as
frequency (%), median values and interquartile range.
Results: Fifty patients were included. Hospital mortality was 48%. Age
was 31.5 years (26.5 to 42.75) in the survivors group versus 33.5 years (30
to 45.25) in nonsurvivors (P = 0.25), and the SAPS II score was 44.5 (37.25
to 55.75) versus 47.25 (38.75 to 54.25) (P = 0.58). The most common TB
presentation was disseminated disease (56%) followed by pulmonary
(44%), with no difference according to survival. The delta of days
between ICU admission and beginning of TB treatment was not different
between groups. Rifampicin (94%), pyrazynamide (94%), isoniazide (92%)
and ethambutol (76%) were administered in the majority of patients,
while fluoroquinolones and aminoglycosides were administered in 64%
and 54% respectively. Nonsurvivors presented with more elapsed time
since HIV diagnosis (1 (1 to 7) vs. 26 (5 to 72), P = 0.10); lower nadir CD4
cell count (72.5 (27.5 to 133.5) vs. 24 (14.5 to 63), P = 0.03); and HAART
initiated within 30 days after admission (62% vs. 29%, P = 0.03, odds ratio
3.9 (95% CI 1.2 to 12.7)). The main reason for ICU admission was
respiratory failure (70%). Nonsurvivors needed mechanical ventilation
(88% vs. 48%, P = 0.006) and vasopressors (71% vs. 41%, P = 0.05) more
frequently. Neurological dysfunction was more common in nonsurvivors
(79% vs. 41%, P = 0.01, odds ratio 5.2 (95% CI 1.5 to 18.2)). After
multivariate analysis, neurological dysfunction was associated with higher
mortality, while HAART in the first 30 days of hospitalization was a
protective associated factor.
Conclusions: The disseminated form was the most common presentation
of TB in HIV/AIDS critically ill patients. Nonsurvivors were more prone to
multiple organ dysfunction syndrome, with neurological dysfunction
associated with hospital mortality. The administration of HAART within
30 days of hospitalization was associated with survival.
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Background: Sepsis is a complex and multifactorial syndrome, whose
incidence, morbidity and mortality have been increasing worldwide. The
knowledge of clinical, epidemiological and hemodynamic parameters
responsible for its evolution, diagnosis and treatment are still the subject
of many studies. Therefore, this study aims to evaluate clinical, laboratory
and hemodynamic parameters of morbidity and mortality in patients with
severe sepsis and septic shock.
Materials and methods: As the diagnostic criteria of the systemic
inflammatory response syndrome (SIRS) are very sensitive and very little
specific, we selected patients with severe sepsis and septic shock in the first
24 hours of ICU admission, 18 years old or more, with two general and one
or more inflammatory criteria of SIRS (ACCP/SCCM/2003). Patients with
pathologies that could confound clinical and laboratory evaluations and
advanced comorbidities or on immunosuppressive drug therapy were
excluded. The ICU had 35 beds, five of them are resuscitation beds located in
Table 1(abstract P31) Demographic and clinical
characteristics observed in patients with severe sepsis
and septic shock
Variable n = 72
Age, median (years; IQR) 53 ± 19
Male gender 64%
Type of admission
Medical 33 (47%)
Surgical 39 (53%)
ICU admission source
Emergency room 34 (47%)
Surgical room 38 (53%)
Interval between hospital admission and ICU
>24 hours 20 (28%)
<24 hours 52 (72%)
Physical examination
Peripheral edema 46 (63.9%)
Capillary refilling time reduced 45 (62.5%)
Sedation
Yes 55 (76.4%)
No 17 (23.6%)
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the emergency room (ER). The same intensivist team assists all patients in the
ER and during ICU permanence. The principal investigator did not perform
any orientation or intervention in the treatment of selected patients. Clinical
(age, sex, infection focus, fluid balance, hemodialysis, use of corticosteroids,
antibiotic therapy, APACHE II, SOFA), laboratory (blood cell counting, lactate,
creatinine, bilirubin, glucose, cortisol, NT-proBNP, C-reactive protein (CRP),
procalcitonin (PCT), Troponin I), hemodynamic (blood pressure, heart rate, left
ventricular systolic function (echocardiography)) and respiratory parameters
(respiratory rate, PaO2/FiO2), PEEP and peak inspiratory pressure (PIP)) were
analyzed from ICU admission until discharge or death. Echocardiography was
performed at 48 hours and on the 10th day after ICU admission.
Results: Seventy-two patients (64% male), mean age 52 ± 19 years, were
consecutively included, 21% (15/72) with severe sepsis and 79% (57/72)
with septic shock. Mortality was 18% (13/72), of these 21% (3/13) for
severe sepsis and 79% (10/13) for septic shock. Median APACHE II score
was 28 (16 to 37) and SOFA score 6 (5 to 10) (Table 1). There was positive
correlation between mortality with: male gender, APACHE II, SOFA, positive
24-hour fluid balance, hemodialysis indication, corticosteroid use,
leukopenia, lactate, NT-proBNP and PCT levels (Table 2). From univariate
analysis, practically the same significant association with mortality was
observed (Table 3). In addition, the final multivariate Cox model showed
Table 1(abstract P31): Demographic and clinical charac-
teristics observed in patients with severe sepsis and sep-
tic shock (Continued)
Comorbidities
Hypertension 23 (31.9%)
Diabetes 11 (15.3%)
Alcoholism 30 (41.6%)
Smoking 29 (40%)
Chronic renal failure 7 (9.7%)
Hemodialysis 18 (25%)
Blood products 39 (54.2%)
Cardiac arrest rate during ICU stay 4 (2.88%)
APACHE II, median (IQR) 28 (18 to 34)
SOFA score
Initial, median (IQR) 3 (2 to 8)
Media, median (IQR) 6 (5 to 10)
Maximum, median (IQR) 11 (7 to 13)
Severe sepsis 15 (20.8%)
Septic shock 57 (79.2%)
ICU stay, median (days; IQR) 8 (4 to 15)
Hospital stay, median (days; IQR) 20 (8 to 40)
Positive cultures
Blood 12 (17%)
Sterile tissue or cavity 11 (15%)
ICU mortality 13 (18%)
Hospital mortality 13 (18%)
Demographic and clinical characteristics observed in patients with severe
sepsis and septic shock in the ICU/HRTN between April 2011 and October
2012. IQR, interquartile range.
Table 2(abstract P31) Clinical and laboratory variables
related to mortality in patients with severe sepsis and
septic shock
Variable Correlation r P value
Male gender 0.248 0.05
Age 0.309 0.01
APACHE II score 0.478 0.01
SOFA score 0.572 0.01
Fluid balance (24 hours) 0.350 0.01
Fluid balance (7 days) 0.590 0.01
Hemodialysis 0.548 0.01
Tachycardia 0.266 0.01
PaO2/FiO2 0.320 0.01
Vasopressor agent (24 hours) 0.445 0.01
MAP (24 hours) 0.485 0.01
Creatinine 0.548 0.01
Lactate 0.375 0.01
Steroid use 0.337 0.01
Leukopenia 0.404 0.01
NT-pro-BNP 0.269 0.05
PCT 0.320 0.01
Clinical and laboratory variables related to the mortality observed in patients
with severe sepsis and septic shock in the ICU/HRTN between April 2011 and
October 2012 (n = 72). Data expressed as Spearman r and P value. MAP, mean
arterial pressure; NT-pro-BNP, N-terminal natriuretic peptide; PCT, procalcitonin.
Table 3(abstract P31) Univariate analysis of variables
associated with mortality in patients with severe sepsis
and septic shock
Variable HR 95% CI P value
Male gender 3.24 1.13 to 22.40 0.06
Age 1.05 0.92 to 13.70 0.00
MAP 24 hours 0.79 0.71 to 0.90 0.00
Tachycardia 1.03 1.00 to 1.06 0.03
Fluid balance (24 hours) 1.00 1.00 to 1.00 0.00
Vasopressor use (24 hours) 1.18 0.84 to 2.80 0.00
Steroid use 5.28 2.30 to 11.80 0.00
Leukopenia 5.36 0.97 to 29.6 0.05
Mechanical ventilation (t) 0.762 0.60 to 0.96 0.12
PEEP 1.24 0.70 to 1.70 0.08
PIP 1.22 1.07 to 1.39 0.04
Hemodialysis 6.29 2.05 to 19.2 0.00
PCT 1.14 0.90 to 1.30 0.06
Lactate 9.55 1.12 to 73.96 0.03
Creatinine 4.07 0.99 to 22.32 0.01
APACHE II score 1.09 0.977 to 1.23 0.00
SOFA score 1.24 1.06 to 1.44 0.00
Univariate analysis of variables associated with mortality observed in patients
with severe sepsis and septic shock in the ICU/HRTN between April 2011 and
October 2012 (n = 72). MAP, mean arterial pressure; PCT, procalcitonin; PEEP,
positive end expiratory pressure; PIP, peak inspiratory pressure; t, time (days).
Table 4(abstract P31) Multivariate analysis of variables
associated with mortality in patients with severe sepsis
and septic shock
Variable HR 95% CI P value
MAP (24 hours) 0.74 0.64 to 0.85 0.0001
Fluid balance (24 hours) 1.001 1.000 to 1.001 0.002
Male gender 5.35 1.10 to 26.15 0.038
Leukopenia 60.85 4.97 to 74 0.001
Multivariate analysis of variables associated with mortality observed in
patients with severe sepsis and septic shock in the ICU/HRTN between April
2011 and October 2012 (n = 72). CI, confidence interval; HR, hazard ratio;
MAP, mean arterial pressure.
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that male gender, hypotension (first 24 hours), leukopenia and positive
fluid balance (first 24 hours) had an impact on mortality (Table 4).
Glycemic control and early antibiotic use were not relevant.
Conclusions: Precocious treatment, judicious fluid management and
individualized care showed benefit in the treatment of patients with
severe sepsis, septic shock.
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Background: Antimicrobial resistance has emerged and increased in the
last 25 years, complicating the treatment of nosocomial infections,
especially for extended-spectrum beta-lactamase Enterobacteriacea
(ESBL). Furthermore, disseminated use of invasive procedures, particularly
in ICU patients favors the emergence of multiresistant pathogens.
More recently, Enterobacteriacea has developed a new mechanism of
antimicrobial resistance and became resistant to carbapenems. Among
Enterobacteriacea resistant to carbapenem, Klebsiella pneumoniae is the
most common. These pathogens manifest resistance to most of
antimicrobials tested and are associated with high mortality rates. The aim
of this study is to describe epidemiologic data about nosocomial infections
due to carbapenem-resistant Enterobacteriacea and identify risk factors
for death.
Materials and methods: Longitudinal study evaluating patients with
infections caused by carbapenem-resistant Enterobacteriaceae, isolated
from blood, urine, tracheal secretions, skin and soft tissues, treated
accordingly to the Brazilian Society of Infectious Diseases guidelines, from
March 2011 to December 2012. Acute Physiology and Chronic Health
Evaluation (APACHE II) was calculated to evaluate severity of disease and
Sequential Organ Dysfunction Assessment (SOFA) to measure organ
dysfunction. Comorbidities were classified according to Charlson
comorbidities index list. Patients were followed until hospital discharge.
Results: During the study period, 174 nosocomial infections caused by
carbapenem-resistant Enterobacteriaceae were identified in 148 patients.
All infections were microbiologically documented and 136 (78.2%)
occurred in patients who were admitted to the ICU. Sepsis (17.8%),
polytrauma (14.4%), cardiovascular disease (13.8%) and respiratory disease
(11.5%) were the most common diagnosis. Most of the patients (78%) had
one or more comorbidities according to Charlson criteria, and 57/148
(43.2%) patients had three or more comorbidities. Median APACHE II was
20.7 (7 to 38) and median SOFA at ICU admission was 7 (0 to 14). Median
length of hospital stay was 43 (6 to 230 days). K. pneumoniae was the most
common enterobacteria (86.8%), followed by Enterobacter spp. (8%). The
mechanism of resistance was identified as Klebsiella pneumonia
carbapenemase (KPC) present in 77.2% of K. pneumoniae infections. Shock
was present in 81/148 (46.6%) patients and dialysis was used in 62/148
(35.6%). Hospital mortality was 62.6% and associated mortality was 33.3%.
Multivariate analysis identified dialysis and pneumonia as independent risk
factors for death.
Conclusions: Many patients infected with carbapenem-resistant
Enterobacteriae were identified, and most of them were caused by
carbapenemase producing bacteria. These infections were associated with
high mortality rate. Shock, dialysis, pneumonia, SOFA discharged >6 and
APACHE >20 were identified as independent risk factors for mortality.
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Background: Rapid response teams (RRTs) represent an intuitively simple
concept: when a patient demonstrates signs of imminent clinical
deterioration, a team of providers is summoned to the bedside to
immediately assess and treat the patient with the goal of preventing ICU
transfer, cardiac arrest, or death [1]. Patients whose condition deteriorates
acutely while hospitalized often exhibit warning signs (such as abnormal
vital signs) in the hours before experiencing adverse clinical outcomes.
Sepsis is an illness in which the body has a severe response to bacteria
or other germs. This response may be called systemic inflammatory
response syndrome (SIRS) [2]. The criteria for calling the RRT are the same
as/similar to symptoms of sepsis. We aimed to describe the various
criteria for calling the RRT for patients who developed sepsis, initial
treatment before transfer to the ICU or step-down unit and outcomes.
Materials and methods: This retrospective study was conducted in 2012
in the ICU of Hospital Israelita Albert Einstein, a general, private tertiary
hospital. During the study period, the hospital had 614 beds, 6.7% (41/
614) of which were in the ICU and 13.5% (83/614) were the step-down
unit. We included patients 18 years of age or older diagnosed with
severe sepsis and septic shock treated by the RRT and transferred to the
ICU or step-down unit for study retrospectively. We excluded patients
who had contraindications to cardiac resuscitation. Severe sepsis and
septic shock were defined according to the American College of Chest
Physicians/Society of Critical Care Medicine Consensus Conference
definitions [3]. Data regarding age, gender, Simplified Acute Physiology
Score II (SAPS II) [4], presence of the following comorbidities, criteria for
calling the RRT, initial treatment for sepsis, length of ICU and total stay,
and patient outcome were recorded.
Results: Sixty-five of 41 (63.1%) were males, 23 (35.4%) were transferred
to the step-down unit and 42 (64.6%) were transferred to ICU. Their age
was 64.7 ± 17.8 years. SAPS II score was 57.8 ± 12.8, length of stay was
median 26 days, ICU stay was median 3 days. The treatment of sepsis
Table 1(abstract P33)
Characteristic and outcomes n (%)
Age (years) 64.7 (± 17.8)
Gender (male) 41 (63.1)
Locale of transfer
ICU 42 (64.6)
Step-down unit 23 (35.4)
Comorbidities
Cancer 30 (46.2)
Cirrhosis 3 (4.6)
Diabetes 18 (27.7)
Chronic renal failure 11 (16.9)
Chronic obstructive pulmonary disease 6 (9.2)
Chronic heart failure 5 (7.7)
Severe sepsis 56 (86.2)
Septic shock 9 (13.8)
Site of infection
Pulmonary 29 (44.2)
Urinary tract 13 (20.0
Abdominal 8 (12.3)
Skin and soft tissue 4 (6.2)
Blood (ICS) 4 (6.2)
Others sites 7 (10.8)
SAPS II score 57.8 (± 12.8)
Initial bundle 6 hours
Serum lactate + blood culture measured 40 (63.5)
Fluids administration 41 (64.1)
Length of stay ICU (days) 3 (1-6)
Length of stay hospital (days) 26 (10-71)
Hospital mortality 13 (20.0)
Data presented as n (%), mean (± SD) or median (IQR).
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was also initiated in the ward. The serum lactate + measured blood
culture was 40 (63.5%) and fluid administration was 41 (64.1%) (Table 1).
Pressing the RRT was in 43 (66.2%) cases by the staff member with
significant concern about the patient’s condition, 27 (41.5%) cases by
changes in systolic blood pressure, and 23 (35.4%) cases due to change in
oxygen saturation (Table 2).
Conclusions: The criteria for calling the RRT can support the prompt
identification of patients who have sepsis and prevent disease progression.
Furthermore, the treatment may also be performed in the ward and may
result in a reduction in mortality.
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Background: The knowledge of the nurse in advanced life support and the
impact of continuing education in cardiopulmonary arrest in the ICU. Faced
with the complications of cardiopulmonary arrest (CPA) in the ICU it is
important for nurses to be prepared for emergency actions, mastering the
techniques of care and maintaining well-trained staff. The objective was to
identify and describe the knowledge of the nurse in advanced life support
(ALS) and the impact of continuing education PCR in ICU.
Materials and methods: Exploratory, descriptive bibliographical
integrative analysis of available literature, using the keywords ‘PCR’, ‘ICU’,
‘Continuing Education’, ‘Education’, ‘Nursing’, which were published
between 2002 and 2012, in both conventional and virtual libraries.
Results: Twenty-six publications found and gave rise to two categories.
First, the identification of clinical signs and CPR maneuver by the nursing
staff and the nurse in the PCR are essential for successful resuscitation: the
authors agree that the service systematized-based SAV protocol is essential
for there to be success in CPR. Recognition theoretical and practical skills
of the staff are among the most important determinants of the success
rates of RC [1]. Thus, it is necessary that health professionals, especially
nursing staff, be aware of the clinical signs of PCR. Furthermore, the
residence time of the professional nursing staff in the ICU causes them to
gain more experience, making it easier to identify clinical signs and cardiac
rhythms [2,3]. Second, the impact of continuing education on quality of
nursing care in a PCR: the proper training of the nursing staff, especially
those that operate in the ICU, is vital for emergency treatment PCR.
Identifying the theoretical and practical knowledge of staff about the PCR
and PCR is an important prerequisite for planning a training service [2]. The
nurse as team leader and organizer of the ICU is the right professional to
establish measures to be taken at the time of the PCR. The nurse has a
responsibility to properly distribute the measures to be implemented at the
time of service of the PCR, identifying it early and minimizing damage [4].
Conclusion: Continuing education has significant impact in improving
the level of knowledge of nursing professionals, leading to survival of
patients in a hospitalized ICU, as it ensures the identification of the signs
and symptoms of CRP in patients in the ICU.
Acknowledgements: The authors thank everyone who contributed to
this work, Professor Dr Marislei Brasileiro for encouragement, and the
dedication of coworkers Denise Machado, Renata Barbosa and Camila
Cunha for their knowledge and effort to achieve this project.
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Background: Increased prevalence of vitamin D deficiency (VDD) in sepsis
and its association with sepsis severity has been documented in adults
[1-3]. However, data on the pediatric population are scarce. This study aims
at assessing the prevalence of VDD (25-hydroxyvitamin D (25(OH)D) level
<20 ng/ml) among children with sepsis in developing nations and its
implication on sepsis severity.
Materials and methods: A prospective observational study conducted
between January and December 2012. During the study period all
consecutive PICU admissions between the ages of 1 and 12 years were
screened for sepsis at the time of admission to the ICU. Out of 613 PICU
admissions, 124 patients satisfying the criteria for sepsis [4] were randomly
enrolled and followed up throughout the hospital stay. Patients with an
immunosuppressed state or receipt of vitamin D within the 3 months prior
to hospital admission were excluded. A control group comprising of 40
healthy children was also included for comparison with the general
population. The serum 25(OH)D level was measured in all patients with
sepsis within 24 hours of admission to the PICU. Severity of sepsis was
assessed using the Pediatric Risk of Mortality III (PRISM III) score and the
daily Sequential Organ Function Assessment (SOFA) score.
Results: Patients with sepsis had low 25(OH)D levels compared with
healthy controls (P = 0.04). Median 25(OH)D level among patients was
19.7 ng/ml (interquartile range (IQR): 12.5, 31.2) and median 25(OH)D level
among controls was 30.4 ng/ml (IQR: 22.1, 38). Prevalence of VDD was high
among patients 51% (95% confidence interval (CI), 42 to 59) compared
with the VDD of 17% (95% CI, 8 to 32) in healthy controls (P < 0.001)
(Table 1). No significant correlation was found between vitamin D level
and PRISM III score or daily SOFA score. Out of 19 deaths, 17 (90%) deaths
occurred in patients with vitamin D deficiency and insufficiency (odds ratio
3.09, 95% CI: 0.6 to 20.7). However, the difference in mortality was not
statistically significant (P = 0.58). Factors such as septic shock, multiorgan
Table 2(abstract P33)
Rapid response system calling criteria n (%)
Heart rate 13 (20.0)
Respiratory rate 8 (12.3)
Systolic blood pressure 27 (41.5)
Oxygen saturation 23 (35.4)
Acute change in mental status 11 (16.9)
Staff member has significant concern about the patient’s
condition
43 (66.2)
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dysfunction syndrome (MODS), duration of mechanical ventilation, blood
culture positivity, hypocalcemia and length of PICU stay were not modified
by the presence of VDD (Table 2).
Conclusions: We found a high prevalence of VDD among children with
sepsis when compared with healthy children but VDD was not associated
with the severity of sepsis or its outcome.
Acknowledgements: This study was carried out as a MD thesis, with
support from the institute (PGIMER, Chandigarh, India)
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Background: Renal transplantation is the treatment of choice for end-
stage renal disease as it is cost-effective, and improves survival and quality
of life as compared with maintenance dialysis [1,2]. However, the need for
immunosuppression increases the hazard of septic complications [3]. Sepsis
is one of the leading causes of death among renal transplant recipients
and little is known about its characteristics in this population [4,5]. The aim
of this study was to evaluate the factors associated with mortality in renal
transplant patients admitted to the ICU with severe sepsis and septic
shock.
Materials and methods: We conducted a single-institution retrospective
observational cohort study in consecutive renal transplant patients admitted
to the ICU with severe sepsis or septic shock in a public high-volume kidney
transplant center from 1 June 2010 and 31 December 2011. We registered
demographic data, transplant characteristics and sepsis management to
identify predictive factors of ICU, hospital and 1-year mortality.
Results: A total of 190 patients were enrolled. The mean age was 51 ±
13 years, 115 (60.5%) were male, 122 (64.2%) were deceased donors,
median APACHE was 20 (16 to 23) and median admission SOFA was 5 (4 to
8). The most common source of infection was respiratory (59.5%) followed
by urinary tract (16.8%). Tachypnea, tachycardia, fever, hypothermia,
leukocytosis and leukopenia were present in 74.7%, 67.9%, 24.2%, 6.3%,
26.3% and 16.3% of the patients. The most prevalent dysfunction was
respiratory (68.4%) followed by cardiovascular (41.1%) and renal (40.5%). The
median time between transplantation and the septic event was 2.1 (0.6 to
7.8) years. The duration of organ dysfunction before the diagnosis of sepsis
was 2.5 (1.1 to 5.2) hours. The median length of ICU and hospital stay was
6 (3 to 13) and 20 (12 to 35) days, respectively. Hospital and 1-year
mortalities were 38.4% and 42.6%, respectively. In the multivariate analysis,
male gender, the variation in the SOFA score after the first 24 hours, the
need for mechanical ventilation, the presence of hematologic dysfunction,
being admitted from the wards and AKI stage 3 were predictors of hospital
mortality.
Conclusions: In the present study, independent factors associated with
mortality were related to features of sepsis severity and not to factors
associated with transplantation. Another interesting finding was the low
frequency of signs of systemic inflammatory response.
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Table 1(abstract P35) Vitamin D status among patients with sepsis and healthy controls
Vitamin D status, % (n)
Deficient, 25(OH)D <20 ng/ml Insufficient, 25(OH)D = 20 to 30 ng/ml Sufficient, 25(OH)D >30 ng/ml
Patients (n = 124) 51 (63) 25 (31) 24 (30)
Controls (n = 40) 18 (7) 30 (12) 52 (21)
P < 0.001.
Table 2(abstract P35) Comparison of clinical characteristics of patients with sepsis by vitamin D status
Vitamin D deficient (n = 63) Not deficient (n = 61) P value
Age (years) 4.2 (2.1 to 9.4) 4.2 (1.8 to 8.5) 0.60
Weight (kg) 15 (10.3 to 24.5) 14 (10 to 20) 0.67
PRISM III score 17 (13 to 22) 14 (13 to 22) 0.26
Mean SOFA score from day 1 to day 5 4 (2 to 6.8) 4 (2 to 6.3) 0.64
Septic shock 52 (32) 49 (30) 0.85
MODS 58 (35) 56 (34) 0.83
Mechanical ventilation (hours) 96 (24 to 144) 120 (72 to 216) 0.52
Bacterial culture positivity 23 (15) 34 (21) 0.19
PICU stay (hours) 86 (12 to 114) 90 (43 to 168) 0.73
Hypocalcaemia (calcium <8 mg/dl) 26 (17) 18 (11) 0.16
Mortality 16 (10) 15 (9) 0.53
Data presented as median (IQR) or % (n).
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Background: The current consensus definition of severe sepsis and septic
shock includes a heterogeneous profile of patients under the same
definition. Although the prognostic value of hyperlactatemia in sepsis is
well established, hyperlactatemia can be found both in severe sepsis and
septic shock patients. We sought to compare features and outcomes of
septic patients stratified by two factors: the presence of hyperlactemia
and persistent hypotension.
Materials and methods: This was a secondary analysis of a multicenter
observational study from 10 private hospitals in Brazil (Rede Amil-SP)
aiming to evaluate the impact of a multifaceted program to implement the
Surviving Sepsis Campaign bundles. We retrieved 1,948 septic patients
with an initial lactate level collected within the first 6 hours of diagnosis.
Based on previous literature, we stratified them into four groups according
to the presence of hypoperfusion (lactate >4 mmol/l) and/or persistent
hypotension despite adequate fluids: 1, severe sepsis (without both criteria);
2, cryptic shock (hypoperfusion without persistent hypotension) [1];
3, vasoplegic shock (persistent hypotension without hypoperfusion); and 4,
dysoxic shock (with both criteria) [2].
Results: Severe sepsis was found in 1,018 (52%), cryptic shock in 162
(8%), vasoplegic shock in 549 (28%) and dysoxic shock in 219 (12%)
patients. Mean age was 60 years, 47% were male and the majority was
admitted form the emergency department (47%). The lung was the
principal source of infection, followed by the urinary tract and abdominal.
Overall, the four groups presented significant differences in APACHE II
and SOFA scores (P < 0.001 for both), dysoxic shock being the most
severe group. In post-hoc analysis, patients in the severe sepsis group
presented similar SOFA score to patients in the cryptic shock group (P =
0.20). Overall, 28-day crude survival was different between groups (P <
0.001), being higher for the severe sepsis group (69%, P < 0.001 vs.
other), similar between cryptic and vasoplegic shock (53%, P = 0.39) and
lower for dysoxic shock (38%, P < 0.001 vs. other). In an adjusted analysis
considering age, APACHE II and SOFA, the 28-day survival remained
different between groups (P < 0.001) and the hazard ratio for the dysoxic
shock group was the highest: HR 2.99 (95% CI 2.21 to 4.05).
Conclusions: Current definitions for severe sepsis and septic shock
include four different phenotypes, which should be considered for
epidemiology purposes, customizing treatment goals and inclusion
criteria for future studies. Although previous studies showed similar
outcomes between cryptic shock and overt septic shock (vasoplegic and
dysoxic profile), we demonstrated that cryptic shock is similar only to
vasoplegic shock.
Acknowledgements: On behalf of the Amil Critical Care Group.
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Background: Antithrombin III (AT III) has been known to contribute to
anti-inflammatory response as well as its anticoagulation. Our previous
study showed AT III deficiency happened in the early stage of sepsis with
no relation to disseminated intravascular coagulation (DIC) status.
Whether AT III concentrate is a beneficial therapy or not for septic
patients is still a controversial issue. Our hypothesis is that AT III
concentrate may have efficacy as an anti-inflammatory for sepsis.
Materials and methods: From January 2009 to June 2013, adult septic
patients with nonovert DIC whom were given AT III concentrate in our
medico-surgical ICU were included in this study. DIC scoring was used
with the definition of the International Society on Thrombosis and
Haemostasis (ISTH). AT III concentrate was administered 30 to 60 U/kg
intravenously every 24 hours for 3 days in the patients. Between before
and after the AT III concentrate therapy, WBC (/mm3), CRP (mg/dl),
platelet (×104/μl), PT (seconds), fibrinogen (mg/dl), FDP (μg/ml), SOFA
score and DIC score by ISTH were compared. Values are expressed as
mean ± SD. Data were analyzed by Wilcoxon signed-rank test. P < 0.05
was considered significant.
Results: There were 157 patients (100 men, 57 women; age range 19 to
96 years (mean 70.0 ± 16.0)), and the 28-day mortality rate was 25.5%
and APACHE II score was 17.2 ± 8.3. WBC, CRP, PT, and SOFA score were
significantly improved after AT III concentrate therapy (13,411 ± 8,794 vs.
11,798 ± 6,562, P = 0.0007, 17.1 ± 11.5 vs. 13.9 ± 7.0, P = 0.0001, 16.5 ±
10.9 vs. 15.2 ± 5.3, P = 0.002, and 8.6 ± 3.6 vs. 7.7 ± 4.5, P = 0.005,
respectively), although platelet was significantly decreased (15.8 ± 11.3 vs.
13.7 ± 11.3, P < 0.00013). There were no significant differences in
fibrinogen, FDP and DIC score (464.7 ± 235 vs. 437.6 ± 185.4, P = 0.10,
25.1 ± 36.9 vs. 25.6 ± 36.2, P = 0.85, 2.0 ± 1.5 versus 2.3 ± 1.7, P = 0.06,
respectively). One week after the therapy, SOFA score was significantly
improved, while the DIC score did not change compared with before the
therapy (6.1 ± 4.7, P < 0.0001 and 2.3 ± 1.7, P = 0.98).
Conclusions: In the patients with septic nonovert DIC, WBC, CRP and
SOFA score were immediately improved after the AT III concentrate
therapy, while fibrinogen, FDP and DIC score did not change. AT III
concentrate may also contribute to anti-inflammatory without DIC
status.
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Background: Intravenous immunoglobulin (IVIG) administration has been
approved to use for severe sepsis with antibiotics by the Ministry of
Health, Labour and Welfare since 1980 in Japan. IVIGs are commonly
used for severe sepsis and septic shock in Japan, while the international
guidelines for management of severe sepsis and septic shock in 2012
suggest not using IVIG in adult patients. Our hypothesis is that IVIG
administration has an efficacy for severe sepsis and septic shock.
Materials and methods: This retrospective observational study included all
adult patients in our ICU who were administered IVIG for severe sepsis and
septic shock from January 2011 to June 2013. IVIG was used at 5,000 mg/day
every 24 hours for 3 days. We compared body temperature (°C), WBC (/mm3),
CRP (mg/dl), procalcitonin (ng/ml) and serum immunoglobulin G (IgG)
(mg/dl; normal >870) between before and after IVIG treatment. Values are
expressed as the median. The Wilcoxon signed-rank test was used for the
statistical analysis. P < 0.05 was considered significant.
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Results: One hundred and fifty-one patients (85 men, 66 women; age
range 23 to 96 (median 67.8)) were included in this study. The 28-day
mortality after IVIG treatment was 13.9%. The SOFA score before IVIG
treatment was 5.0. Values of WBC, CRP and procalcitonin were significantly
decreased after IVIG treatment (10,905 vs. 9,805, P < 0.0001, 12.3 vs. 7.7,
P < 0.0001, 2.4 vs. 1.7, P = 0.0003, respectively). Body temperature did not
significantly change (37.4 vs. 37.2, P = 0.07). Serum IgG was significantly
increased after the treatment (1,046 vs. 1,563, P = 0.003).
Conclusions: The present study has some limitations because of being a
retrospective observational study. However, the mortality was quite low in
the group of patients included in this study. Moreover, after IVIG treatment
values of WBC, CRP and procalcitonin were improved. The median value of
serum IgG before treatment was within the normal range, but after
treatment was also significantly improved. There is a possibility that severe
septic patients require additional IgG regardless of its normal concentrations
in their blood.
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Background: In our previous study, we reported that polymyxin B-direct
hemoperfusion (PMX-DHP) (Toraymyxin®; Toray Medical Co., Tokyo, Japan)
therapy could contribute to oxygen delivery due to improved hemodynamic
status, while decreasing inotropic agents in septic patients immediately after
that treatment. The randomized controlled studies are ongoing in other
countries, because its efficacy and indication are still controversial issues.
The purpose of this study is to evaluate whether PMX-DHP therapy sustains
to improve hemodynamic status after the treatment.
Materials and methods: All adult patients treated with PMX-DHP and
receiving a pulmonary arterial catheter (PAC) in our ICU from July 1994 to
June 2010 were included in this retrospective observational study.
Patients’ clinical, microbiological and PAC data were collected from
medical archives. PAC variables were compared between immediately
before and after 24 hours of PMX-DHP therapy. Values were expressed as
mean ± SD. Data were analyzed by Wilcoxon signed-rank test. P < 0.05
was considered statistically significant.
Results: There were 63 patients (36 men, 27 women; age mean 63.4 ±
14.8) studied. The mortality rate was 30.2% 28 days after PMX-DHP.
APACHE II score and SOFA score on the day of PMX-DHP therapy were
20.2 ± 14.8 and 7.3 ± 3.8, respectively. Mean arterial pressure (MAP)
(mmHg) was significantly increased after PMX-DHP therapy (77.5 ± 22.5 vs.
87.2 ± 15.9, P = 0.02). The inotropic score decreased 24 hours after PMX-
DHP, but did not reach statistical change (10.0 ± 16.1 vs. 6.3 ± 11.6, P =
0.08). The cardiac index (CI) (l/minute/m2), systemic venous resistance
index (SVRI) (dyn·second·m2/cm5), mixed venous oxygen saturation (SvO2)
(%), oxygen delivery and consumption (DO2 and VO2) (ml/minute) and P/F
ratio were not statistically different before and after PMX-DHP therapy.
Conclusions: Only the increasing of MAP was sustained after 24 hours of
PMX-DHP therapy, while the inotropic agents were decreased. Although
the CI, DO2, VO2, and P/F ratio were improved immediately after PMX-
DHP therapy in our previous study, these were not significantly changed
between before and after 24 hours. PMX-DHP could improve MAP with
decreasing inotropic agents, while alterations of other PAC variables were
not sustained in 24 hours of PMX-DHP.
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Background: Information about the prevalence of fungal diseases in
critically ill AIDS patients is sparse. Our goal is to describe the prevalence
of fungal diseases in this population, when they are admitted to the ICU.
Materials and methods: Prospective, observational study. Blood and
urine samples were collected from 65 AIDS patients at a specialized ICU
in infectious diseases, from August 2011 to June 2013. When indicated by
clinical suspicion, samples of respiratory, bone marrow and/or tissue were
collected. Cultures, cytopathology and serologic tests were performed to
evaluate fungal colonization or infection. Clinical data were collected
from medical records. Values are expressed as the median and
percentage.
Results: Table 1 presents general characteristics of the HIV/AIDS patients.
Patients with fungal disease did not differ from patients without fungal
infection: age 35 versus 38 years (P = 0.43), male gender 76% versus 70%
(P = 0.29); nadir CD4 cell count 27 versus 57 cell/mm3 (P = 0.15). Most
patients were exposed to HAART previously, while there were 47% naïve
patients in the fungal group versus 31% in the no fungal group. The ICU
mortality of patients without fungal disease was 31% versus 64.7% with
fungal disease (P = 0.02); hospital mortality was not different between
groups (52% vs. 64.7%, P = 0.4). Figure 1 presents 17 diagnoses of
disseminated fungal diseases (prevalence 26%). All histoplasmosis
diagnoses were made from marrow bone culture (11%). Disseminated
cryptococcosis was diagnosed from serum serologic latex, direct
examination and positive culture in LCR. Three patients (4.6%) were
diagnosed with candidiasis in blood cultures. Pnemunocystosis was
diagnosed from immunofluorescence and Grogot positive in sputum. One
patient had disseminated esporotricosis with positive cultures in LCR,
blood, tissue, urine and sputum. The only case of aspergilosis is a
previous tuberculosis-treated patient that developed a disseminated
disease (galactomanana-positive) from a fungal ball.
Conclusions: One in four HIV/AIDS critically ill patients presents with
fungal disease when they are admitted to the ICU. Surveillance of fungal
pathogens shall be necessary in the first screening of medical HIV/AIDS
patients in the ICU.
Table 1(abstract P41) Population characteristics
No fungal
(n = 48)
Fungal
(n = 17)
P value
Age (years) 38 (31 to 43) 35 (33 to 46) 0.43
Gender (male) 34 (71%) 13 (76%) 0.29
CD4+ lymphocyte
count (cell/mm3)
69 (32 to 204) 28 (14 to 115) 0.15
Nadir CD4+ (cell/mm3) 57 (27 to 153) 27 (14 to 122) 0.40
Time since HIV diagnosis
(months)
31 (1 to 123) 13 (1 to 77) 0.53
HAART näive 15 (31%) 8 (47%) 0.56
Mortality 15 (31%) 11 (64.7%) 0.02
Figure 1(abstract P41) Fungal diseases.
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Background: Sepsis is responsible for a high rate of hospitalization and
mortality. Traditional methods for bacterial isolation and identification, such
as blood culture, have limitations in sensitivity and specificity and their
results usually are not available before 48 to 72 hours. The PCR allows a
rapid diagnosis of infectious agents. Broad-range PCR allows an earlier and
more sensitive bacterial identification in just one reaction, even after the
initiation of antibiotics. Therefore, this study evaluates the use of broad-
range PCR in the etiologic diagnosis of septic patients, and compares it with
traditional methods of culture.
Materials and methods: Thirty-five patients with sepsis, admitted to the
Emergency Unit of Clinical Hospital of Ribeirao Preto Medical School, were
included in the study. Clinical, laboratory, and culture data were collected at
hospital admission. On the first day of admission, DNA extraction was
performed from serum, plasma and buffy-coat samples from all patients.
Broad-range 16S rDNA PCR was then performed using two different pairs of
primers (Bak11W/Bak2 and Taf/Tar).
Results: Eighteen (51%) patients were female; mean age was 58 ± 18 years;
15 (43%) had severe sepsis and 20 (57%) septic shock, and mortality was
54%. Mean C-reactive protein (CRP) was 14.39 ± 9.52 and 28 (80%) patients
have levels of CRP greater than 5.0 ng/l. The primary site of infection was
detected in all patients, 20 (57%) patients had respiratory tract infection,
nine (26%) urogenital tract infection, three (8.5%) cutaneous infection, and
three (8.5%) other sites. Blood culture was positive in 14 (40%) samples.
Broad-range PCR was positive in 19 (51%) samples. Only 10 (29%) samples
were positive for both techniques. In 11 (31%) patients, neither blood
culture nor PCR were positive.
Conclusions: Broad-range PCR was effective for diagnosis of bacterial
infection in septic patients, and could be an option to be used in
patients with severe sepsis and septic shock. Moreover, it is faster than
blood culture and can detect bacteria even after the initiation of
intravenous antibiotics. The combination of both techniques could
increase the likelihood of etiologic diagnostic in septic patients.
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Background: Despite the advances in treatment, tuberculosis (TB)
remains a global health threat and is the leading co-infection among
Brazilian HIV-infected patients. Mortality of TB in the presence of sepsis
and shock septic is still high, with respiratory failure being the leading
cause of ICU admission. Clinical factors enhancing mortality among HIV-
TB patients are yet to be explored.
Materials and methods: We retrospectively accessed data of HIV/AIDS
critically ill patients from January 2007 until May 2012, at a referral
infectious diseases hospital. All patients admitted to the ICU with
laboratory-confirmed tuberculosis were included in the analysis.
Demographic and clinical data were categorized for survivors and
nonsurvivors and the results were displayed as frequency (%), median
values and interquartile range.
Results: Fifty patients were included. Hospital mortality was 48%. Age was
31.5 years (26.5 to 43) in the survivors group versus 33.5 years (30 to 45) in
nonsurvivors (P = 0.25), and SAPS II score was 44.5 (37 to 56) versus 47 (39
to 54) (P = 0.58). The most common TB presentation was disseminated
disease (56%) followed by pulmonary (44%), with no difference according
to survival. The interval of days between ICU admission and TB treatment
was not different between groups. Rifampicin (94%), pyrazynamide (94%),
isoniazide (92%) and ethambutol (76%) were administered in the majority
of patients, while fluoroquinolones and aminoglycosides were
administered in 64% and 54% respectively. Nonsurvivors presented with
more elapsed time since HIV diagnosis (1 (1 to 7) vs. 26 (5 to 72), P = 0.10);
lower nadir CD4 cell count (72.5 (27.5 to 133.5) vs. 24 (14.5 to 63), P =
0.03); and HAART initiated within 30 days after admission (62% vs. 29%,
P = 0.03; odds ratio 3.9 (95% CI 1.2 to 12.7)). The main reason for ICU
admission was respiratory failure (70%). Nonsurvivors needed mechanical
ventilation (88% vs. 48%, P < 0.01) and vasopressors (71% vs. 41%, P =
0.05) more frequently. Neurological dysfunction was more common in
nonsurvivors (79% vs. 41%, P = 0.01, odds ratio 5.2 (95% CI 1.5 to 18.2)).
After multivariate analysis, neurological dysfunction was associated with
hospital mortality, while HAART in the first 30 days of hospitalization was a
protective associated factor.
Conclusions: Disseminated TB was the most common presentation in
HIV/AIDS critically ill patients. Nonsurvivors were more prone to multiple
organ dysfunction syndrome, and neurological dysfunction was
associated with hospital mortality. The administration of HAART within
30 days of hospitalization was associated with survival.
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Background: Sepsis is a systemic inflammation caused by severe infection.
It is a life-threatening condition, progresses rapidly, and affects multiple
system functions. An evidence-based medical sepsis bundles model has
been used for sepsis care in clinical practice. All patients who have at least
two signs or symptoms of systemic inflammatory response syndrome (SIRS)
secondary to an infectious process are considered septic. Sepsis is the
leading cause of death in ICUs and a major cause of late hospital mortality
rate, exceeding the acute coronary syndromes and neoplasms. Mortality in
Brazil reaches 60%, while the world average is around 30%, overcoming
countries such as India and Argentina. The early recognition and treatment
of these patients are key to reducing mortality. The aim of this study is to
evaluate the implementation of the protocol of sepsis in a university general
hospital in Porto Alegre.
Materials and methods: Retrospective evaluation of protocols for sepsis
in emergency in 2012.
Results: A total of 200 patients were enrolled in the protocol during the
study period. The average age was 35 years (SD ± 16.5), 51% of patients
were male, the most frequent focus was respiratory 61%, and the second
urinary with 14%. Clinical criteria for inclusion in the protocol that most
prevailed were: axillary temperature and heart rate, with more than 95%.
Altered axillary temperature was present in 98% of the sample. Of these
cases, 86.5% (n = 173) of patients were discharged within 24 hours. Twenty-
seven patients met criteria for hospitalization, 22% required the ICU. Around
75% (n = 20) of inpatients had no blood cultures collected before starting
antibiotics. Only 7% mortality (n = 2).
Conclusions: The criteria for inclusion in the protocol are quite sensitive
and the number of visits per month in the emergency exceeds 10,000. A
total of 200 patients enrolled to the sepsis care protocol in a year, over
80% of these being discharged within 24 hours, suggests a low
adherence to institutional protocol, especially in patients with septic
shock, which is reinforced by the very low mortality compared with
literature data. The evaluation of these data was essential to bring the
knowledge that adherence to the protocol is still very low in our
institution.
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Background: A 69-year-old woman underwent elective surgical repair of
an abdominal aortic aneurysm. Intraoperative lesions were intestinal and
splenic, requiring performing segmental bowel resection and splenectomy.
By hemodynamic instability the patient was maintained on mechanical
ventilation in norepinephrine and was transferred to the ICU. After 3 days
she had fever, tachycardia, hypotension and anuria, with output fetid and
purulent secretion by the tracheal tube. Chest X-ray showed opacity in the
right lung; cultures were collected and cefepime initiated empirically for
treatment of ventilator-associated pneumonia. Acinetobacter baumannii
was isolated sensitive only to polymyxin-E in the sample of tracheal
secretions. An exchange of antimicrobial therapy was made, but the
patient developed refractory shock and died.
Materials and methods: We report the case of a patient with septic
shock.
Results: Despite the upgrading of intensive therapies with the presence of
increasingly prepared professionals and all of the technological and
scientific developments that occurred in the last 10 years, sepsis remains a
major challenge for contemporary medicine. Mortality rates may vary from
20 to 80%. Several factors contribute to this high mortality rate, such as the
growing population of patients aged over 65 years with various chronic
diseases, the most frequent use of invasive procedures, increased demand
for immunocompromised patients and the development of nosocomial
microorganism infections increasingly resistant to antimicrobial agents.
Besides the pathophysiology, evidence substantiated that early intervention
reduces mortality in severe sepsis and thus several ICUs have sought to
improve the quality of clinical management of septic patients. In 2002, the
Medical Society of Intensive American (SCCM) and European (ESICM)
together with the International Sepsis Forum initiated the Surviving Sepsis
Campaign (SSC). The SSC initiative was based on six strategies, including:
implement surveillance sepsis; improve the early diagnosis and safety;
establish protocols for treatment and early intervention; create programs
continuing professional education; proposed therapy post-ICU; and develop
global standards for intensive care.
Conclusions: The emergence of antimicrobial-resistant microorganisms is
a growing problem worldwide and this complicates the choice of
empirical antimicrobials and can compromise the evolutionary outcome
of patients.
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Background: Severe sepsis is an important cause of morbidity and
mortality for patients in ICUs [1]. Since instituting rapid treatment for
patients with sepsis is critical, the need for reliable predictors of mortality
to guide therapy is evident. This study attempts to identify the risk
factors for mortality in patients admitted with severe sepsis to the ICU.
Materials and methods: Case-control study conducted in the ICU of
Hospital Anchieta, Brasília, DF, Brazil, during 5 months. Patients were
divided into two groups: survivors group (SG) and nonsurvivors group
(NSG).
Results: During the study, 38 patients were admitted with severe sepsis,
with a mortality rate of 47% (n = 18). Upon admission, the patients in the
NSG presented higher values of: SAPS3 score (82 ± 12 vs. 60 ± 14, P =
0.00), heart rate (119 ± 21 vs. 99 ± 15 bpm, P = 0.00), serum creatinine
(2.4 ± 1.4 vs. 1.5 ± 0.9 mg/dl, P = 0.00), decreased level of consciousness
(92% vs. 58%, P = 0.03), need for vasopressor (85% vs. 25%, P = 0.00),
need for invasive mechanical ventilation (62% vs. 12%, P = 0.00) and
previous cardiac arrest (15% vs. 0%, P = 0.00). The platelet count was
lower in the NSG (119,000 ± 70,000 vs. 220,000 ± 103.000/mm3, P = 0.00).
There was no significant difference between the groups regarding the
following factors: age (65 ± 19 vs. 65 ± 19 years, P = 0.98), respiratory
rate (29 ± 9 vs. 26 ± 7 rpm, P = 0.30), axillary temperature (36.9 ± 0.7
vs. 37.2 ± 1.8°C, P = 0.43), leukocyte count (17,500 ± 7,800 vs. 13,000 ±
6.000/mm3, P = 0.08), immunosuppression (38.5% vs. 12.5%, P = 0.07),
and prior use of corticosteroids (23% vs. 25%, P = 0.90).
Conclusions: SAPS3 score, metastatic cancer, decreased level of
consciousness, need for vasopressors, invasive mechanical ventilation,
previous cardiac arrest, heart rate, serum creatinine, and platelet count
were associated with mortality in severe sepsis for this sample of patients.
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Background: Elevated serum arterial lactate levels are often associated
with an imbalance between oxygen demand and delivery, which has a
strong correlation with poorer outcomes in critically ill patients [1,2]. This
study aims to evaluate serum arterial lactate as a predictor of mortality in
critical patients admitted with severe sepsis and septic shock.
Materials and methods: Retrospective cohort study conducted in the
ICU of Hospital Anchieta, Brasília, DF, Brazil, during 3 years. For the first
analysis, patients were divided into two groups: group with arterial
lactate >2 mmol/l and group with low arterial lactate ≤2 mmol/l at the
time of admission. For a second analysis, patients were divided into two
groups: group with arterial lactate >3.3 mmol/l and group with arterial
lactate ≤3.3 mmol/l at the time of admission.
Results: A total of 195 patients with sepsis were enrolled, 41% (n = 80)
with septic shock. Mean age was 63 ± 22 years, ICU length of stay 9 ±
11 days, SAPS3 62 ± 16, and APACHE II 21 ± 9. ICU mortality in 4 days
was 10.8% (n = 21), in 28 days was 12.3% (n = 24), and hospital mortality
was 26.2% (n = 51). The nonsurvivor patients had higher lactate values
(2.0 ± 1.4 vs. 1.3 ± 1.1, P = 0.00). Considering the arterial lactate cutoff
value of 2.0 mmol/l, there was no difference between groups regarding
ICU length of stay (10 ± 13 vs. 9 ± 2 days, P = 0.47), mortality in 4 days
(12% vs. 10%, P = 0.85), mortality in 28 days (13% vs. 16%, P = 0.77), and
hospital mortality (30% vs. 32%, P = 0.86). However, considering the
lactate cutoff value of 3.3 mmol/l, the high lactate group had higher
mortality in 4 days (27% vs. 9%, P = 0.04) and hospital mortality (67% vs.
23%, P = 0.00). There was no statistical significant difference regarding
mortality in 28 days (27% vs. 11%, P = 0.08), and ICU length of stay (8 ±
7 vs. 9 ± 11 days, P = 0.59). The relative risk of hospital death in patients
with arterial lactate >3.3 mmol/l was 2.93 (95% CI: 1.87 to 4.58). The
specificity of arterial lactate >3.3 mmol/l for hospital mortality was 96.5%
(95% CI: 92.1 to 98.5%), sensibility was 19.6% (95% CI: 11.0 to 32.5%), and
LR+ was 5.65 (95% CI: 2.03 to 15.7%). The arterial lactate area under the
ROC curve for mortality was 0.634 (95% CI: 0.540 to 0.748).
Conclusions: In the patients admitted with severe sepsis and septic
shock for this sample, the nonsurvivors had higher lactate values. Arterial
lactate >2 mmol/l at the time of admission was not associated with
mortality. Arterial lactate >3.3 mmol/l was associated with mortality in
4 days, and hospital mortality. Indeed, lactate >3.3 mmol/l had high
specificity for hospital mortality.
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Background: Severe sepsis and septic shock are common and are
associated with substantial mortality and substantial consumption of
healthcare resources [1]. Although the incidence of septic shock has
steadily increased during the past several decades, the associated
mortality rates have remained constant or have decreased only slightly
[2]. This study aims to compare demographics and outcomes of
patients admitted to the ICU with severe sepsis and with or without
septic shock.
Materials and methods: The present study is a retrospective cohort
conducted over a 3-year period in the ICU of Hospital Anchieta, Brasília,
Brazil. Patients were divided into two groups: severe sepsis without shock
septic (SW) and severe sepsis with septic shock (SS). The patients coming
from other ICUs or transferred to other ICUs were excluded.
Results: A total of 198 patients with severe sepsis were enrolled in this
study. Among them, 97 patients (49%) had septic shock. In this cohort,
the mean age was 59 ± 16 years, the SAPS 3 score was 63 ± 17 and the
APACHE II score was 21 ± 9. The mortality in four days was 12.6% (n =
25), in 28 days was 14.1% (n = 28) and the hospital mortality was 29.3%
(n = 58). There was no difference between the two groups regarding age
(64 ± 20 vs. 59 ± 21, P = 0.08) and length of stay in the ICU (12 ± 1 vs.
11 ± 1, P = 0.51). The SS group presented higher SAPS3 (70 ± 17 vs. 57 ±
15, P = 0.00) and APACHE II (1 vs. 8 ± 9 ± 1, P = 0.00) scores. Patients in
the SS group also had higher mortality in 4 days (18% vs. 8%, P = 0.04),
in 28 days (20% vs. 9%, P = 0.03) and hospital mortality (37% vs. 22%,
P = 0.02).
Conclusions: Patients admitted with septic shock had higher mortality
than patients admitted with severe sepsis without septic shock, but there
was no difference between the groups with respect to length of stay in
the ICU.
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Background: Severe sepsis and septic shock are common and are
associated with substantial mortality and substantial consumption of
healthcare resources [1]. Although the incidence of septic shock has
steadily increased during the past several decades, the associated
mortality rates have remained constant or have decreased only slightly
[2]. Our study aimed to identify the prognostic factors during the first
hour after admission for intra-hospital mortality in patients with septic
shock in a general ICU.
Materials and methods: Case-control study conducted on patients
admitted to the ICU of Hospital Anchieta, Brasília, DF, Brazil, during
17 months. Patients were divided into two groups during the hospital
stay: survivors group (SG) and nonsurvivors group (NSG). Patients
proceeding from or transferred to another ICUs were excluded.
Results: During the period of the study, 1,918 patients were admitted,
120 with septic shock (6.2%). For this sample, the mean age was 62 ± 20,
SAPS3 was 71 ± 18, 55.8% were males, and the hospital mortality was
49% (n = 59). In the NSG group, there was a higher incidence of
decreased level of consciousness (83.1% vs. 52.5%, P = 0.00), acute
respiratory failure (96.6% vs. 83.6%, P = 0.03), hypocapnia (60.8% vs.
39.2%, P = 0.02), acidemia (77.4% vs. 50%, P = 0.01), need for invasive
mechanical ventilation (83.1% vs. 45.9%, P = 0.00), and thrombocytopenia
<60,000/mm3 (25.4% vs. 4.9%, P = 0.00). There was no difference
between the groups regarding age (64 ± 21 vs. 61 ± 18, P = 0.37), PaO2/
FiO2 ratio (174 ± 129 vs. 250 ± 236, P = 0.07), gender (47.5% vs. 63.9%,
P = 0.37), incidence of acute renal injury (47.5% vs. 32.8%, P = 0.14), and
arterial lactate (2.1 ± 1.1 vs. 1.8 ± 1.0, P = 0.13). The NSG group had
greater SAPS3 score (82 ± 14 vs. 60 ± 15, P = 0.00). After logistic
regression, only decreased level of consciousness (P = 0.00) and need for
invasive mechanical ventilation (P = 0.01) were independently associated
with hospital mortality.
Conclusions: In patients with septic shock, decreased level of
consciousness and need for invasive mechanical ventilation were
independently associated with hospital mortality.
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Background: Sequential Organ Failure Assessment (SOFA) is a largely used
score in the evaluation of organ dysfunction/failure in septic patients [1].
Repeated scoring can also assess patient condition and disease
development [2]. The present study aims to describe the association
between SOFA score and the organ dysfunction components of this score
with mortality in septic patients admitted to an ICU.
Materials and methods: Prospective study conducted on patients
admitted to the ICU of Hospital Regional de Samambaia, Brasília, DF,
Brazil, during 7 months. The SOFA was evaluated at the time of
admission to the ICU. Patients were divided into two groups: survivors
group (SG) and nonsurvivors group (NSG). Accuracy of SOFA and the
organ dysfunction components of SOFA score to predict ICU mortality
were measured with the area under the receiver operating characteristic
(ROC) curve.
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Results: One hundred and seven patients were enrolled. Mean age was
53 ± 20, APACHE II 14 ± 6, SAPS 3 52.9 ± 14.9 and SOFA 6.2 ± 3.3. ICU
mortality was 34.6% (n = 37). The SOFA score was higher in nonsurvivors
(7.4 ± 3.0 vs. 5.8 ± 3.4, P = 0.01), cardiovascular (2.0 ± 1.8 vs. 1.4 ± 1.6,
P = 0.01) and kidney dysfunctions (0.7 ± 1.0 vs. 0.4 ± 0.9, P = 0.04) being
higher in this group. There were no differences between the groups
regarding coagulation (0.4 ± 0.8 vs. 0.4 ± 0.8, P = 0.59), liver (0.0 ± 0.3 vs.
0.0 ± 0.7, P = 0.65), respiratory (2.0 ± 1.2 vs. 1.6 ± 1.4, P = 0.87), and
neurologic (2.2 ± 1.7 vs. 1.7 ± 1.6, P = 0.96) organ dysfunctions. The area
under the ROC curve (Figure 1) for SOFA was 0.650 (95% CI 0.541 to
0.759). The components of the cardiovascular system, renal system,
coagulation, liver, respiratory, and nervous systems had areas under the
ROC curve of 0.612 (95% CI 0.501 to 0.732), 0.565 (95% CI 0.478 to 0.712),
0.484 (95% CI 0.369 to 0.600), 0.457 (95% CI 0.344 to 0.571), 0.580 (95%
CI 0.469 to 0.691), and 0.582 (95% CI 0.465 to 0.699), respectively.
Conclusions: The SOFA score was moderately associated with ICU
mortality. The scores for cardiovascular and renal impairment were
individually associated with mortality.
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Background: The PaO2/FiO2 ratio is a well-known parameter to assess
respiratory dysfunction, used in Sequential Organ Failure Assessment
(SOFA) [1]. This study aims to determine whether the SaO2/FiO2 ratio can
be used in the assessment of respiratory impairment and as a predictor
of ICU mortality in patients with sepsis and to evaluate its correlation
with PaO2/FiO2.
Materials and methods: A retrospective cohort study conducted in the
ICU of Hospital Santa Luzia, Brasilia, DF, Brazil, during 5 months. An
arterial blood sample was collected at the time of admission. Patients
with sepsis were divided into two groups: survivors group (SG) and
nonsurvivors group (NSG). Correlation with SaO2/FiO2 and PaO2/FiO2 was
evaluated with the Pearson correlation coefficient. Accuracy of SaO2/FiO2
and PaO2/FiO2 to predict ICU mortality was measured with the area
under the receiver operating characteristic curve.
Results: A total of 118 patients with sepsis were enrolled. The mean age
was 66 ± 21 years, SAPS3: 50 ± 14, APACHE II: 13 ± 8, PaO2/FiO2: 317
Figure 1(abstract P50) ROC curve for SOFA.
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(IQ 233 to 426) and SaO2/FiO2: 362 (IQ 247 to 453). ICU mortality was
17.8% (n = 21). The main sites of infections were respiratory (57%, n =
67), urinary (19%, n = 23) and cutaneous (8.5%, n = 10). Nonsurvivor
patients had lower SaO2/FiO2 (258 vs. 366, P = 0.00) and PaO2/FiO2 (285
vs. 354, P = 0.04). PaO2/FiO2 and SaO2/FiO2 had a good correlation (r =
0.645, P = 0.00). The relative risk of death in patients with SaO2/FiO2 <400
was 1.81 (95% CI: 1.47 to 2.24), SaO2/FiO2 <300 was 2.5 (95% CI: 1.54 to
4.05), SaO2/FiO2 <200 was 2.45 (95% CI: 1.27 to 4.71). The sensitivity for
ICU mortality of SaO2/FiO2 <300 was 28% and of SaO2/FiO2 <200 was
35%. The specificity for ICU mortality of SaO2/FiO2 <300 was 90% and of
SaO2/FiO2 <200 was 86% (95% CI: 93.5 to 100.0%). The area under the
ROC curve for SaO2/FiO2 was 0.776 (95% CI: 0.677 to 0.875) and for PaO2/
FiO2 was 0.655 (95% CI: 0.507 to 0.804) (Figure 1).
Conclusions: A low SaO2/FiO2 was associated with mortality in this
group of patients and had a good correlation with PaO2/FiO2. SaO2/
FiO2 <300 showed high specificity for mortality. Further analysis is
necessary to the validation of less invasive measures such as pulse
oximetry saturation (SpO2/FiO2 ratio) in the assessment of patients
with sepsis.
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Background: The platelet count is an established index in the evaluation
of severity in patients with sepsis, and therefore is a component of the
SOFA score [1]. Furthermore, the alterations in leukocyte count are also
used in the definition of SIRS. The present study aims to evaluate the
accuracy of the platelet/leukocyte ratio (P/L) as a predictor of mortality in
septic patients.
Materials and methods: Retrospective cohort study conducted on
patients admitted to the ICU of Hospital Anchieta, Brasília, DF, Brazil,
during 3 years. The patients with sepsis were divided according to P/L as
follows: P/L ≥8 group (HPL) or P/L <8 (LPL). The primary outcome was
Figure 1(abstract P51) ROC curve for SaO2/FiO2 and PaO2/FiO2.
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mortality at 4 and 28 days. Accuracy of P/L to predict ICU mortality was
measured with the area under the receiver operating characteristic curve.
Results: In the present study, 195 patients were enrolled, 41% (n = 80)
with septic shock. Their mean age was 62.8 ± 21.6 years, SAPS 3 was
62.1 ± 15.0, APACHE II was 20.6 ± 8.6, and length of stay in the ICU
was 9 ± 11 days. Mortality at 4 days was 10.8% (n = 21) and at 28 days
was 12.3% (n = 24). The groups P/L <8 and P/L ≥8 did not present
differences regarding age (59 ± 20 vs. 65 ± 22, P = 0.07) and APACHE II
(22 ± 9 vs. 20 ± 9, P = 0.19). The LPL group had higher SAPS3 (68 ± 18 vs.
59 ± 13, P = 0.00). The LPL was significantly associated with mortality in
4 days (18% vs. 7%, P = 0.02) and 28 days (19% vs. 9%, P = 0.03). The area
under the ROC curve of P/L for mortality at day 4 was 0.628 (95% CI 0.498
to 0.757) and at day 28 was 0.613 (95% CI 0.489 to 0.736).
Conclusions: P/L <8 at admission was associated with higher mortality in
4 and 28 days in patients with sepsis.
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Background: The increase of the older population, with higher incidence of
co-morbidities and age-related decline in organic functions, suggests a need
for better understanding the peculiarities of the process leading to adequate
critical care in this group of patients [1,2]. This study aims to evaluate
morbimortality of sepsis on older and nonolder patients and its impact on
their outcomes.
Materials and methods: Retrospective cohort study conducted in the ICU
of Hospital Santa Luzia, Brasilia, DF, Brazil, during 6 months. Patients
diagnosed with sepsis were divided into two groups: older, defined as age
≥65 years, and nonolder, with age <65, for the analysis of the outcomes.
Results: A total of 130 patients with sepsis were enrolled, 11.5% (n = 15)
with septic shock. Mean age was 64 ± 22 years, ICU length of stay 9.6 ±
13.2 days, SAPS3 50 ± 13. ICU mortality in 4 days was 6.9% (n = 13), in
28 days was 9.2% (n = 12) and hospital morality was 17.7% (n = 23).
Seventy patients were older (60.8%). The older patients had higher SAPS3
(56 ± 12 vs. 40 ± 9, P = 0.00), Charlson Comorbidity Index (CCI) (2.4 ±
1.9 vs. 1.0 ± 1.7, P = 0.00), and incidence of Glasgow Coma Scale <15 (19% vs.
5.9%, P = 0.03). There was no difference between the groups regarding the
incidence of septic shock (12.7% vs. 9.8%, P = 0.62), need for dialysis (8.9% vs.
7.8%, P = 0.84), vasopressor agents (6.3% vs. 7.8%, P = 0.74) or invasive
mechanical ventilation (25.3% vs. 15.7%, P = 0.19). There was also no
difference regarding ICU length of stay (15 ± 2 vs. 10 ± 1 days, P = 0.22),
mortality in 4 days (8.9% vs. 3.9%, P = 0.28) and in 28 days (12.7% vs. 3.9%,
P = 0.09). However, hospital mortality was higher amongst the group of older
patients (26.5% vs. 3.9%, P = 0.00). The relative risk of hospital death in older
patients was 6.78 (95% CI: 1.66 to 27.68).
Conclusions: Older septic patients had higher SAPS 3, CCI, and incidence
of GCS <15. Although there was no difference regarding mortality in 4
and 28 days or ICU length of stay, hospital mortality was higher for this
group of patients.
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Background: The ACCP/SCCM consensus conference definitions for sepsis
are used worldwide [1]. However, consensus definitions do not
adequately reflect the intricacies of sepsis and can overestimate the
diagnosis due to their high sensitivity. Moreover, the consensus criteria
do not allow the staging or the prediction of sepsis outcome [2]. This
study aims to evaluate the individual components of SIRS criteria as
predictors of mortality in patients admitted to an ICU with sepsis.
Materials and methods: A case-control study conducted in the ICU of
Hospital Santa Luzia, Brasilia, DF, Brazil, during 4 months. Patients were
divided into two groups: survivors group (SG) and nonsurvivors group
(NSG). The accuracy of individual components of SIRS criteria as
predictors of mortality was measured with the area under the receiver
operating characteristic (ROC) curve.
Results: A total of 76 patients were enrolled, 10.5% (n = 8) with septic
shock. Age was 70 ± 18 years, SAPS3: 52.9 ± 13.9, APACHE II: 15.5 ± 8.8.
The ICU length of stay was 9 ± 10 days. ICU mortality was 21% (n = 16).
The most prevalent sites of infections were respiratory (57.9%, n = 44),
followed by urinary (25%, n = 19) and cutaneous (6.6%, n = 5). The
incidence of tachycardia was the only parameter higher in the NSG
(37.5% vs. 9.1%, P = 0.00). There was no difference regarding the
incidence of fever or hypothermia (15.4% vs. 24.0%, P = 0.38), tachypnea
(25.0% vs. 17.5%, P = 0.42) or leukocytosis or leucopenia (20.9% vs.
21.2%, P = 0.97) between the groups. The relative risk of death in
patients with tachycardia was 4.13 (95% CI: 1.46 to 11.63). Tachycardia
also had the larger area under the ROC curve: 0.708 (95% CI: 0.566 to
0.850), versus 0.442 (95% CI: 0.287 to 0.597) for fever/hypothermia, 0.556
(95% CI: 0.397 to 0.715) for tachypnea, and 0.498 (95% CI: 0.338 to 0.658)
for leukocytosis/leucopenia.
Conclusions: For this sample, tachycardia was the only SIRS component
associated with ICU mortality in patients admitted with sepsis.
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Background: Assessment and monitoring of hemodynamics is a
cornerstone in critically ill patients as hemodynamic alteration may
become life-threatening in a few minutes [1,2]. This study aimed to
determine whether the SaO2-SvO2 difference could be used as risk
stratification for patients with sepsis and septic shock.
Materials and methods: A retrospective cohort study conducted in the
ICU of Hospital Santa Luzia, Brasilia, DF, Brazil, during 6 months. An arterial
blood sample was collected at admission. Patients with sepsis were
divided in two groups: survivors group (SG) and nonsurvivors group (NSG).
The accuracy of SaO2-SvO2 difference to predict ICU mortality was
measured with the area under the receiver operating characteristic curve.
Results: A total of 131 patients with sepsis were enrolled, 11.5% (n = 15)
with septic shock. Age was 66 ± 21 years, SAPS3: 37 ± 17, APACHE II: 14 ± 8,
PaO2/FiO2: 342 ± 142 and SaO2/FiO2: 347 ± 109. ICU mortality was 18% (n =
23). The main sites of infections were respiratory (56.5%, n = 74), urinary
(19%, n = 25) and cutaneous (7.6%, n = 10). Nonsurvivor patients had higher
SaO2-SvO2 difference (26 ± 9 vs. 19 ± 9, P = 0.03). In the group of patients
with septic shock, SaO2-SvO2 difference was also higher in nonsurvivors
(29 ± 3 vs. 10 ± 2, P = 0.02). All patients with septic shock who died had
SaO2-SvO2 difference greater than 25%. The SaO2-SvO2 difference area
under ROC curve was 0.714 (95% CI 0.534 to 0.894).
Conclusions: A higher SaO2-SvO2 difference is associated with mortality
in patients with sepsis, especially in patients with septic shock.
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Background: Measures to ensure an appropriate early treatment for
critically ill patients result in significant decreases in mortality [1,2]. This
study aims to evaluate the impact of the elapsed time between ICU
request and actual admission of patients with SIRS/sepsis on ICU
mortality and length of stay.
Materials and methods: Retrospective cohort study conducted in the
ICU of Hospital Santa Luzia, Brasilia, DF, during 3 months. Patients being
consecutively admitted to the ICU with diagnostic of SIRS/sepsis were
divided into two groups: those with elapsed time between ICU request
and admission less than 6 hours (short waiting period group (SWP)) or
over 6 hours (long waiting period group (LWP)).
Results: A total of 70 patients were enrolled (46% of admissions), 14
patients with SIRS, 27 with sepsis, 13 with severe sepsis and 17 with
septic shock. For the entire cohort, the mean age was 61 ± 22 years,
APACHE II was 12 ± 7.7, ICU length of stay was 15 ± 22.8 days, and 39
were male (54,9%). Thirty-five patients belonged to the LWP (50%). LWP
patients had higher mortality (50% vs. 19.6%, P = 0.04), and longer ICU
length of stay (13.6 ± 18.5 vs. 23.5 ± 40.7 days, P = 0.04). Relative risk for
death in the LWP was 2.83 (95% CI: 1.28 to 6.28).
Conclusions: The elapsed time between ICU request and actual
admission of patients with SIRS/sepsis over 6 hours resulted in increased
ICU mortality and ICU length of stay for this group of patients.
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Background: Advances in the treatment of burns have reduced mortality
rates and improved quality of life of victims. However, the most frequent
complication is infection [1]. Thermal injury over 20% of the body surface
area may lead to conditions similar to SIRS, as in septic shock. Beyond the
extent of body surface area burned, which causes structural changes in skin
coverage, other factors lead to infectious complications in burned patients:
immunosuppression resulting from thermal injury, the possibility of
gastrointestinal bacterial translocation, prolonged hospitalization, the use
of devices and surgical procedures related to the burned areas [2,3].
C-reactive protein (CRP) is a known marker of infection and sepsis in
patients admitted to the ICU.
Materials and methods: CRP was measured in a cohort of 18 critically ill
mechanically ventilated victims of a fire disaster in the city of Santa Maria,
Brazil, on 27 January 2013, admitted to the ICU of the Hospital de Clínicas
de Porto Alegre. The patients were divided into groups according to CPR
levels, group 1 (CPR ≤190 mg/l) and group 2 (CRP >190 mg/l), and the
Mann-Whitney test was performed to compare groups according to
mortality, length of ICU and hospital stay, presence of sepsis and SOFA score
on days 1, 3 and 7.
Results: Six patients were male and the mean age was 23.1 ± 4.5 years. No
differences were detected when patients were compared according to
mortality (group 1: 0% vs. group 2: 11.1%; P = 0.48), length of ICU stay
(group 1: 11 ± 8 days vs. group 2: 17.2 ± 9.7 days; P = 0.237) or length of
hospital stay (group 1: 16.4 ± 8.5 days vs. group 2: 20.6 ± 10.2 days; P =
0.408). CPR levels were not associated with the development of sepsis
(group 1: 50% vs. group 2: 80%; P = 0.321). The SOFA score was not
significantly different between groups on day 1 and day 3 (day 1 - group 1:
4.6 ± 2 vs. group 2: 4.5 ± 2.7; P = 0.740; day 3 - group 1: 3.2 ± 2.7 vs. group
2: 5.8 ± 4.2; P = 0.203). However, the SOFA score was significantly higher on
day 7 in group 2 (day 7 - group 1: 3 ± 0.7 vs. group 2: 5.8 ± 1.9; P = 0.017).
Conclusions: CRP was not a good marker of sepsis and multiple organ
dysfunction in this cohort of burned patients, possible due to the intense
inflammatory response associated with burns.
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Background: The soluble CD14 subtype (sCD14-ST: renamed presepsin),
which is approximately 13 kDa, has been identified as a protein whose
levels increase specifically in the blood of sepsis patients. In this study,
we evaluated the clinical performance of a point-of-care assay for
measurement of presepsin in admitted sepsis patients.
Materials and methods: We obtained 43 cases with blood culture test-
positive from patients admitted to our hospital and compared presepsin
levels with procalcitonin (PCT), CRP and white blood cell count.
Results: Positive ratios of presepsin levels of patients with Gram-negative
bacterial infection, Gram-positive bacterial infection and fungal infection
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were higher than those of PCT. When 43 cases were divided into four
groups (sepsis, severe sepsis, septic shock and infection groups),
presepsin levels were only significantly different between sepsis/infection
group and severe sepsis group (P < 0.05). Presepsin levels reflected the
blood culture test and sepsis severity more than other biomarkers.
Conclusion: This assay has sufficient clinical performance in patients
admitted to the hospital in addition to the emergency room and ICU.
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Background: Severe sepsis is the main cause of death in the ICU.
Relatives are at risk for post-traumatic stress disorder (PTSD) or anxiety
and depression [1]. The objective is to assess whether the ICU experience
may predict these psychological symptoms of relatives at 90 days after
the patient’s death or discharge.
Materials and methods: Prospective observational study in four ICUs of
one university hospital, including all patients with severe sepsis and end-
of-life-decisions. At 90 days, the main relative was interviewed with the
Impact of Event Scale (to measure PTSD), the Hospital Anxiety and
Depression Scale and self-developed items on satisfaction with the ICU
experience, including medical care and communication in general as well
as specifically in the end-of-life context, and decision-making. Three
multiple linear regression models were calculated to predict anxiety,
depression and post-traumatic stress each.
Results: Eighty-four relatives were included. They were mostly female
(74%), spouse (42%) or child (42%), median age was 57 years. Seventy-
seven percent acted as proxies. After 90 days, 51% relatives were at risk
for PTSD, 48% for anxiety and 33% for depression. Overall satisfaction
with the ICU experience was high. Relatives’ satisfaction with medical
care and communication in general predicted lower anxiety (P = 0.025).
Conclusions: Relatives of patients with sepsis have a high psychological
burden. Improving communication between ICU staff and relatives may
reduce their symptoms of anxiety.
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Background: Severe sepsis has a high mortality and high healthcare
costs. Rapid recognition and treatment can save lives but requires a
coordinated response [1]. Hospital-wide audits in 2005 and 2010 showed
significant deficiencies when compared with international guidelines, with
35% of cases receiving antibiotics in <1 hour and only 25% receiving
basic pre-ICU interventions in a timely manner. By time-lining our
response to severe sepsis, we identified system and process failures [2].
Some system improvements (for example, providing first-line antibiotics
in acute areas) were straightforward to tackle, but sepsis care remained
reliant on individual clinician response. Equally, whilst dissemination of
organisation-level audit data raised the profile of sepsis, it appeared that
individual clinicians did not view it as ‘their problem’. It is recognised that
individualised feedback can improve care, as pride and the competitive
nature of healthcare workers drives improvement. This is especially true
when adherence to recommended practice is low [3]. We tried to change
behaviour by creating a rapid response audit/feedback mechanism that
informed clinicians of their own response to the severely septic patient,
from which they could learn and improve.
Materials and methods: Patients admitted to any critical care unit
(58 beds, four units, two sites) with a primary admission diagnosis of
Figure 1(abstract P61) Example report.
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infection were screened for severe sepsis. The pre-ICU care of patients
who met the criteria was then audited against the Surviving Sepsis
Guidelines [1]. Time zero was defined as when the criteria for severe
sepsis were first met. Information on timings of key interventions (such as
doctor review and request for critical care escalation) was also gathered.
An individualised traffic-light report was then generated and emailed to
the patient’s consultant and other stakeholders such as junior doctors or
nurses involved in the patient’s care (Figure 1). We aimed to report cases
back within 7 days of arrival to ensure the patient story was fresh in the
clinician’s mind. A cumulative report is generated monthly to track
organisation-wide performance.
Results: Since November 2011 we have provided feedback on over 300
severe sepsis cases. Antibiotic administration in <1 hour has risen from
35% to 75% (Figure 2), and pre-ICU bundle compliance has risen from
25% to 70% (Figure 3). Since November 2012 all sepsis cases in our
critical care units have been audited (30 to 35 cases/month).
Conclusions: Individualised feedback on sepsis care has led to
substantial improvements in guideline compliance.
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Background: To introduce the LD50 values of ISS or NISS from the Chinese
Trauma Data Bank, and to compare the roles of some formulae including
LD50 values in predicting the onset of post-trauma sepsis.
Materials and methods: Data of 6,542 patients (aged ≥16) from the
Chinese Trauma Data Bank were analyzed to obtain the LD50 values of ISS or
NISS using probit regression. A total of 908 trauma patients (aged ≥16)
admitted to Daping Hospital of Chongqing from January 2011 until June
Figure 2(abstract P61) Compliance with antibiotics in <1 hour.
Figure 3(abstract P61) Compliance with pre-ICU bundle of care.
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2013 were enrolled, Discrimination and calibration of the ISS, NISS, SIRS
score (the first 3 days post trauma), ISS/LD50ISS, NISS/LD50NISS, ISS´SIRS score,
NISS´SIRS score, ISS/LD50ISS´SIRS score, NISS/LD50NISS´SIRS score, ISS+SIRS
score, NISS+SIRS score, ISS/LD50ISS+SIRS score, and NISS/LD50NISS+SIRS score
in predicting post-trauma sepsis were compared using receiver operator
characteristic (ROC) curves and Hosmer-Lemeshow statistics.
Results: The LD50 values of ISS for age 16 to 44, 45 to 64, and ≥65 were
55, 49, and 33, respectively (for males: 54, 50, and 31; for females: 60, 47,
and 39). The LD50 values of NISS for age 16 to 44, 45 to 64, and ≥65
were 62, 56 and 43, respectively (for males: 62, 56, and 42; for females:
65, 53, and 48). The predicting capability of ISS/LD50ISS+SIRS score and
NISS/LD50NISS+SIRS score were equivalent (area under the ROC curve =
0.932 versus 0.932) and both showed better discrimination than others in
predicting post-trauma sepsis. For ISS/LD50ISS+SIRS score, the cutoff value
of ROC curve was 2.2128, with a positive predictive value of 65.86%, a
negative predictive value of 95.95%, a sensitivity of 87.13%, a specificity
of 87.11%, a positive likelihood ratio of 6.76, a negative likelihood ratio of
0.15, a Youden index of 0.7424, and an accuracy of 87.11%. For NISS/
LD50NISS+SIRS score, the cutoff value of ROC curve was 2.3208, with a
positive predictive value of 66.87%, a negative predictive value of 95.98%,
a sensitivity of 87.13%, a specificity of 87.68%, a positive likelihood ratio
of 7.07, a negative likelihood ratio of 0.15, a Youden index of 0.7481, and
an accuracy of 87.56%.
Conclusions: This study calculates for the first time the LD50 values of ISS
or NISS from Chinese trauma patients. The novel and simple formulae ISS/
LD50ISS+SIRS score and NISS/LD50NISS+SIRS score are then set up to predict
the incidence of sepsis following traumatic injury, which perform better at
predicting capability than ISS, NISS, SIRS score and other formulae
including LD50 values of ISS or NISS.
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Background: Sepsis is a major challenge in medicine, its high incidence,
mortality and high costs making this syndrome the leading cause of
mortality in ICUs, and is considered a health problem in a worldwide
extension that affects millions of people and results in high morbidity
and mortality. It is believed there are 18 million annually reported cases,
and of every four people diagnosed one is victimized by sepsis [1-3]. The
aim of this study was to identify the main aspects in the treatment of
sepsis in the last 10 years.
Materials and methods: A quantitative, descriptive and cross-sectional,
literature study, concerning the main aspects in the treatment of sepsis.
A semi-structured instrument developed by the authors was used to
collect data to categorize the studies obtained. After collection, an
electronic spreadsheet was generated, and data were analyzed using
descriptive statistics.
Results: Ten studies with a central theme focused on the treatment of
sepsis were used. Seventy percent of these studies were between the
years 2008 and 2011. Fifty percent of the articles mentioned that the
early approach of the infectious agent is very important for successful
treatment, while 60% reported that the control of the infectious focus is
one of the main alternatives. Fifty percent of the studies also reported an
infusion of antibiotics in accordance with the infectious focus as essential
to the treatment of sepsis, and 80% reported the use of activated protein
C as an indicator for diagnosis septic patients. It is observed that most
studies seek early detection of the infection and early antibiotic
administration, which reinforces the need for optimization of processes
for the bundle of the first hour of the sepsis protocol proposed by the
Latin American Institute of Sepsis (ILAS).
Conclusions: The present study therefore concludes that for effective
treatment of sepsis an early approach right after diagnosis of the
disease is indispensable. Likewise, the treatment of sepsis primarily
seeks to control the infectious focus using specific antibiotics. Also, the
use of activated protein C may be a good alternative in the diagnosis
of this pathology and a good indicator for controlling this disease.
Acknowledgements: Faculty of Nursing, Hospital Israelita Albert Einstein,
Department of the Post-graduate.
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Background: Severe sepsis and septic shock are challenges in critical
medicine care and there are few epidemiologic studies in public
university hospitals in Brazil.
Materials and methods: A prospective study was performed to
determine the epidemiology of the sepsis in hospitalized patients in our
institution (600-bed tertiary teaching urban hospital) from September
2012 to May 2013. The criteria for sepsis definition were obtained from
the 2013 guidelines [1]. Clinical and epidemiological data were collected
from patients’ records. A univariate, bivariate and multivariate analyses
were performed.
Results: In total, we analyzed 103 patients with severe sepsis and septic
shock during the period of study. The frequency of male gender was
55.8% and a median age of 62 years was observed in the patients. The
median acute physiology and chronic health disease classification system
II (APACHE II) score estimated was 21.1 and a community origin of sepsis
was present in 53.4% of them with a mortality rate of 61.3%. Yet in 57
(64.0%) patients with healthcare-associated sepsis, the mortality rate was
63.1% and the risk of death was higher for this group (odds ratio (OR) =
5.54; 95% confidence interval (CI) = 2.19 to 14.0; P < 0.05). In the entire
group, 53.4% had septic shock and 60.1% entered the vasopressor
protocol. In relation to the source of infection, the top three were:
pulmonary (51.4%), abdominal (14.5%) and urinary (12.6%). We observed
the greatest risk of death in the group with pulmonary infection (OR =
3.08; 95% CI = 1.1 to 8.5; P = 0.03). The prevalence of positive blood
cultures was 32.1% and 23 microorganisms were identified, these being
65.2% Gram-negative bacilli (Klebsiella pneumoniae (21.7%), Escherichia coli
(17.3%)), 21.7% Gram-positive cocci and 13.6% fungi. Lethality in sepsis
episodes was associated independently with the delay in starting
antibiotic therapy (more than 6 hours: OR = 2.94; 95% CI = 1.05 to 8.02;
P = 0.04), inappropriate plasmatic volume expansion use (less than
20 ml/kg: OR = 2.84; 95% CI = 1.07 to 7.5; P = 0.03) and pulmonary
source of sepsis (OR = 3.08; 95% CI = 1.1 to 8.5; P = 0.03). The use of
corticosteroids seemed to increase the mortality rate, but in the
multivariate analysis this association failed to reach statistical significance
(OR = 2.2; 95% CI = 0.08 to 6.5, P = 0. 1).
Conclusions: Enterobacteriaceae and pulmonary sepsis were the main
factors responsible for triggering sepsis. Fast and aggressive fluid therapy
and early adequate antibiotics are mandatory to change the lethality in
severe sepsis and septic shock. Further studies evaluating the effect of
therapy with corticosteroids should be assessed.
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Background: Sepsis represents a substantial healthcare burden. Limited
epidemiologic information about the demography of sepsis mortality or
about its temporal changes is available. Few population-based sources of
data have been used to investigate the burden of sepsis-associated
mortality on a national level. We investigated the epidemiology of sepsis
deaths in Brazil from 2002 to 2011 using secondary data from the
Brazilian Mortality Information System (Sistema de Informações de
Mortalidade (SIM)).
Materials and methods: A retrospective descriptive study using data
reported to the Brazilian SIM for the years 2002 to 2011. SIM is an
electronic, case-based mortality registry that derives its information almost
entirely from death certificates. Sepsis-associated deaths from 2002 to
2011 were identified based on International Classification of Diseases 10th
Revision codes listed on the underlying and on the contributing causes-of-
death. Population-based sepsis-associated mortality rates and trends were
estimated. In addition, age, gender, ethnicity, and outcome variables were
assessed. Considering the cases of sepsis identified during the study
period, annual population-based mortality rates were calculated using as
denominators population estimates provided by the Brazilian Institute of
Geography and Statistics with the 2010 census age-stratified population as
the standard. Trends of mortality rates over time were explored with the
chi-square test for trend. Rate changes were considered significant when
P < 0.05.
Results: The total number of deaths recorded in SIM increased over the
decade. In 2002 there were 982,294 deaths reported and in 2010 this
number was 1,133,761. The number of sepsis deaths increased from
95,972 (9.8%) to 186,712 (16.5%). The average age of sepsis-associated
deaths progressively increased from 60.2 years in 2002 to 2003 to 67.1
years in 2010 to 2011. During the same period the average age of all
deaths increased from 57.8 years to 62.7 years. White individuals were
more frequent (60.4%), as compared with mixed race (24.4%) and blacks
(6.6%). A substantial part of sepsis deaths occurred in the hospital
(94.8%). The age-adjusted rate of sepsis-associated mortality increased
from 69.5 deaths per 100,000 to 97.8 deaths per 100,000 from 2002 to
2010 (P < 0.001).
Conclusions: Between 2002 and 2011, the contribution of sepsis to all-
cause mortality increased significantly in Brazil. Moreover, age-adjusted
mortality by sepsis also augmented in the last decade. These numbers
confirm the importance of sepsis as a significant healthcare issue in Brazil
as well as the need for adequate strategies of early recognition and
treatment.
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Background: Critical patients requiring prolonged intensive care are more
at risk of being colonized by germs acquired in an ICU and present
infections. The factors that contribute to the high rate of infection and
mortality in ICUs are possibly associated with the severity of the
underlying disease, invasive proceedings, the long period of hospitalization
and use of antibiotics, especially the expanded spectrum, so that there are
multidrug-resistant bacteria, which complicates therapy. Approximately 5%
of patients admitted to ICUs will acquire a nosocomial infection, resulting
in increased length of hospitalization, around 5 to 10 days, and will be
considered a consequence of healthcare in 30% of cases. Diagnostic or
therapeutic interventions provide breakdown of the mechanical barrier of
the skin and mucus assigned to invasive, skin lesions caused by
devitalization, trauma or by removing the skin secondary to burns or
debridement. In addition to the mechanical factors that disrupt the natural
barriers of defense, there are others that are inherent in clinical conditions
of patients and promote the acquisition of infections in the hospital
environment; the immune ability is compromised because the natural
defense mechanisms are altered by the very nature base or as a result of
therapeutic interventions. The rate of infection is high among intensive
care patients, especially respiratory infections. Pseudomonas aeruginosa
was the prevalent bacteria in our ICU. That is why the prevalence of
infection acquired in the ICU is high and suggests that preventive
measures are important to reduce the occurrence of infection in critical
patients.
Materials and methods: Retrospective study, analyzing culture results
for 1 year in a ICU with 10 beds in the northern of state of Rio de
Janeiro. We considered cultures of urine, blood, cerebrospinal fluid,
tracheal aspirate, nasal swabs and catheter tip, and detected the most
prevalent microorganisms in our ICU.
Results: We analyzed 453 cultures, 178 (39.29%) were positive for some
germ, 240 (52.98%) were negative and 35 (7.72%) had impaired analysis.
Among the cultures were performed 152 blood cultures, 38 (25%)
positive and 114 (75%) negative, 96 urine cultures, 36 (52.17%) positive
and 60 (47.83) negative, 31 samples of tracheal secretions, 20 (64.51%)
positive and 11 negative (35.49%), 141 nasal swabs, 71 (50.35%) positive
and 70 negative (49.65%), and 27 cultures from the catheter tip, six
(22.22%) positive and 21 (77.78%) negative. Among the positive blood
cultures assayed as being prevalent was 31.57% with P. aeruginosa, the
second Staphylococcus aureus and Proteus mirabilis with the same number
of specimens, 15.78%. Among the 36 positive urine cultures, Candida
albicans was the prevalent with 22.22%, second place was 13.88%
Escherichia coli and P. mirabilis was third with 11.11%. The cultures were
tracheal P. aeruginosa as the most prevalent in half of the cases (50%),
and secondly C. albicans and Acinetobacter baumannii at 10%. Among the
cultures of nasal swab taken on admission of patients, the prevalent
germ was P. aeruginosa with 26.76%, in second place with 12.67% was
P. mirabilis and third with the same number of cases were A. baumannii
and Serratia marcescens, 11.26%. Among the catheter tip cultures,
P. aeruginosa was prevalent with 40%, and P. mirabilis second with 20%.
There no was positive cerebrospinal fluid culture in the period.
Conclusions: This study contributes to the knowledge of local resistance
rates, which is one of the basic steps for the establishment of individualized
strategies regarding the use of antimicrobials.
Acknowledgements: We are thankful to the Director, Laboratory and
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Background: Sepsis score classifications increase conditionally with
concurrent systemic inflammatory response syndrome (SIRS) score,
Sequential Organ Failure Assessment score, and clinical intervention.
However, hierarchical criteria fail to accurately classify sepsis when related
physiological manifestations are resolved, while the underlying infection
remains.
Materials and methods: To enable hour-to-hour sepsis classification, we
examined the diagnostic performance of a continuous sepsis score. We
identified 36 adult patients in the Christchurch Hospital ICU with sepsis
from a patient database. A severe sepsis biomarker was developed from
model-based insulin sensitivity, temperature, heart rate, respiratory rate,
blood pressures, and SIRS score. Sepsis and nonsepsis patient-hours were
categorized by the ACCP/SCCM guidelines, where each category was
scored independently, rather than hierarchically. Kernel density estimates
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were used to classify severe sepsis (including septic shock) of 1,690 hours
over 6,550 total hours. Optimal diagnostic performance from the receiver
operating characteristic (ROC) curve was determined for in-sample, out-of-
sample, and overall estimates.
Results: The severe sepsis biomarker achieved 86% sensitivity (81 to
94%), 85% specificity (80 to 95%), 0.93 (0.88 to 0.99) area under the ROC
curve, 8.2 (4.0 to 19.0) positive likelihood ratio, 0.17 (0.06 to 0.23)
negative likelihood ratio, 68% (58 to 87%) positive predictive value, 94%
(92 to 98%) negative predictive value, and a diagnostic odds ratio of
116 (17 to 308) at an optimal probability cutoff value of 0.25.
Conclusions: This clinical biomarker can thus be readily assessed at the
bedside to yield a non-invasive and continuous estimate of the
probability of severe sepsis. The results show high accuracy as a potential
severe sepsis diagnostic and monitoring response to sepsis interventions
in real time.
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Background: Acute lung inflammation (ALI) is a life-threatening pathology
and can develop during the course of several clinical conditions such as
pneumonia, acid aspiration or sepsis. Adenosine plays a significant role in
controlling acute inflammation via binding to A2A receptors on
inflammatory cells; that is, neutrophils or macrophages. The present study
was designed to evaluate the anti-inflammatory and immunomodulatory
effects of 2-chloroadenosine (2-CADO), alone or in combination with
amoxicillin/clavulanic acid (AMC), in Klebsiella pneumoniae B5055-induced
acute lung infection in mice.
Materials and methods: Acute lung infection in mice was induced by
directly instilling the selected dose (104 colony-forming units/ml) of
bacteria intranasally. Histopathological examination of the lungs was
performed to reveal neutrophil infiltration into the lung alveoli. In
addition to the major proinflammatory cytokines TNFa and IL-1a,
levels of the anti-inflammatory cytokine IL-10 were also determined by
ELISA.
Results: Intranasal instillation of bacteria caused profound neutrophil
infiltration into the lung alveoli as well as a significant increase in the
levels of proinflammatory mediators (that is, TNFa and IL-1a). However,
intravenous administration of 2-CADO 10 μg/kg/day, alone or in
combination with an antibiotic (that is, AMC 20 μg/ml/day i.p. 1 day
after establishment of infection), significantly decreased neutrophil
infiltration into the lung alveoli. A significant decrease in TNFa and
IL-1a along with elevation of IL-10 levels in the lung homogenate of
mice with acute lung infection was observed upon treatment with 2-
CADO alone, with no significant decrease in bacterial counts. Moreover
in combination with AMC, 2-CADO exhibited its immunomodulatory
action in acute lung infection and prevented ALI observed during acute
bacterial pulmonary infection, whilst an antibacterial action was
exhibited by AMC.
Conclusions: 2-CADO proved a potent immunomodulatory agent
during acute Gram-negative bacteria-induced ALI and exhibited its anti-
inflammatory and immunomodulatory potential even in the presence of
antibiotics. Thus, it has a potential to be used as an adjunct immuno-
modulatory agent during acute inflammatory conditions like ALI or
sepsis.
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Background: Fluid replacement has been a usually recommended
maneuver in sepsis; however, growing clinical controversies in the
management of critically ill patients with severe sepsis have questioned its
benefit. Herein, we evaluated the effect of a rapid hyperhydration (HH)
therapy in varying stages of sepsis.
Materials and methods: Wistar-EPM rats, weighing 200 to 250 g, were
submitted to two sepsis models: S8 group, submitted to 2 ml Escherichia
coli 108 CFU/ml intravenous (i.v.) inoculation, LD60, or S9 group, with
E. coli 109 CFU/ml inoculation, LD80. Both groups were treated with HH
(30 ml/kg of Ringer lactate i.v., in 20 minutes) in the early (E30 minute)
and late (L6 hour) phases of sepsis. The mortality was followed up to
30 days (n = 6/group) and the splanchnic microcirculation was monitored
by sidestream dark field imaging (SDF) video microscopy at 6-hour and
24-hour periods (n = 3/group/period).
Results: The HH at the E30 minute phase of S8 improved the survival
rate from 40% to 90%, and L6 hour phase HH promoted an 80%
survival rate. Besides, the survival rate in S9 (LD80), with E30 minute HH,
improved the survival rate from 20% to 50%. However, it was less
effective as compared with the E6H phase HH, which resulted in an
expressive survival rate (from 20% to 70%). These intriguing results
suggested that there is an interdependent and time-dependent
pathophysiology feature within the host response based on sepsis
severity stage and a rapid high-volume reposition. The SDF analysis in
control sepsis groups (S8 and S9), without fluid therapy, showed a
broadly distributed microcirculation dysfunction in the liver lobules and
kidney tubules at 6 hours after sepsis challenge, and such findings were
similar between groups, but after 24 hours the survivors showed an
improved microcirculation hemodynamic pattern and it was more
evident in the S8 group. The survivals of the S8 E30 minute treated
group showed less injury at 6 hours and 24 hours as compared with
nontreated groups and S8 L6 hour treated animals. In S9 treated
groups, both showed a partial repair at 24 hours post sepsis.
Conclusions: The hyperfluid therapy given rapidly in both early and late
phases in sepsis and severe sepsis states showed that its beneficial effect
was more or less effective dependent on the phase and sepsis intensity;
however, the more prominent survival rates were seen at the early phase
of sepsis (S8) and at the later phase of severe sepsis (S9). The underlying
pathophysiology evolved in these paradoxical conditions needs to be
better elucidated.
Acknowledgements: Grant number 2012/20841-7, São Paulo Research
Foundation (FAPESP).
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Background: A positive blood culture (BC) is considered the gold
standard method for the sepsis diagnosis, although its sensibility is low
(10 to 30%) which demands a better diagnostic tool to limit broad-
spectrum antibiotic use in the majority of patients without culture-based
sepsis diagnosis. Besides, after microbial invasion, they can remain live,
dead or fragmented in the bloodstream, thus limiting BC efficiency.
Herein we evaluated the PCR diagnostic efficacy under live, dead and
bacterial DNA contents in the bloodstream.
Materials and methods: Wistar rats were distributed in three groups
(n = 20/group) based on live, dead and DNA inoculations. The LPS+DNA
group (1 mg/kg LPS injection plus 4 hours later DNA injection, n = 10)
was designed for DNA detection under an induced inflammatory state.
Live, Dead and extracted DNA forms of Pseudomonas aeruginosa (ATCC
27853) relative to 2 ml of 107 colony-forming units/ml were injected into
the circulation. Blood samples were collected after 20 minutes and
6 hours (n = 10/group/period), and were submitted to nested PCR assay
using general and specific primers. BC was performed with 200 μl and
3,000 μl only in the Live group.
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Results: In the Live group, at 20 minutes the sensibility was 100% by both
BC and PCR and at 6 hours the sensitivity was 60% (with 200 μl) and 90%
(with 3,000 μl) in BC, and 80% in PCR sampled with 50 μl blood volume. In
the Dead group, the PCR sensitivity was 90% at 20 minutes and 50% at
6 hours. In the DNA group, the sensitivity remained at 50% independent of
time. The inflamed condition did not change PCR sensitivity. Overall data
showed that in both techniques the sensitivity dropped with time. In the BC
assay the positivity was dependent on sampled blood volume, and in the
PCR it was related to live or dead condition. These findings suggest that the
live bacteria remain for a short period of time in the bloodstream while DNA
can last for longer periods.
Conclusions: Considering that PCR is performed with 40× less blood
compared with a habitual BC, PCR can be an assay of choice when BC is
negative and in conjunction in a live bacteria circulating condition. Besides,
the PCR assay with specific primers can be a useful method for sepsis
diagnosis in specific bacterial surge events in the ICU, thus improving
antibiotic usage potentials.
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Background: Prior exposure to infection, particularly during the neonatal
phase, contributes to individual differences in susceptibility to disease
during adult life. Animal neonates undergoing lipopolysaccharide
administration (LPS) react differently to the front endotoxemia in adulthood.
Ghrelin, a peptide hormone originally found in the stomach, has effects on
the modulation of the inflammatory response. Specific receptors are found
for ghrelin on neutrophils, macrophages and lymphocytes and their
activation by ghrelin inhibits the production of several inflammatory
cytokines, including nitric oxide (NO). Therefore, our objective is to evaluate
the role of ghrelin in the attenuation of fever during endotoxemia in
adulthood induced by neonatal exposure to LPS.
Materials and methods: The study was conducted using rats in the
pregnancy period. After the birth of pups (day 0 of the experiment) we
selected only male rats. All animals were weaned at 21 days and at 14 days
of age received neonatal administration of LPS 100 μg/kg intraperitoneally
(i.p.). Subsequently they were separate in cages until they reached 8 to
12 weeks of age for the experiment (by endotoxemia in adult
administration of 10 mg/kg LPS i.p.). To determine the body temperature,
the animals were anesthetized and a capsule inserted into the peritoneal
cavity biotelemetry. Body temperature was measured for a period of
6 hours after induction of endotoxemia. To verify the effect of ghrelin and
ghrelin antagonist on body temperature during endotoxemia, ghrelin was
administered 0.1 mg/kg ghrelin antagonist or 50 nmol/kg i.p. concomitant
administration of LPS. After decapitation, blood samples were collected
and centrifuged to separate the plasma. The plasma was stored at -70°C
for subsequent determination of NO.
Results: In our preliminary data we observed no significant difference in
fever-induced endotoxemia in animals subjected to LPS administration in
the neonatal period, when compared with their respective controls.
Conclusions: These data do not corroborate the findings of the literature
and we believe it is due to the fact that the animals used until now have
had prior exposure to pathogens. So in our next experiments we will use
experimental animals that are specific pathogen free.
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Background: Considering that the communication of the intestinal
immunity with the systemic bloodstream can be a relevant adjuvant
factor in the amplification of the host systemic inflammatory response
and subsequent multiple organ dysfunction in sepsis, we aimed to
evaluate the effect of the obstruction of the mesenteric lymph duct
(OMLD) associated with massive fluid therapy in the early phase of sepsis
and severe sepsis models.
Materials and methods: Adult Wistar-EPM rats were submitted to 108
(S8) or 109 (S9) CFU/ml Escherichia coli inoculum intravenously (i.v.)
(DL80 within 26 hours), and were treated with hyperhydration (HH) with
or without previous OMLD (n = 5/group). Control group were naïve
animals (N) and animals submitted to HH or sepsis only. The mortality
of groups was followed up to 30 days after experiments and micro-
circulation monitoring was observed at 6 hours post sepsis induction by
videomicroscopy (sidestream darkfield imaging (SDF)).
Results: The effect of OMLD + HH reduced significantly the sepsis
mortality rate: S8 (60% to 14.5%) and S9 (80% to 60%). Besides, the liver
and kidney microcirculatory features were better preserved as compared
with untreated sepsis groups under video-microscopy (SDF) monitoring.
(Figure 1).
Conclusions: These preliminary findings showed that both HH and OMLD
have a potential therapeutic application in sepsis by minimizing the
splanchnic organ’s microcirculation dysfunction.
Acknowledgements: Grant number 2011/204014, São Paulo Research
Foundation (FAPESP).
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Background: Recent studies from our laboratory showed that animals
subjected to 50% shortening of the small intestine developed bacterial
translocation unleashed chronically. Bacterial translocation has shown the
effect of exacerbation of systemic inflammatory response by crosstalk
between intestinal and systemic immune response. In this sense, the aim
of this study was to evaluate whether a septic challenge in the state of
chronic inflammation resulting from the shortening of the small bowel
can modify the mortality outcome and trigger organ alterations in the
long term.
Materials and methods: Wistar-EPM rats were submitted to 50% small
intestine shortening (IS group, n = 20) or sham intestinal anastomosis (IA
group, n = 20), and after 4 months were submitted to sepsis challenge
with 2 ml 108CFU/ml Escherichia coli i.v. The mortality was observed up to
30 days and the survivors of both groups were killed after 6 months for
histological analysis. The other 10 animals were killed after 4 months of
intestinal shortening in order to determine the histological pattern
related to the bowel shortening effect.
Results: The mortality rate after sepsis was 80% in the IS group and 35%
in the IA group. The bowel shortening without sepsis challenge showed
hepatic mild steatosis with inflammation similar to acute hepatitis, vascular
congestion and focal necrosis. The distal ileum showed shortening and
broadening of villus, focal cryptic necrosis and mild macrophages and
eosinophil infiltration in the lamina propria. In the IS group was seen a
generalized steatosis and vascular congestion in the liver; alveolar
atelectasis, BALT hyperplasia, a large number of macrophages, mast cells,
foam cells, lymphocytes, eosinophil and plasmocyte infiltration and
alveolar edema, plus vascular congestion and sclerosis in the lung; villus
apical necrosis, intense inflammatory cell infiltration and vascular
congestion in the lamina propria of the ileum; and the kidney with tubular
nephrosis, tubular obstruction, vascular congestion with interstitium
hemorrhage and tubular hyaline material deposition. In the IA group was
seen moderate liver steatosis, intestinal lamina propria cellular infiltrations,
glomerulonephritis, kidney tubular edema, parenchymal hemorrhage and
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Bowman capsule thickness. However, the alterations were less compared
with the IS group.
Conclusions: The chronic inflammatory state, in combination with
sepsis, might be an important aggravating factor related to sepsis
morbidity and mortality by promoting an increasing organ dysfunction
in the long term.
Acknowledgements: Grant number 2011/20401-4, São Paulo Research
Foundation (FAPESP).
Figure 1(abstract P72) Splanchnic organ’s microcirculation following 6 hours after sepsis or HH procedures by SDF monitoring: (a) HH; (b) S8 +
OMLD + HH; (c) S9 + OMLD + HH.
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Background: Cholecystokinin (CCK) receptors are expressed in macro-
phages and are upregulated by inflammatory stimulus. In vitro and in vivo
studies have demonstrated the ability of CCK to decrease the production
of various proinflammatory cytokines. This study investigates the role of
CCK on iNOS expression in lipopolysaccharide (LPS)-activated peritoneal
macrophages, as well as the intracellular signaling pathways involved in
affecting iNOS synthesis.
Materials and methods: Experimental procedures were approved by the
Comitê de Ética em Experimentação Animal - FMRP (protocol number 152/
2009). Thioglicollate-elicited macrophages were obtained by peritoneal
lavage and cultured in RPMI 1640 medium, 10% fetal bovine serum and
antibiotics. Nuclear p65, cAMP and iNOS levels were determined using
ELISA kits, CCK receptors and IBa expression by western blot and nitrite
by the Griess method. Data were compared by one-way ANOVA and
significant differences obtained using the Tukey multiple variances post
hoc test.
Results: CCK reduced NO production attenuating iNOS mRNA expression
(15.49 ± 10.80 vs. 113.16 ± 0.23 AU; P < 0.05) and protein formation.
Furthermore, CCK inhibited the NF-B pathway reducing IBa degradation
and minor p65-dependent translocation to the nucleus (543.78 ± 84.57 vs.
90.42 ± 9.13%, P < 0.05). Moreover, CCK restored the intracellular cAMP
content activating the cAMP-protein kinase A (PKA) pathway, which resulted
in a negative modulatory role on iNOS expression and nitrite production. In
peritoneal macrophages, the CCK-1R expression was predominant and
upregulated by LPS (0.61 ± 0.08 vs. 0.30 ± 0.09 AU; P < 0.05). The
pharmacological studies confirmed that CCK-1R subtype is the major
receptor responsible for the biological effects of CCK.
Conclusions: These data suggest an anti-inflammatory role for the
peptide CCK in modulating iNOS-derived NO synthesis, possibly
controlling the macrophage hyper-activation through NF-B, cAMP-PKA
and CCK-1R pathways.
Acknowledgements: Fapesp and CNPq.
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Background: The interaction of endotoxins (lipopolysaccharides (LPS)) from
Gram-negative bacteria with peripheral blood mononuclear cells leads to
the assembly of a receptor cluster composed from mCD14, CD11b/CD18,
TLR4, CD16A and CD36 [1,2]. It is well known that the main signal
transducing receptor complex is TLR4/MD-2 while mCD14 is involved in the
recognition of S or R endotoxin’s glycoforms [3,4]. A growing body of
evidence indicates that the CD11b/CD18 receptor plays the significant role
in the endotoxin signaling machinery because it can influence TLR4-
mediated cell activation [5]. So, using mAbs, we carried out experiments to
elucidate the influence of CD11b inhibition on neutrophil priming by
endotoxins for N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced
respiratory burst.
Materials and methods: Human neutrophils were isolated from
heparinized blood of healthy volunteers by standard procedure and
incubated with or without anti-TLR4 mAbs (HTA125, IgG2a) or anti-CD11b
mAbs (clone 44, IgG1) or isotypic immunoglobulin controls, respectively, for
30 minutes before stimulation with S-LPS or Re-LPS from Escherichia coli O55:
B5 or JM103, respectively. The cells (2 × 105), 2% of autologous serum,
glucose and luminol in Ca2+-PBS buffer (pH 7.3), were placed in the
chemiluminometer’s chambers (37°C) and primed by S-LPS or Re-LPS
(100 ng/ml) for 30 minutes (37°C). Reactive oxygen species (ROS) production
was triggered by addition of fMLP (1 µM). The chemiluminescence reaction
was monitored continuously for 7 minutes. Total ROS production by control
and LPS primed neutrophils during the first 50 seconds after fMLP addition is
presented in Figure 1.
Results: Re-LPS revealed the most neutrophil priming activity in
comparison with S-LPS (Figure 1A), which is in accordance with our
previous work [6]. Actually, mAbs against TLR4 as well as against CD11b
did not inhibit neutrophil priming by E. coli endotoxins. Moreover, the
incubation of cells with anti-TLR4 or anti-CD11b mAbs followed by
endotoxin priming increased fMLP-induced ROS production (Figure 1A).
However, the differences between priming effectiveness of S-LPS and Re-
LPS, which had been seen in endotoxin primed cells, were leveled by
prior cell exposure to anti-CD11b mAbs. Neutrophils exposed to anti-TLR4
mAbs retained their ability to distinguish between S-LPS or Re-LPS being
primed, respectively (Figure 1A). Incubation with isotypic IgG2a decreased
fMLP-induced ROS production from unprimed neutrophils (Figure 1B) that
was not observed in the case of IgG1. These results demonstrate that Fc
regions of isotypic immunoglobulins and therefore of mAbs used in our
study are not silent parts of these molecules regarding neutrophil surface
receptors and their intracellular signaling pathways. Finally, the
incubation of cells with isotypic immunoglobulins and then with Re-LPS
did not abrogate neutrophil priming for subsequently fMLP-triggered ROS
production.
Conclusions: The inhibition of human neutrophil CD11b by specific
mAbs (clone 44) did not abolish LPS-dependent neutrophil priming for
fMLP-induced respiratory burst, but eliminated the capacity of these cells
to distinguish between S-LPS or Re-LPS glycoforms. Unlike the effect of
anti-CD11b mAbs, neutrophil exposition to anti-TLR4 mAbs (HTA125) did
not inhibit neutrophil priming and capacity of these cells to distinguish
endotoxin’s glycoforms.
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Introduction: Attention has been paid in recent years to studies showing
immune cell death mechanisms during the course of sepsis in response
to proinflammatory and anti-inflammatory mediators that are involved in
its pathophysiology. Taurine (Tau) is an abundant amino acid in
polymorphonuclear leucocytes that reacts with hypochlorous acid to form
taurine chloramine (TauCl) under inflammatory conditions. In this context,
we investigated potential interactions between lymphocytes and TauCl in
rats submitted to cecal ligation and perforation (CLP), analyzing cell
viability and cytokine secretion profile (TNFa, IFNg, IL-6, IL-17A, IL-23 and
IL-10).
Materials and methods: Adult male rats were divided in two groups:
sham and CLP that were killed 24 or 120 hours after sepsis induction to
isolate lymphocytes from the blood and spleen. Lymphocytes (>95.0%
purity determined by differentiation with Giemsa staining) were cultured
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for 24 hours at a concentration of 1 × 106 cells/ml and activated by
2 mg/ml concanavalin A. After 24 hours, Tau and TauCl were added
at concentrations of 0.1, 0.2, 0.3, 0.4 and 0.5 mM for 1 hour. After this
time, cells were incubated with MTT (500 μg/ml) for 3 hours to evaluate
cell viability and supernatants were used to determine cytokine
concentrations.
Results: Tau-treated cells exhibited better viability than those treated
with TauCl, in both time and organs. TauCl, in a time and dose-
dependent ratio, decreased cytokines secretion when compared with
untreated cells. See Figures 1 to 7.
Conclusion: These findings show a possible impairment in lymphocyte
function promoted by TauCl, correlated with immunosuppression and cell
death characteristic of the late stages of sepsis.
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Figure 1(abstract P75)
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Figure 1(abstract P76) Cell viability by MTT assay. Viability of lymphocytes treated with Tau and TauCl in different molar concentrations. Rats were
submitted to CLP or Sham, and 24 or 120 hours after the surgery their blood and spleens were collected, the lymphocytes were isolated, cultured and
the cell viability was measured by MTT assay. (A) blood, 24 hours; (B) blood, 120 hours; (C) spleen, 24 hours; (D) spleen, 120 hours. *P < 0.05, compared
with sham group (Tau-treated); #P < 0.05, compared with sham group (TauCl-treated), n = 5.
Figure 2(abstract P76) Cytokine secretion. Effect of TauCl on production of proinflammatory mediator IL-17A by Th17 lymphocytes. Activated
lymphocytes (1 × 106 cells/ml) were preincubated with TauCl (0.1 or 0.5 mM) for 1 hour. After this, supernatants were collected and IL-17A was
measured by ELISA. (A) blood; (B) spleen. Results are expressed as means ± SD. *Compared with sham control 24 hours; #compared with Clp control
24 hours; &compared with sham control 120 hours; $compared with Clp control 120 hours, all with P < 0.05 significant (n = 5).
Figure 3(abstract P76) Effect of TauCl on production of proinflammatory mediator IL-23 by Th17 lymphocytes. Activated lymphocytes (1 × 106
cells/ml) were preincubated with TauCl (0.1 or 0.5 mM) for 1 hour. After this, supernatants were collected and IL-23 was measured by ELISA. (A) blood;
(B) spleen. Results are expressed as means ± SD. *Compared with sham control 24 hours; #compared with Clp control 24 hours; &compared with sham
control 120 hours; $compared with Clp control 120 hours, all with P < 0.05 significant (n = 5).
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Background: Sepsis is a clinical condition resulting from the excessive
inflammatory response of the host against an infectious agent and is
associated with high morbidity and mortality in patients in ICUs. In sepsis
the brain can be targeted, associated with mental damage and decline,
impaired attention, disorientation, delirium and coma. It has been seen that
the permeability of the blood-brain barrier (BBB) is associated with septic
encephalopathy, allowing cell infiltration and increased oxidative stress.
Accordingly, such events can be potentiated through the involvement of
molecules that when activated perpetuate the inflammatory response and
the breaking of the BBB, and it is possible to postulate that the CD40
molecule may be involved by being under increased expression in microglia
in inflammatory events occurring systemically. The aim of this study
therefore is to evaluate the role of CD40 in the breakdown of the BBB, cell
infiltration and oxidative damage in the brain of rats with sepsis.
Materials and methods: Male Wistar rats were subjected to cecal
ligation and puncture (CLP) to induce sepsis. The animals (n = 10) were
Figure 4(abstract P76) Effect of TauCl on production of proinflammatory mediator IFNg by Th1 lymphocytes. Activated lymphocytes (1 × 106
cells/ml) were preincubated with TauCl (0.1 or 0.5 mM) for 1 hour. After this, supernatants were collected and IFNg was measured by ELISA. (A) blood;
(B) spleen. Results are expressed as means ± SD. *Compared with sham control 24 hours; #compared with Clp control 24 hours; &compared with sham
control 120 hours; $compared with Clp control 120 hours, all with P < 0.05 significant (n = 5).
Figure 5(abstract P76) Effect of TauCl on production of proinflammatory mediator TNFa by Th1 lymphocytes. Activated lymphocytes (1 × 106
cells/ml) were preincubated with TauCl (0.1 or 0.5 mM) for 1 hour. After this, supernatants were collected and TNFa was measured by ELISA. (A) blood;
(B) spleen. Results are expressed as means ± SD. *Compared with sham control 24 hours; #compared with Clp control 24 hours; &compared with sham
control 120 hours; $compared with Clp control 120 hours, all with P < 0.05 significant (n = 5).
Figure 6(abstract P76) Effect of TauCl on production of proinflammatory mediator IL-6 by Th2 lymphocytes. Activated lymphocytes (1 × 106 cells/ml)
were preincubated with TauCl (0.1 or 0.5 mM) for 1 hour. After this, supernatants were collected and IL-6 was measured by ELISA. (A) blood; (B) spleen. Results
are expressed as means ± SD. *Compared with sham control 24 hours; #compared with Clp control 24 hours; &compared with sham control 120 hours;
$compared with Clp control 120 hours, all with P < 0.05 significant (n = 5).
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divided into sham, CLP, CLP + 1 ng, CLP + 10 ng and CLP + 100 ng anti-
CD40 antibody administered intracerebroventricularly. The rats were killed
at 24 hours for assessment of oxidative damage in lipids (TBARS),
damage to proteins by protein carbonylation, nitrite/nitrate concentration
(NO), myeloperoxidase (MPO) and breakdown of the BBB. The other
group was subjected to CLP and after 24 hours they were killed and the
hippocampus removed to analyse expression of CD40 and CD40L by
western blotting. Data were evaluated by ANOVA and post-hoc Tukey test
with significance P < 0.05.
Results: Our results show that in the most effective dose of 100 ng/kg
anti-CD40 showed a decrease in the breakdown of the BBB, MPO, nitrite/
nitrate concentration and TBARS. A dose of 1 ng/kg was effective only in
the reduction of nitrite/nitrate concentration and 10 ng/kg was not
effective in TBARS and carbonyl. Western blotting analysis showed
increased expression of CD40 and CD40L in CLP animals when compared
with sham.
Conclusions: Modulation of the levels of CD40 may represent a potential
therapeutic target in sepsis.
Acknowledgements: CAPES, CNPq, UNESC and UNISUL.
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Background: Endothelial dysfunction is a key step in endotoxemia-
derived sepsis syndrome pathogenesis. It is well accepted that the
bacterial endotoxin lipopolysaccharide (LPS) induces endothelial cell (EC)
dysfunction through immune system overactivation [1-3]. However, LPS
can also affect ECs in the absence of participation by immune cells [4-6].
Although interactions between LPS and ECs evoke endothelial death, a
significant portion of ECs are resistant to LPS challenge [6-8]. However, the
mechanism that confers endothelial resistance to LPS is not known.
Considering that LPS-resistant ECs exhibit a fibroblast-like morphology,
suggesting that these ECs enter in a fibrotic program in response to LPS,
our aim was to investigate whether LPS induces endothelial fibrosis and
explore the underlying mechanism.
Materials and methods: We used two different models: primary ECs, and
intact blood vessels (IBV). Both preparations were freshly obtained from
umbilical cord veins from normal pregnancies, after patients’ informed
consent. The investigation conforms with the principles outlined in the
Declaration of Helsinki. The Commission of Bioethics and Biosafety of
Universidad Andres Bello approved all experimental protocols. Once the
preparation was established they were cultured with or without LPS as a
model of endotoxemia. ECs were exposed to 20 mg/ml LPS for 72 hours,
while IBV was challenged to 20 mg/ml LPS on the inside for 48 hours.
Results: ECs exposed to LPS showed a fibroblast-like morphologic change.
In addition, LPS-treated ECs showed an upregulation of both fibroblast-
specific protein expression such as fibroblast specific protein-1 and a-
smooth muscle actin, and extracellular matrix proteins secretion including
fibronectin and collagen type III. In concordance, ECs exposed to endotoxin
showed a severe downregulation of endothelial markers such as vascular
endothelial cadherin and the platelet endothelial cell adhesion molecule-1
(CD31). Similar results were obtained in the endothelial monolayer from IBV
perfused with LPS in which abundant fibrosis was observed. Furthermore,
we demonstrate that LPS-induced EC fibrosis is dependent on the endotoxin
receptor toll-like receptor-4. In addition, the participation of NAD(P)H oxidase
activity and ROS generation was demonstrated using specific blockers.
Finally, we demonstrated by means of small interfering technology and a
pharmacological inhibitor that LPS-induced EC fibrosis is dependent on the
activin like kinase-5 kinase activity, suggesting that tumor growth factor
beta is involved in this fibrotic process.
Conclusions: We conclude that LPS is able and sufficient to promote
endothelial fibrosis. It is noteworthy that LPS-induced endothelial fibrosis
perpetuates endothelial dysfunction as a maladaptive process rather than
a survival mechanism for protection against LPS. These findings are useful
in improving current treatment against endotoxemia-derived sepsis
syndrome and other inflammatory diseases.
Acknowledgements: Fondecyt 1121078 (FS), 1120380 (CCV), MECESUP
UAB0802 (CE), UNAB DI-67-12/I (CE), and Millennium Institute on
Immunology and Immunotherapy P09-016-F (FS).
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Figure 7(abstract P76) Effect of TauCl on production of anti-inflammatory mediator IL-10 by Th2 lymphocytes. Activated lymphocytes (1 × 106
cells/ml) were preincubated with TauCl (0.1 or 0.5 mM) for 1 hour. After this, supernatants were collected and IL-10 was measured by ELISA. (A) blood;
(B) spleen. Results are expressed as means ± SD. *Compared with sham control 24 hours; #compared with Clp control 24 hours; &compared with sham
control 120 hours; $compared with Clp control 120 hours, all with P < 0.05 significant (n = 5).
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Background: Calcium activity is essential to vascular smooth muscle
contraction. Although it is well established that arteries from rats in septic
shock present hyporesponsiveness to vasoconstrictor drugs, the role of
calcium mobilization in this contractile dysfunction is far less investigated.
We hypothesized that during septic shock calcium dynamics is changed
and may have a role in the vascular dysfunction in sepsis.
Materials and methods: Female Wistar rats (3 months old) were
anesthetized by oxygen-isoflurane (3%) inhalation and subjected to cecal
ligature and puncture surgery (CLP). Immediately after and every 12 hours
rats received physiological saline solution (PBS 30 ml/kg, subcutaneously)
and tramadol (5 mg/kg, subcutaneously). After 6 hours (CLP-6) or 24 hours
(CLP-24) rats were killed, the aorta was harvested and cut in rings, the
endothelium was removed and rings were mounted in baths. Rings were
exposed to KCl 120 mM and phenylephrine (PE 1 µM). Aorta rings were
kept in a modified depolarizing Krebs solution nominally Ca2+ free and
contracted by CaCl2 (1 to 100 mM). The same protocol were repeated in
presence of thapsigargin (3 µM), DTNB (100 µM) or PTIO (100 µM).
Different vessels were exposed to single concentrations of PE (1 μM) or
caffeine (20 mM) in Ca2+-free solution, in the presence or absence of
thapsigargin.
Results: Maximal contraction (Emax) induced by KCl or PE was reduced,
especially in the CLP-24 group. Similarly, CaCl2-induced contraction was
reduced (60%) in the CLP-24 group. Thapsigargin (sarcoplasmatic calcium
reuptake blocker) and DTNB (sulphydryl oxidation) restored the
contraction elicited by CaCl2 in septic rings, but without effect in control
rings. PE-induced contraction in calcium-free solution was significantly
reduced in CLP-24 rings (Emax 1.6 ± 0.4 g control vs. 0.3 ± 0.1 g CLP-24
rings). Thapsigargin did not change the hyporesponsiveness to PE but
PTIO (nitric oxide scavenger) restored it partially. Caffeine-induced
contraction in Ca2+-free solution was reduced in CLP-24 rings (0.2 ± 0.06 g
control vs. 0.03 ± 0.01 g in CLP-24). Thapsigargin or PTIO restored the
contraction induced by caffeine.
Conclusions: These data suggest that in septic shock septic calcium
mobilization is strongly impaired. Although preliminary, our results
suggest that calcium channel nitrosylation and calcium reuptake may be
reasons for the vascular hyporesponsiveness of septic shock.
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Background: Hypotension and cardiac dysfunction are frequently found in
severe sepsis and septic shock. Vasoactive and inotropic drugs are largely
used to reverse hypotension, but its effects on heart function have been
scarcely investigated [1]. We thus evaluated the influence of both
norepinephrine and dobutamine on the cardiovascular function of rats
subjected to cecal ligation and puncture (CLP).
Materials and methods: The measurement of the cardiac function was
performed in male Wistar rats (3 to 4 months old), kept under isoflurane-
induced anesthesia (1 to 3%), using a pressure-volume catheter, which was
inserted into the left ventricle through the carotid artery. Blood samples
were collected from all animals for hematological analyses. The experi-
ments were conducted at 24 and 48 hours after CLP. For this, the cecum
was ligated with a ratio of 50% and perforated with a needle (18 G, four
holes; mortality rate ~50% after 48 hours), followed by four subcutaneous
injections (12/12 hours) of sterile saline (30 ml/kg) and tramadol (5 mg/kg),
for fluid resuscitation and analgesia, respectively. Data were recorded at
baseline and after single bolus administration of norepinephrine (1, 3 and
10 nmol/kg, i.v.) or dobutamine (3, 10 and 30 nmol/kg, i.v.). The results
obtained in CLP groups were compared with control (CT) animals, which did
not undergo any manipulation.
Results: Both CLP 24 and 48 hour groups presented thrombocytopenia
(~40% reduction), lymphopenia, hypoglycemia and leukopenia (P < 0.05),
a clear indication of severe sepsis. However, only CLP 48 hour animals
displayed refractory hypotension (MAP = 59 mmHg, vs. 78 mmHg in CT;
P < 0.05) in spite of volume resuscitation. The highest doses of
norepinephrine and dobutamine increased the MAP to 133.8 ± 8.1 and
97.8 ± 3.1 mmHg in CT, and to 120.6 ± 6.7 and 77.3 ± 4.4 mmHg in CLP
48 hour animals, respectively. The heart rate was significantly increased
by norepinephrine and dobutamine in control, but not in CLP 48 hour
animals. In addition, the basal values of both dP/dtmax and dP/dtmin, as
well as after 1 nmol/kg dobutamine, were reduced in CLP 48 hour
animals.
Conclusions: Using a pressure-volume catheter in a closed-chest
approach we demonstrated that, in spite of the ability to increase blood
pressure, the chronotropic effects of norepinephrine and dobutamine are
reduced at 48 hours after CLP in rats subjected to CLP. In addition, all
doses of norepinephrine, but only by the highest doses of dobutamine,
improved systolic and diastolic function in these animals.
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Background: The cardiovascular dysfunction of sepsis/septic shock is
characterized by hypotension, tachycardia/bradycardia, endothelial
dysfunction and hyporesponsiveness to vasoconstrictors. Hypotension and
low tissue perfusion trigger an increase in sympathetic tone probably as an
attempt to restore blood pressure to normal levels. The persistently higher
sympathetic stimulation may lead to the exhaustion of the capacity of
vascular response and thus create a vicious circle contributing to vascular
hyporesponsiveness and higher adrenergic stimulation. In addition, in
septic shock patients, increased arterial levels of norepinephrine (NE) were
significantly associated with mortality. The aim of this work was to
evaluate the vascular response to an adrenergic agonist during severe
sepsis and the effects of the early inhibition of sympathetic tone in sepsis-
induced cardiovascular dysfunction.
Materials and methods: Sepsis was induced by cecal ligation and puncture
(CLP) surgery in female Wistar rats. Septic animals and controls (CT) were
treated with the ganglionic blockers pentolinium (PENT; 5 mg/kg, s.c.) or
hexamethonium (HEX, 15 mg/kg, s.c.) or vehicle (saline) 1 hour after surgery.
The vascular response to the administration of NE was assessed 6 hours
or 24 hours after CLP surgery. The survival rate was also evaluated. All
procedures were approved by our Institutional Ethics Committee (PP00631/
CEUA-UFSC) and are in accordance with NIH Animal Care Guidelines.
Results: Six hours after CLP surgery, septic animals were hypotensive.
Treatment with hexamethonium or pentolinium prevented the
development of hypotension (control 84.8 ± 2.6; CLP 60.7 ± 4.5*; CLP +
HEX 72.7 ± 3.1; CLP + PENT 78.1 ± 2.7 mmHg; *P < 0.05 compared with
control group). However, 24 hours after surgery, the ganglionic blockers
failed to prevent hypotension (control 88.5 ± 1.7; CLP 62.7 ± 1.7*; CLP +
HEX 68.8 ± 2.7*; CLP + PENT 70.9 ± 3.4* mmHg; *P < 0.05 compared with
control group). The vascular hyporesponsiveness to NE observed both
6 hours and 24 hours after CLP was completely blocked by the early
treatment with both ganglionic blockers (NE 10 nmol/kg, expressed as
increase in blood pressure compared with baseline: control 54.2 ± 4.5;
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CLP 6 hours 21.9 ± 3.1*; CLP 6 hours + HEX 52.6 ± 7.0; CLP 6 hours +
PENT 54.1 ± 4.9; CLP 24 hours 31.1 ± 5.6*; CLP 24 hours + HEX 74.6 ±
3.0; CLP 24 hours + PENT 64.4 ± 7.8 mmHg; *P < 0.05 compared with
control group). The early ganglionic blockade with PENT decreased the
mortality observed after 96 hours.
Conclusions: Our data indicate that increased sympathetic tone in sepsis
contributes, at least in part, to the development of hypotension,
hyporesponsiveness to vasoactive agents and mortality. Blockade of
increased sympathetic tone thus may be considered as an adjuvant
therapy for the treatment of septic cardiovascular dysfunction.
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Background: Low levels of nitric oxide (NO) play a key role in vascular
tonus maintenance. Previous results from our laboratory show that
hypotension and mortality during sepsis are prevented by the early
administration of NOS-1 inhibitors. The aim of this study was thus to
investigate the role of NOS-1 and NOS-3-derived NO and of other
reactive oxygen species (ROS) in smooth muscle cell activation.
Materials and methods: Smooth muscle cell line of rat aorta (A7r5) was
used. Control cells and NOS-1 or NOS-3 silenced cells (siNOS-1 and siNOS-3,
respectively) were stimulated with LPS 1 µg/ml and IFN 200 U/ml (LPS/IFN).
NO and ROS production was assessed with fluorescent probes. NOS content
was evaluated by western blot and NOS-2 activity was indirectly measured
by Griess reaction. Further, control cells were treated for 30 minutes with a
NO scavenger (c-PTIO), a NOS inhibitor (7-NI) or a NADPH oxidase inhibitor
(DPI) before stimulation. Immunofluorescence was used to evaluate protein
nitration and NF-B nuclear translocation. To confirm the role of per-
oxynitrite in cell activation, control cells were stimulated with a sub-effective
amount of LPS/IFN together with a NO donor and a superoxide anion
generator and treated with a NOS-2 inhibitor 4 hours after stimulation. Griess
reaction was performed 48 hours after. Statistical comparisons were
performed by two-way ANOVA followed by the Bonferroni test.
Results: A7r5 control cells stimulated with LPS/IFN presented a rapid
increase in intracellular NO and ROS content. These increases were
prevented by c-PTIO, 7-NI and DPI, as well as in siNOS-1 and siNOS-3
cells. NOS-2 was only expressed after cell stimulation. Control cells
incubated with c-PTIO or 7-NI and stimulated with LPS/IFN presented a
diminished NOS-2 expression and activity. Only in siNOS-1 cells was NOS-
2 expression and activity also reduced. Nuclear translocation of NF-B
and positive nitrotyrosine reaction were reduced in c-PTIO or 7-NI treated
groups. Sub-effective concentrations of LPS/IFN did not induce significant
nitrite production. However, when sub-effective LPS/IFN was associated with
the production of low concentrations of peroxynitrite, nitrite accumulation
was as high as in cells stimulated with activating concentrations of LPS/IFN.
Conclusions: We show for the first time the importance of NOS-1-derived
NO and peroxynitrite for smooth muscle cell activation. Cell stimulation
with LPS/IFN causes an early NOS-1-derived NO pulse and a ROS pulse
that forms peroxynitrite. The interplay between these species seems to
be key events for NF-B nuclear translocation and NOS-2 expression.
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Background: Sepsis and its common complication septic shock are
generally induced by the action of lipopolysaccharide (LPS) and characterized
by peripheral arteriolar vasodilatation that results in hypotension and
inadequate tissue perfusion. During sepsis, secretion occurs of large amounts
of inflammatory mediators such as nitric oxide (NO), interleukin 1 (IL-1) and
TNFa that will modulate the inflammatory response. One significant finding
in clinics is that men and women respond differently to sepsis, with better
prognosis related to women [1].
Materials and methods: Male and female (ovariectomized and sham
surgery) rats were injected intraperitoneally (i.p.) for three consecutive
days with ECP 40 µg/kg or vehicle. On the third day, after ECP injection,
rats receive i.p. injection of 10 mg/kg bacterial LPS or saline solution.
Plasma was collected 2, 4 and 6 hours after LPS for NO and cytokine
measurements.
Results: Administration of LPS increased the NO plasma concentration in
males and females (2, 4 and 6 hours). ECP pretreatment decreased the NO
concentration in sham females at 4 and 6 hours; conversely, it increased
nitrate levels in ovariectomized and in males at 4 and 6 hours. IL-1 plasma
concentration was increased in the three groups after LPS administration
at 2 and 4 hours and in Sham at 6 hours; ECP pretreatment decreased IL-1
plasma concentration in all groups at 2 hours. LPS administration also
increased TNFa plasma concentration at 2, 4 and 6 hours in the three
groups; ECP pretreatment inhibited the increase of TNFa at 2 hours in
three groups.
Conclusions: Our results indicate that estradiol may have
proinflammatory or anti-inflammatory actions depending on the gender
and the mediator evaluated; this balance in mediator secretion may be
protective and explain in part the better outcomes of woman during
sepsis.
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Background: The profound decrease in vasomotor tone accompanied by
hyporesponsiveness to vasoconstrictors is an important contributor to
morbidity and mortality in septic shock. Overproduction of nitric oxide
(NO) has been shown to play a relevant role in septic shock vascular
dysfunction. One of the mechanisms whereby NO exerts some of its
effects is the reaction with thiol groups of cysteine residues in a process
called S-nitrosylation, producing S-nitrosothiols. The aim of the present
study is to show that modification in S-nitrosylation has an important
impact in sepsis-induced vascular dysfunction and mortality.
Materials and methods: Wistar female rats were anesthetized and
submitted to cecal ligation and puncture (CLP) for induction of sepsis.
Thirty minutes before and 4 hours after surgery, animals received 5,5’-
dithio-bis-(2-nitrobenzoic acid) (DTNB), an oxidizing agent of sulfhydryl
groups or vehicle. Eight hours after CLP the rats were prepared for
invasive blood pressure measurements and vascular reactivity to
phenylephrine was assessed. The effect of DTNB on survival was also
evaluated. All of the procedures were approved by the institutional
Animal Ethics Committee (protocol number PP00790/CEUA/UFSC).
Results: Eight hours after sepsis induction, rats displayed a pronounced
hyporesponsiveness to phenylephrine (10 nmol/kg; 21.3 ± 1.1 mmHg CLP
group compared with 42.3 ± 0.8 mmHg in control group; P < 0.05, n = 6).
When DTNB was injected 30 minutes before and 4 hours after CLP
surgery, the response to phenylephrine was completely normalized
(10 nmol/kg; 46.2 ± 2.2 mmHg; P < 0.05, n = 6). DTNB also reduced the
mortality of septic rats by 40%.
Conclusions: Our results suggest that NO overproduction during septic
shock may cause nitrosylation of critical proteins important for alpha-
adrenergic contractile response. Oxidation of protein sulfhydryls by DTNB
prevents nytrosylation and restores the response to phenylephrine in
septic animals. Another important finding is that DTNB restored the
alpha-adrenergic response even after sepsis is installed. Understanding
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the role of S-nitrosylation may help to develop strategies to prevent or
reverse the vascular dysfunction of sepsis.
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Background: The objective was to evaluate the profile of respiratory
mechanism of septic female rats previously submitted to exposure of
cigarette smoking.
Materials and methods: Initially, female rats (230 to 300 g) were
randomly divided into a control group (NS) kept with no manipulation and
a cigarette smoking-induced respiratory disorders group (S). A rat model
used to induce respiratory disorders was established by exposure to
cigarette smoking (8 units/15 minutes) daily for 6 weeks. Twenty-four
hours after the last cigarette smoking exposure session, each group
underwent cecal ligation and puncture procedures to induce polymicrobial
sepsis (CLP group) or only underwent a laparotomy (sham group),
resulting in the following four experimental groups: Sham-NS (n = 11),
Sham-S (n = 11), CLP-NS (n = 6) and CLP-S (n = 9). The profile of
respiratory mechanism was evaluated by forced oscillation measurements
using a computer-controlled piston ventilator (flexiVent; SCIREQ Inc.) at
24 hours CLP or Sham procedures. The respiratory system parameters
evaluated were calculated in flexiWare7 software. All experimental
procedures used in our study were approved by the Institutional Animal
Ethics Committee (nº 11221971-3/47).
Results: Among the experimental groups, no significant difference in
airway resistance was verified, while prior exposure to cigarette smoking
decreased the tissue resistance of sham-operated rats (0.77 ± 0.03 vs.
0.55 ± 0.01 cmH2O.second/ml, Sham-NF and Sham-F, respectively) as well
as inhibiting the increase in tissue resistance induced by sepsis (1.11 ±
0.11 vs. 0.76 ± 0.03 cmH2O.second/ml, CLP-NS and CLP-S, respectively).
The prior exposure to cigarette smoking did not alter the lung
compliance of sham-operated rats, but it blocked the CLP-induced
reduction of lung compliance (0.82 ± 0.04, 0.21 ± 0.11 and 0.57 ± 0.07
cmH2O.second/ml, Sham-NS, CLP-NS and CLP-S, respectively). Similarly,
cigarette smoking blocked the CLP-induced decrease of inspiratory
capacity (7.85 ± 0.25, 4.96 ± 1.49 and 7.00 ± 0.41 cmH2O.second/ml,
Sham-NS, CLP-NS and CLP-S, respectively) but did not alter the inspiratory
capacity from sham-operated rats (8.68 ± 0.2 cmH2O.second/ml, Sham-S)
compared with Sham-NS.
Conclusions: In contrast to sham-operated rats, cigarette smoking
inhibited changes in the resistance, compliance and inspiratory capacity
of the respiratory system of CLP-operated rats.
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Background: New therapy is required that improves the prognosis of
patients suffering from severe sepsis or septic shock. C1-esterase inhibitor
(C1-Inh) was introduced in clinical medicine for patients with hereditary
angioedema. Some studies show that C1-Inh administration may also
have a beneficial effect in other clinical conditions such as sepsis [1,2].
We examined the effect of C1-Inh administration to the sepsis pig model.
Materials and methods: The experiments were performed divided into
two groups: the treatment group and the control group. We administered
LPS (40 μg/kg) to pigs of about 10 kg over 30 minutes. At the same time,
we administered C1-Inh in the control group (500 U, n = 3; 1,000 U,
n = 3), and saline in the control group (n = 3). We examined the effect of
C1-Inh for the outcome of the two groups, physiological indicators such
as heart rates (HR) and mean arterial pressure (MAP), and autopsy results
such as pleural effusion and ascites.
Results: The outcome of the two groups was that 5/6 in the treatment
group and 2/3 in the control group survived at 240 minutes from the
end of LPS administration. HR (/minute) at 180 minutes from the end of
LPS administration was 157.5 ± 12.3 in the treatment group and 205.3 ±
42.6 in the control group, and MAP (mmHg) at the same time was 60.0 ±
8.2 in the treatment group and 58.3 ± 5.6 in the control group. As for the
autopsy results, pleural effusion (ml) was 13.28 ± 3.13 in the treatment
group and 9.87 ± 4.33 in the control group, and ascites (ml) was 165.8 ±
32.99 in the treatment group and 210.0 ± 60.8 in the control group.
Seeing each individual, the individual showing a large effect of C1-inh
was observed.
Conclusions: C1-Inh tended to stabilize the hemodynamics of the sepsis
pig model, but was not able to reduce significantly the amount of pleural
effusion and ascites.
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Background: Several preclinical and clinical reports indicate a significant
role for systemic inflammation in chronic neurodegenerative diseases [1],
with commitment of different brain regions. Several studies have
demonstrated hippocampal atrophy, EEG changes [2], profound glial
activation, the generation of nitric oxide and changes in expression of
mediator apoptosis [3]. The release of these mediators and oxidative
stress occur mainly in acute phase inflammation in sepsis survivor rats
and are associated with long-term cognitive impairment [4]. These
cognitive deficits have been associated with decreased quality of life and
increased long-term morbidity. Some of these alterations resembled the
pathophysiological mechanisms of neurodegenerative diseases. For this
reason, we analyzed parameters related to neurodegeneration in rats that
survived sepsis, and their relation to cognitive dysfunction.
Materials and methods: Wistar rats were subjected to sepsis by cecal
ligation and puncture and 30 days after surgery the hippocampus and
prefrontal cortex were isolated just after cognitive evaluation by the
inhibitory avoidance test. The immunocontent of b-amyloid peptide (Ab),
receptor for advanced glycation endproducts (RAGE) and synaptophysin
were analyzed by western blot.
Results: Ab was increased in septic animals in the hippocampus, but
not in the prefrontal cortex. RAGE was upregulated in both structures
after sepsis, and the immunocontent of synaptophysin was decreased
only in the prefrontal, and inversely correlated to Ab levels. Prefrontal
levels of synaptophysin correlated with performance in the inhibitory
avoidance.
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Conclusions: The brain from sepsis survivor animals presented several
markers of neurodegeneration, and inhibitory avoidance test performance
seems to be dependent on the levels at some of these markers.
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Background: Sepsis remains a clinical challenge for the ICUs. However, it is
known that the tolerance mechanism using low doses of lipopolysaccharide
(LPS) reduces the expression of proinflammatory genes and involves
epigenetic regulation. The chromatin openness is regulated by histone
acetyltransferases (HATs) and these enzymes could be modulated by nitric
oxide (NO) interaction. In the present work, we demonstrate the pathway of
tolerance to LPS from HAT activity and level of histone openness to
production of cytokines as well as the influence of NO inhibition.
Materials and methods: THP1 differentiated into macrophages (with
2.5 nM PMA treatment) were cultivated in RPMI medium (Control group),
submitted to tolerance (500 ng/ml LPS 24 hours before challenge with
1,000 ng/ml LPS - Tolerant group) and challenge (1,000 ng/ml LPS - D group)
during 24 hours. NO production was inhibited by addition of 100 μM LNAME.
The HAT activity and cytokine production (IL-6) were measured with
biochemistry kits. Histone acetylated H3 and H4 were analyzed by western
blotting.
Results: Tolerance reduced HAT activity compared with the group directly
challenged (P < 0.05). Acetylated H4 was maintained at basal levels in the
tolerant group and increased in the D group (P < 0.05). However, the
tolerance increases the acetylation of histone H3 in a NO-dependent
response. Similarly, the IL-6 release was reduced by induction of tolerance
(P < 0.05 vs. D group). However, this effect was abolished by inhibition of
NO production.
Conclusions: The induction of tolerance diminishes HAT activity and
cytokine production. The tolerance triggers a complex epigenetic
modulation dependent of NO.
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Background: Tolerance is a defense strategy capable of reducing the
proinflammatory impact of infection. Tolerance capacity differs among the
different tissues. It is known that epigenetic regulation is cell type specific.
The cell machinery regulates the expression and activity of the enzymes
that regulate chromatin openness. Understanding the epigenetic
mechanism activated by different doses of LPS is important to define new
approaches for the treatment of systemic infections. The objective of this
work was to study the LPS-induced epigenetic response, analyzing the
expression of histone acetyltransferases (HAT) and DNA methyltransferases
(DNMTs).
Materials and methods: THP-1 human promonocytes were cultivated in
RPMI (C group), submitted to different doses of LPS (T group - tolerance
with 500 ng/ml during 24 hours and challenge with 1 µg/ml during
24 hours; D group - 1 µg/ml during 24 hours). The inhibition of nitric oxide
production was performed with LNAME (100 µM). Male Balb C mice
(8 weeks old) were divided into two groups: C group - without
manipulation; D group - received 5 mg/kg LPS. The spleens were collected
48 hours after. The HAT, DNMTs, lysine acetylated and histone H3 acetylated
amounts were determinate by western blot. The results represent three
similar experiments. The statistical analysis was performed by ANOVA.
Research protocol number 0950/09 was approved by the ethics committee.
Results: The challenge with LPS reduced the expression of DNMT1 in
THP1 cells. However, the tolerance increased the amount of this enzyme
(25%). Challenge with LPS reduces DNTM3a production (50%) in mice
spleen. The expression of HAT was reduced (50%) in the T group and this
event was NO dependent. The LPS addition to THP1 culture decreases
the production of acetylated lysine (P < 0.05) in a dose-dependent way
(68% and 33% with 0, 1 and 5 µg/ml LPS respectively). Low doses of LPS
reduce the acetylation of histone H3 (30% and 60% with 500 ng and
1 µg/ml LPS respectively).
Conclusions: Different concentrations of LPS are required for selective
regulation of subsequent LPS-stimulated epigenetic mechanisms.
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Background: Recent clinical studies have shown that sepsis survivors can
develop long-term cognitive impairment. The cellular and molecular
mechanisms involved in these events are not yet completely understood.
In this study, we investigate the synaptic deficits in sepsis and the
involvement of glial cells in this process.
Materials and methods: Using a clinically relevant model of sepsis (cecal
ligation and puncture), we observed a decrease of recognition memory
9 days after sepsis. At the same time, by colocalization between pre-
synaptic and post-synaptic protein, synaptophysin and PSD-95, we
observed a reduction of structural synapses in the hippocampus and
cerebral cortex of septic mice. To define the molecular mechanisms
accountable for synaptic loss in sepsis, we used an in vitro approach
treating neuronal cultures with conditioned medium from astrocyte
(ACM) and microglial (MCM) cultures stimulated with LPS.
Results: We observed that the MCM reduced the synapse number and
the ACM increased the number of synapses. The analysis of conditioned
medium composition showed that MCM had increased levels of IL-1b
while the ACM had increased levels of TGF-b1, as compared with
medium from the non-LPS-stimulated cultures. The increased levels of
IL-1b, from microglial activated with LPS, accompanied by an increase of
TGF-b1, from LPS-activated astrocytes, suggests an anti-synaptic activity
in IL-1b and pro-synaptic actions in TGF-b1. Inhibition assays with the
addition of soluble IL-1b receptor (IL-1 Ra) prevented the MCM-induced
synapsis loss. To understand whether the loss in synapse density would
have functional outcomes we performed patch clamp experiments in
neurons treated with microglia conditioned medium (MCM) and MCM of
LPS-stimulated cultures. Patch-clamp recordings in the MCM-treated
neurons showed a reduction in postsynaptic current frequency, while an
increase in current amplitudes suggests a functional synaptic deficit.
Conclusions: These findings show, for the first time, a correlation
between synaptic deficits and memory dysfunction, suggesting a possible
mechanism for cognitive impairment after sepsis as well as a glial-derived
molecule mediating synapse reduction.
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Background: An ideal sepsis biomarker should be able to segregate
infected patients from other causes of SIRS, and also to allow some kind of
risk stratification. Furthermore, it should be capable of identifying
subgroups of patients with specific sepsis complications, enabling target-
specific preventive and therapeutic measures. Finally, access to this
biomarker should not depend on complex and high-cost equipments and
reagents, allowing access to more patients. New hematologic automated
analyzers used for evaluation of the complete blood count provide a series
of advanced analytical parameters that permit more detailed evaluations
of circulating blood cells. Parameters such as the immature reticulocyte
fraction (IRF) and immature platelet fraction (IPF) identify early signs of
hematopoietic recovery, and have been studied in several inflammatory
conditions. Recently, a study performed in critically ill patients suggested
that the IPF could be a more accurate biomarker of sepsis development
than C-reactive protein (CRP) and procalcitonin. The aim of this study was
to evaluate whether IPF and IRF levels presented any association with
clinical and laboratory parameters of sepsis severity.
Materials and methods: During 30 days the IPF and IRF were obtained
using an automated hematologic analyzer (Sysmex XE5000) within
24 hours from admission for consecutive patients with sepsis.
Results: In total, 23 patients with sepsis were enrolled in the study, of which
12 (52%) presented severe sepsis or septic shock. The median APACHE II and
SOFA scores at admission were 15 (6 to 37) and 6 (1 to 17). Median IPF and
IRF levels at admission were 4% (1.1 to 11.0%) and 14% (1.6 to 47.1%)
respectively, and were significantly higher than in a population of healthy
individuals (IPF = 2.1% and IRF = 2.9%; both P < 0.001). As opposed to the
CRP, both IPF and IRF were significantly correlated with the SOFA at
admission (Rs = 0.52 and 0.45; P = 0.01 and 0.02 respectively). However,
when patients were stratified by the median SOFA score at admission, only
the IPF was significantly higher in patients with SOFA ≥6 (IPF = 6.2% vs.
2.9%; P = 0.01). Similar results were observed when patients were stratified
by the presence of severe sepsis. The IPF presented a significant correlation
with the platelet count (Rs = -0.71; P < 0.001), but with not with PT, aPTT
and D-dimer.
Conclusions: In patients with sepsis, both IPF and IRF were higher than
in healthy individuals, and the IPF was associated with increased sepsis
severity. Larger studies are warranted to define and validate the precise
role of the IPF as a sepsis biomarker.
P92
Feasibility of gene transfer with nonviral vectors in murine models
of sepsis
Vanessa B Faiotto*, Rodolfo ME Hubert, Devanira S Paixao, Gleice R Souza,
Maiara ML Fiusa, Carolina Costa-Lima, Sara TO Saad,
Joyce M Annichino-Bizzacchi, Erich V De Paula
Faculty of Medical Sciences, University of Campinas, SP, Brazil
Critical Care 2013, 17(Suppl 4):P92; doi:10.1186/cc12991
Background: Although several target-specific therapies for sepsis failed to
translate into clinical benefits during the last decades, the increasing
knowledge about sepsis pathogenesis continues to reveal new therapeutic
targets that could be explored in the future. One of the challenges of
previous target-specific treatments for sepsis was the short half-life of
agents, some in the range of minutes. Gene transfer strategies can
overcome this limitation, by providing a platform for longer expression of
secreted therapeutic proteins. On the other hand, the transient nature of
sepsis precludes the use of gene transfer strategies leading to long-term
expression such as viral vectors. In this context, the use of nonviral vectors
emerges as an attractive strategy for the treatment of sepsis, provided that
sufficient expression of any therapeutic gene can be obtained.
Materials and methods: Two gene constructs were used to evaluate the
feasibility of gene transfer in the endotoxemia model: a lacZ expression
plasmid driven by the CMV promoter, and a coagulation factor IX expression
plasmid with the hAAT liver-specific promoter. The latter was used as a
reporter gene for secreted proteins. C57Bl/6 mice were challenged with LPS
and gene transfer was performed 6 hours thereafter, so as to mimic the
timepoint when sepsis treatments would be initiated. Fifty micrograms of
plasmid were injected into the tail vein using hydrodynamic transfection.
A less aggressive protocol, which could in principle be translatable to the
clinical setting, was also tested. Gene expression was evaluated 72 hours
after gene transfer by a blinded investigator.
Results: Factor IX activity levels (FIX:C) were significantly lower in
nontransfected LPS-challenged mice (n = 12) compared with nontrans-
fected controls (n = 14), suggesting that endotoxemia decreases baseline
FIX:C levels. Higher FIX:C levels (twofold higher than controls) were
observed in control mice submitted to hydrodynamic transfection (n = 5),
as expected. When gene transfer was evaluated in the context of sepsis,
LPS-challenged mice (n = 9) presented 1.7-fold higher FIX:C levels than
control mice (n = 12) (P < 0.01). Moreover, mice that were exposed to a
less aggressive intravenous transfection protocol (n = 8) presented FIX:C
levels that were 1.4-fold higher than controls (P = 0.04). Liver-expression
of b-galactosidase also demonstrated the feasibility of gene transfer in
LPS-challenged mice.
Conclusions: Our results suggest that the cellular and molecular events of
sepsis reproduced in the endotoxemia model could facilitate gene transfer,
thus offering a unique opportunity for gene therapy with nonviral vectors,
without the need for traumatic gene transfer protocols that would be
required in other pathological conditions.
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Background: Recently, we observed that blocking the IL-1-IL-1r signaling
pathway by central administration of IL-1ra (an IL-1 receptor antagonist)
can result in increased AVP secretion and survival rate in the late phase
of sepsis [1]. The mechanism of this effect of IL-1ra on AVP concentration
and survival rate remains elusive. Many studies have implicated excessive
production of nitric oxide (NO) as one of the important factors
responsible for decreased AVP secretion during the late phase of sepsis
[2]. Currently, the effect of IL-1ra on the central NO production and
release during sepsis is not known.
Materials and methods: In this study, we checked the effect of IL-1ra on
sepsis-induced increased release of NO in cerebrospinal fluid (CSF). Sepsis
was induced by cecal ligation and puncture (CLP). IL-1ra (9 nmol/animal)
and vehicle (PBS: 2 μl/animal) were injected intracerebroventricularly to
separate groups of CLP (n = 8/group) and control (n = 8/group) animals.
CSF and blood samples were collected from different groups of rats (n =
6 to 8/group) after 1, 2, 4, 6 and 24 hours. The NO concentration in CSF
was determined by chemiluminescence assay. Specific ELISA was used for
AVP analysis. All experiments were carried out according to an
institutional ethic committee-approved protocol (CEUA protocol number
12.1.1205.53.0).
Results: NO levels were significantly (P < 0.05 to 0.005) increased in post-
CLP 6-hour and 24-hour as compared with control, post-CLP 1-hour,
2-hour, and 4-hour animals. IL-1ra administration did not significantly
alter the NO concentration in CSF after 1, 2, 4 and 6 hours as compared
with vehicle treatment in CLP animals as well as in control. In contrast,
after 24 hours NO levels were significantly (P < 0.02) lowered in IL-1ra-
treated animals (22.36 ± 2.07 μM) as compared with vehicle-treated
animals (31.97 ± 2.88 μM). The AVP concentration in IL-1ra-treated rats
was significantly higher in IL-1ra-treated animals in comparison with
vehicle treatment. Moreover, the survival rate of IL-1ra-treated rats was
>80% while that of vehicle-treated rats was 47%.
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Conclusions: Our results have demonstrated that blocking the IL-1-IL-1r
signaling pathway by central administration of IL-1ra increases AVP
secretion in the late phase of sepsis, which may be beneficial for survival.
We believe that one of the mechanisms for this effect of IL-1ra is through
reduction of NO concentration in CSF of the septic rats.
Acknowledgements: This research work was funded by FAPESP. FW is
supported by a postdoctoral fellowship of FAPESP.
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Background: Since its discovery by Kojima and colleagues in 1999 [1], the
hormone ghrelin has been studied in different contexts, since this peptide
has the ability to promote hormonal, vascular and immune changes. His
well-established functions are the release of growth hormone, by a
mechanism distinct from the growth hormone release factor, and
stimulation of hunger, by activating hippothalamic neurons, leading to
release of neuropeptide Y, thus promoting orexigenic effects [2]. Because of
its ability to release hormones, including vasopressin [3], and by possessing
immunomodulatory properties, ghrelin has been studied in different
contexts of inflammatory states, as present in endotoxemia and sepsis [4].
The infusion of lipopolysaccharide (LPS) is capable of generating an
inflammatory state, with augmenting of TNFa, IL-1b and nitric oxide, which
in turn leads to cardiac depression and systemic vasodilation and
hypotension [5]. Due to its properties to modulate the inflammatory
response, in a way of diminishing the levels of TNFa, IL-1b and nitric oxide,
which are augmented in the endotoxemic state, as well the ability to
augment the plasma levels of vasopressin, ghrelin emerges as a potential
neuro-immunomodulator in hypotension caused by endotoxemia. We
speculate that ghrelin, mediating the inflammatory response and by
augmenting vasopressin blood levels, could attenuate the hypotension
caused by endotoxin.
Materials and methods: Male Wistar rats (250 to 300 g) had their
jugular vein and/or their right cerebral ventricle cannulated for drug
administration, and the femoral artery cannulated for mean arterial
pressure (MAP) and heart rate (HR) records, respectively. All experimental
procedures were approved by the Comitê de Ética em Experimentação
Animal-campus de Ribeirão Preto (protocol number 12.1.1441.53.5). The
endotoxemia model was induced by endovenous injection of
lipopolysaccharide (LPS; 1.5 mg/kg). Data were compared using two-way
analyses of variance and significant differences were obtained using the
Bonferroni post test.
Results: LPS administration leads to a drop in MAP in the first 2 hours,
followed by a partial recovery of the MAP, and then a second drop in MAP,
with a peak in 6 hours. The HR was augmented in this group. Systemic
administration of ghrelin alone, through a bolus followed by subcutaneous
implantation of an osmotic pump, did not alter the response, in
comparison with the saline-treated group. The icv administration of
ghrelin, however, diminished the HR in some intervals, although did not
present a difference in MAP, in comparison with the saline-treated group.
The administration of ghrelin, centrally and peripherally, when given at the
same time as the LPS bolus, attenuated the first drop in MAP and
completely restored the second drop present in the LPS group.
Conclusions: Ghrelin is capable of attenuating the hypotension caused
by endotoxin, and we speculate that the improvement is due to
modulation of cytokines, nitric oxide and augmented vasopressin blood
levels.
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Background: Animal research in sepsis needs analytical tools that can
capture and exploit the complexity of the condition. To summarise the
disease progression in a porcine model of severe Staphylococcus aureus
sepsis, we used principal component analysis (PCA) as a multivariate
approach to identify early dynamic expression patterns of 34 selected
genes in the liver, lung, and spleen tissue.
Materials and methods: We combined data from two related
experimental studies in pigs haematogenously infected with a porcine
pathogenic strain of S. aureus [1,2]. Seventeen infected pigs were
euthanised at the following time points post infection (p.i.): 6 hours (n =
3), 12 hours (n = 3), 24 hours (n = 3), 30 hours (n = 1), 36 hours (n = 2),
and 48 hours (n = 5). Five healthy controls were managed in parallel.
Gene expression of 34 genes related to acute inflammation and
haemostasis was measured in the liver, lung, and spleen by quantitative
real-time PCR. The data matrix of 22 samples and 102 (34 × 3) variables
were log-transformed, scaled to unit variance, and subjected to PCA.
Results: Three (PC1 to PC3) distinct dynamic response patterns were
identified. PC1: hepatic positive and negative acute-phase genes were
the main influencers of a protracted pattern induced between 12 and
48 hours of infection, which explained 23% of the total variation in the
dataset (Figure 1A, C). PC2: an acute pattern distinguished infected pigs
from controls already after 6 hours and peaked around 12 hours p.i.
After 30 to 48 hours, pigs had either reverted back to basal levels (n =
7) or below basal levels (n = 2) (Figure 1A). This pattern explained 14%
of the total variation and was influenced by a systemic (nonorgan-
specific) mixture of proinflammatory, anti-inflammatory and haemostatic
genes (Figure 1C). The two pigs with low PC2 levels had suffered from
overt disseminated intravascular coagulation when euthanised [3], and
this outcome was clearly reflected by PC2. PC3: a per-acute pattern,
influenced mainly by pulmonary proinflammatory genes (explaining
11% of the total variation), was induced in infected pigs at 6 hours p.i.,
while at later time points most pigs had moved towards basal levels
(Figure 1B, D).
Conclusions: Multivariate analysis (PCA) identified three temporally
distinct patterns in gene expression data from the liver, lung, and spleen
tissue: pulmonary inflammation was rapidly induced, followed by
transient induction of a generalised inflammatory and haemostatic
response, and initiation of the hepatic acute-phase response.
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Background: Previous studies demonstrated the presence of microparticles
(exosomes) in plasma of septic patients. These are cell-derived vesicles
containing specific collections of proteins, lipids and genetic material that
participate in the intercellular communication, changing the function and
physiology of their target cells. The role of exosomes in sepsis, however,
remains deeply unexplored. This study aimed to investigate the composition
of microRNAs and messenger RNAs related to inflammatory response in
circulating microparticles of septic shock patients.
Materials and methods: Fourteen patients had 30 ml blood collected in
the first 48 hours of sepsis and 7 days after for those who survived. Five
healthy volunteers served as controls. Exosomes were isolated from
plasma by filtration (0.22 μM) and ultracentrifugation. Thirty nanograms of
the total RNA were reversely transcribed and the expression profile of 754
human miRNAs and 91 mRNAs from immune response was evaluated by
real-time quantitative PCR using the Taqman Low Density Array (Applied
Biosystems). The raw data were processed in Expression Suite v1.0.1
software and analyzed in StatMiner v3.0 software considering the global
expression level for normalization. The fold-change was calculated based
on the estimated mean difference (2(-ΔCT)).
Results: Different miRNA expression was observed in the exosomes from
septic patients in comparison with healthy donors. In the first 48 hours of
septic shock, three miRNAs were differentially expressed: miR-1290 (2.78-
fold, P = 0.02), miR-1298 (4.02-fold, P = 0.03) and miR-146a (-2.51-fold,
P = 0.02). In the recovery phase of sepsis, five miRNAs were differently
Figure 1(abstract P95) Pigs (scores) and genes (loadings) in PC1-PC2 (A, C) and PC1-PC3 space (B, D). (A) Increased PC1 scores are seen in infected
pigs from 12 hours until the end of the study (48 hours), with a peak around 24 hours. PC2 scores are increased after 6 hours of infection, with a peak at
12 hours. Thereafter, scores decline towards basal levels, or below. (B) PC3 scores are increased mainly in infected pigs at 6 hours p.i. (C) Genes with
largest influence on the PC1 axis are mainly hepatic positive and negative acute phase genes (for example, SAA, ITIH4, TTR, TRF). Genes with largest
influence on the PC2 axis are not specifically related to a single tissue. (D) The main influencers of the PC3 axis are inflammatory genes measured in lung
tissue. Gene symbols are used according to the National Center for Biotechnology Information (NCBI).
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expressed as compared with controls: miR-1260 (2.29-fold, P = 0.02), miR-
1274A (2.83-fold, P = 0.02), miR-1274B (3.31-fold, P = 0.02), miR-192 (1.83-
fold, P = 0.02) and miR-604 (-6.41-fold, P = 0.02). The miRNA expression
profiles in different stages of sepsis were similar. Moreover, exosomes
from patients after 1 week of sepsis carry less CCL5 mRNA than in the
beginning of the disease (-2.49-fold, P = 0.02).
Conclusions: Exosomes from septic shock patients carry different miRNA
expression profiles at different stages of the disease, as compared with
healthy individuals. CCL5 mRNA is less expressed in the recovery phase of
sepsis. The composition of these vesicles may help to understand the
underlying mechanisms involved in their role in the pathogenesis of sepsis.
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Background: Septic encephalopathy (SE) is a frequent complication in
severe sepsis. Here we have explored the role of NADPH oxidase in
different aspects of SE pathophysiology. We investigated the involvement
of NADPH oxidase in neuroinflammation and in the long-term cognitive
impairment of sepsis survivors.
Materials and methods: Our approach included pharmacological
inhibition of NADPH oxidase activity with apocynin and the use of
genetically deficient (knockout) mice for gp91phox (gp91phox-/-), the
catalytic subunit of Nox2. Sepsis was induced by cecal ligation and puncture
and fecal peritonitis. We measured the hippocampal oxidative stress, Nox2
and Nox4 gene expression and neuroinflammation in WT and gp91phox-/-
mice at 6 hours, 24 hours and 5 days post sepsis. Behavioral outcomes were
evaluated 15 days after sepsis with the inhibitory avoidance and the Morris
water maze tests.
Results: The data show progressive oxidative damage to the hippocampus,
identified by increased 4-hydroxynonenal expression, associated with
an increase in Nox2 gene expression in the first days after sepsis.
Pharmacological inhibition of Nox2 with apocynin completely inhibits
hippocampal oxidative damage in septic animals as well as the development
of long-term cognitive impairment in the survivors. Pharmacologic inhibition
or the absence of Nox2 in gp91phox-/- mice prevents glial cells activation, one
of the central mechanisms associated with SE and other neurodegenerative
diseases.
Conclusions: We identified Nox2 activation as a necessary step for glial cell
activation in SE. Our data indicate that Nox2 is as a major source of
oxidative stress in the brain and consequently has a central role in the
development of cognitive impairments observed in sepsis survivors.
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Background: Previously, we have shown that methicillin-resistant
Staphylococcus aureus (MRSA) sepsis was associated with more severely
pronounced vascular leakage compared with Pseudomonas aeruginosa
sepsis. We have also demonstrated that the arginine vasopressin V1a
receptor (V1aR) agonist significantly attenuated the severity of MRSA-
induced vascular leakage [1]. The goal of the present study was to explore
mechanistic aspects of V1aR agonist’s action.
Materials and methods: Twelve adult female sheep were operatively
prepared for chronic study. After 5 days of recovery, tracheostomy was
performed under anesthesia and injury was given. The injury consisted of
insufflation of cooled cotton smoke (48 breaths) and instillation of 2.5 × 106
CFU MRSA into the lungs by bronchoscope under maintenance isoflurane
anesthesia. Following the injury, sheep were awakened, placed on
mechanical ventilation and randomly allocated into two groups: control
group, saline treated, n = 6; and POV group, treated with intravenous V1aR
agonist, Phe2-Orn8-Vasotocin (POV) (Ferring Research Institute, Inc., San
Diego, CA, USA), n = 6. The titration of POV was started when mean arterial
blood pressure (MAP) dropped by 10 mmHg from the baseline with the
initial dose of 30 pmol/minute, which was further adjusted to maintain MAP
close to baseline. All sheep were resuscitated with lactated Ringer’s solution
with initial rate of 2 ml/kg/hour that was further adjusted according to
hematocrit. The experiment lasted 24 hours. Plasma levels of nitric oxide
(NO; Grease reaction), asymmetric dymethylarginine (ADMA; mass
spectrometry) and bradykinin (mass spectrometry) were determined at
0 hours and every 3 hours after the injury.
Results: MRSA-induced plasma levels of NO (nitrite/nitrate) as well as
cumulative body fluid were significantly inhibited by V1aR agonist. The
treatment with POV also attenuated the MRSA-induced hypotension. The
plasma levels of ADMA were higher in the treated group compared with the
control at 24 hours after the injury (0.93 ± 0.14 in control, n = 3 vs. 1.23 ±
0.08 in POV, n = 6). In addition, the treatment with POV significantly
inhibited the MRSA-induced bradykinin increases at 3 hours after the injury
(1.14 ± 0.4 in control vs. 0.52 ± 0.001 in POV, P < 0.05).
Conclusions: Arginine vasopressin V1aR agonist attenuates the severity
of MRSA-induced vascular leakage by inhibiting potent permeability
factor bradykinin and excessive NO. The V1aR agonist may modulate NO
production by promoting the release of endogenous NO synthase
inhibitor ADMA.
Reference
1. Rehberg S, et al: Selective V(1a) agonism attenuates vascular dysfunction
and fluid accumulation in ovine severe sepsis. Am J Physiol Heart Circ
Physiol 2012, 303:H1245-H1254.
P99
Modulation of peroxynitrite improves host response to vasopressin in
ovine sepsis
Osamu Fujiwara1*, Yong Zhu1, Daniel Traber1, Lillian Traber1, David Herndon2,
Perenlei Enkhbaatar1
1Department of Anesthesiology, University of Texas Medical Branch,
Galveston, TX, USA; 2Shriners Hospital for Children, Galveston, TX, USA
Critical Care 2013, 17(Suppl 4):P99; doi:10.1186/cc12998
Background: The standard therapy for sepsis is becoming less effective due
to increasing microorganism resistance to antibiotics and cardiovascular
collapse refractory to fluid resuscitation and vasopressors. In this study, we
demonstrate a critical role of peroxynitrite in vascular hyporesponsiveness to
vasopressin (VP) in methicillin-resistant Staphylococcus aureus (MRSA)-
induced ovine sepsis.
Materials and methods: Sheep were instrumented with Swan Ganz
(common jugular vein), femoral artery, and left atrium catheters to monitor
hemodynamics for 24 hours. Sepsis was induced by instillation of live MRSA
(2.5 to 3.5 × 1011 CFU) into the lungs by bronchoscope under anesthesia.
Sheep were then awakened, placed on a ventilator, and fluid resuscitated.
Urine output was measured via a Foley catheter. Groups: MRSA, received
MRSA, n = 4; MRSA + peroxynitrite decomposition catalyst (PDC), received
MRSA and were treated with PDC starting 6 hours post injury (0.1 mg/kg
bolus followed by 0.02 mg/kg/hour), n = 4; MRSA + VP, received MRSA and
were titrated with VP when mean arterial pressure fell by 10 mmHg, n = 4;
and MRSA + VP + PDC, received MRSA, treated with VP and PDC, n = 4.
Results: MRSA induced severe hypotension refractory to aggressive fluid
and AVP. PDC and AVP alone partially attenuated the severe hypotension.
When combined they more effectively reversed the hypotension. Inhibition
of peroxynitrite formation by PDC also markedly reduced AVP requirement.
In addition, the in vitro effects of AVP (5 nM) on isolated arterial ring tone
were abolished with co-incubation with peroxynitrite (50 μM).
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Conclusions: Peroxynitrite modulation may be a novel treatment option
for management of sepsis-induced cardiovascular collapse refractory to
vasopressors. These findings are especially provocative since peroxynitrite
is the product of excessive nitric oxide regardless of which NOS isoform
is involved and the major debate of whether the use of NOS inhibitors in
management of sepsis is beneficial still remains.
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Background: Studies suggest that curcumin, found in the tropical plant
Curcuma longa, has anti-inflammatory and antioxidant properties and can
act in sepsis, decreasing the release of proinflammatory mediators and free
radicals. In the search to increase curcumin’s bioavailability a fitotecnologic
process was developed that generated a solid dispersion of curcumin
named DS17. This dispersion is water soluble and seems to increase the
curcumin absorption by the gastrointestinal tract. The aim of our study
was to assess the biological activity of the solid dispersion of curcumin
(DS17) in immunological and metabolic alterations observed in a model of
sepsis in rats induced by CLP.
Materials and methods: Male Wistar rats (250 to 300 g) were divided into
two groups: polymicrobial sepsis model by cecal ligation and puncture
(CLP) and sham operation (OF). The animals were pretreated with DS17
(100 mg/kg) orally for 7 days prior to CLP and treated 2 hours after
surgery. The animals were used to analyze curcumin absorption through
HPLC, plasma glucose, cytokines, nitric oxide (NO) and HSP70. Another
group had the survival rate assessed for 48 hours.
Results: Our results showed that curcumin is present in the plasma at
4 and 6 hours but absent 24 hours following the DS17 administration.
The dispersion decreased IL-6 in plasma and peritoneal fluid at 6 and
24 hours, and IL-1b 6 hours after sepsis stimulus. Moreover, we observed
an increase in the hematocrit and a decrease in plasma glucose in the
same animals. Paradoxically, plasma IL-10 and serum HSP70 decreased in
24 hours while plasma NO increased in the same period. These changes
were not sufficient to increase significantly the survival although we
observed a biological improvement of 20% 24 hours following CLP.
Conclusions: Our results suggest that despite a significant decrease in
proinflammatory cytokines (IL-1b and IL-6), treatment with curcumin solid
dispersion produced no beneficial biological effect in septic animals.
Further studies are necessary to better clarify the suggested antioxidant
and anti-inflammatory effect of curcumin.
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Background: Sepsis is a systemic inflammatory response syndrome against
infection, which can develop in sepsis-associated immunosuppression.
Actually, several inflammatory dysfunctions have been described in dendritic
cells (DCs) that could be responsible for impairing the immune response
towards the secondary infection. PPARg is a lipid-activated nuclear
receptor, which participates in inflammation, lipid metabolism and cellular
differentiation. Previous studies have shown the role of PPARg in acute
sepsis besides its effects in sepsis-induced immunosuppression still being
unclear. Our aims were to evaluate the phenotypic changes in DCs in lungs
from post-septic mice and to assess the effects of PPARg on DC functions.
Materials and methods: Mice were subjected to cecum ligation and
puncture (CLP) or Sham and, 6 hours after, all groups were treated with
antibiotics. Fourteen post-septic and Sham mice were infected with BCG
and 24 hours after challenge the lungs were collected, minced and
digested to investigate the cytokine production, gene expression and
phenotype analysis. To evaluate the effects of PPARg, post-septic derived
BMDC were pretreated with PPARg agonist (rosiglitazone) before BCG
infection. After 24 hours, lipid droplet formation, phagocytosis, cytokines
and oxide nitric production were analyzed.
Results: Post-septic mice were susceptible against Mycobacterium bovis,
BCG and exhibited higher cellular infiltration. Lungs from post-septic mice
showed increased IL-10 level and COX2, CCR2 and IL-1b expression.
When post-septic and Sham mice were infected with BCG, we observed
higher increased COX2, CCR2 and IL-1b expression in lungs from post-
septic mice as compared with lungs from Sham mice but the IL-10 level
was reduced. In addition, lungs from post-septic mice showed higher
Ly6G cells compared with lungs from Sham mice. Infected BMDC
exhibited an immature profile (lower expression of CD80 and CD40) and
a positive shift to anti-inflammatory cytokine production (increased IL-10
and reduced TNFa, CCL2 and IL-1b levels). PPARg flanked mice in CD11c
cells were more susceptible to severe sepsis. Activation of PPARg in
infected BMDC from post-septic mice reduced lipid droplet formation,
phagocytosis and oxide nitric production but not cytokine production
when compared with infected BMDC from Sham mice.
Conclusions: After severe sepsis, phenotypic changes modulate DC
functions and may contribute to sepsis-induced immunosuppression. The
understanding of PPARg could be important for development of new therapy
in sepsis-associated immunosuppression and long-term inflammatory
diseases.
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Background: Sepsis is a systemic inflammatory response syndrome against
infection, which can develop in sepsis-associated immunosuppression.
Actually, several inflammatory dysfunctions have been described in dendritic
cells (DCs), which could be responsible for impairing the immune response
towards the secondary infection, although how these stable modifications
maintain is still unknown. Our hypothesis is that DCs from post-septic mice
have chromatin alteration and differential microRNA expression.
Materials and methods: To investigate the global gene expression, post-
septic and Sham-derived BMDC were infected or not with BCG for 24 hours.
Total RNA were collected and the gene expression profile was assessed by
Affymetrix GeneChip technology. The gene expression profiles were
classified by Gene Ontology (GEO). Also, the microRNA analysis was
obtained from Affymetrix microarray. To investigate the chromatin
modifications, post-septic and Sham BMDC were performed to Chip-Seq
analysis.
Results: Supervised analysis identified a set of 2,755 genes that
distinguished very accurately between post-septic BMDC and Sham BMDC.
The gene expression signature showed 1,805 stimulated genes and 950
inhibited genes in post-septic BMDC compared with Sham BMDC. The gene
expression signature of post-septic BMDC provided a molecular and
functional profile based in GEO. It is noteworthy that post-septic BMDC were
mostly found in the downregulated genes to encode proteins involved in
the biological pathways of the inflammatory process (IL-1a, IL-12, CD28,
TLR2, Hmgb1, CCL2), lipid metabolism (FABP4, Elovl2, PTGS1, PPARδ) and
histone modifications (ACAT3, CBx2, Oip5, Hist2hX). When post-septic and
Sham BMDC were infected with BCG, downregulated gene sets were
classified in 130 significant GEO terms (mainly involved in inflammatory and
Critical Care 2013, Volume 17 Suppl 4
http://ccforum.com/supplements/17/S4
Page 55 of 59
lipid metabolism process) while surprisingly upregulated gene sets were
classified in 10 significant GEO terms (nine inflammatory processes of
10 terms). In microRNA expression, we observed higher microRNA
expression in post-septic compared with Sham BMDC. When BMDC were
infected with BCG, post-septic BMDC exhibited higher numbers of microRNA
compared with Sham BMDC. Furthermore, we assessed the presence of
H3K27ac and H3K4me3 in inflammatory (IL-10, TNFa, IL-6 and TGF-b) and
lipid metabolism genes (ABCA1, PLIN2, CD36 and FABP4). Both H3K4me3
and H3K27ac on PLIN2, CD36 and FABP4 gene bodies were reduced and the
presence of H3K4me3/H3K27ac was increased on TNFa and TGF-b gene
bodies.
Conclusions: These results demonstrate the global gene expression
signature, higher microRNA expression and H3K4me3/H3K27ac profile on
chromatin structure in post-septic BMDC. The present study suggests
epigenetic changes may play a role in transcriptional regulation in post-
septic DCs.
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Background: Vasopressin (AVP) plasma levels increase in the early phase
of sepsis but remain at basal levels in the late phase of sepsis [1]. It is
also known that one-half of septic patients do not properly respond to
an osmotic challenge, one of the strongest stimuli for AVP secretion [2].
However, whether these AVP secretion changes persist in sepsis survivors
is not known. This study investigated the possible alterations in plasma
AVP levels in sepsis-surviving animals.
Materials and methods: Male Wistar rats were separated into two
groups: sepsis induced by cecal ligation and puncture (CLP), or sham
animals. They received saline solution (50 mg/ml; s.c) immediately and
12 hours after CLP, and also ceftriaxone (30 mg/kg; s.c.) and clyndamicin
(25 mg/kg; s.c.) after every 6 hours for 3 days. Sham animals received
the volume of saline corresponding to antibiotic administration. After
10 days, the animals were dehydrated or left as control. After 2 days, the
animals were decapitated, and the serum and plasma collected for
sodium, hematocrit and hormone determination. The posterior pituitary
glands were removed for hormone stock analysis.
Results: Sepsis-surviving animals presented a higher serum sodium even
without the osmotic stimulus (147.8 ± 0.97 SEM vs. 151.4 ± 0.6 SEM mmol/l
CLP; P < 0.001). Following dehydration, as expected, there was an increase
of serum sodium in CLP animals (151.4 ± 0.6 SEM vs. 155.71 ± 0.47 SEM
mmol/l; P < 0.001) and sham animals (147.8 ± 0.97 SEM vs. 154 ± 0.26 SEM
mmol/l dehydrated; P < 0.001) with difference between the groups (154 ±
0.26 SEM vs. 155.71 ± 0.47 SEM mmol/l CLP; P < 0.041). Hematocrit also
increased in both CLP (42.63 ± 1.58 SEM vs. 50.17 ± 1.67% SEM
dehydrated; P = 0.002) and sham (mean: 41.8 ± 1.43 SEM vs. 49.5 ± 1.0%
SEM; P = 0.003) groups but without difference between the groups. The
animals responded with an increase in the AVP plasma levels (6.12 ± 0.68
SEM vs. 6.16 ± 0.94 SEM pg/ml CLP, P > 0.05), and a decrease in AVP
neurohypophysis stocks (4.0 ± 1.02 SEM vs. 1.91 ± 0.67 SEM ng/μg CLP;
P = 0.107), with no difference between the groups.
Conclusions: The results suggest that sepsis-surviving animals do not
present alterations in secretion of AVP in relation to volemia. However,
serum sodium results suggest that AVP secretion is impaired in sepsis-
surviving animals.
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Background: Sepsis is a severe medical condition characterized by
systemic inflammatory response secondary to infection, which frequently
progresses to multiple organ dysfunction and death. It is currently the
leading cause of death in ICUs worldwide. The most frequent source of
infection in sepsis is the lung with a high lethality rate. Pseudomonas
aeruginosa is one of the most common pathogens found in sepsis
patients. Cognitive impairment is a significant consequence of sepsis
reported among survivors. The encephalopathy associated with systemic
inflammation is not well understood so the development of new clinical
relevant models to help understand this sequelae is important. In this
study we aimed to evaluate acute inflammatory markers and establish a
long-term consequence in a murine model of pneumosepsis.
Materials and methods: C57/BL6 mice were submitted to intratracheal
instillation of 105 colony-forming units of P. aeruginosa. Six hours later
the bronchoalveolar lavage fluid was collected for cell migration, protein
(BCA method) and cytokine (ELISA) analysis. Caudal vein blood samples
were collected for cell counting. Another group of animals had their
lungs perfused for myeloperoxidase quantification and histological
analysis. Evan’s blue dye method was used for the assessment of lung
permeability. The survival rate of animals submitted to P. aeruginosa
instillation was observed daily during 7 days. This group of animals
received a single dose of antibiotic meropenem (30 mg/kg), 6 hours after
pneumonia induction. Cognitive damage was evaluated through the
freezing test.
Results: Our results showed that P. aeruginosa infection caused an
expressive recruitment of leukocytes, mainly neutrophils to the lung.
Myeloperoxidase, a marker for neutrophil migration, was significantly
increased in the lungs of animals instilled with P. aeruginosa. The animals
instilled with P. aeruginosa also showed a significant increase in IL-6, KC
and protein levels. Histological analysis showed an intense cell infiltrate in
the lung tissue and the survival rate was extensively lower in P. aeruginosa
infected mice. Additionally, the animals submitted to pneumosepsis had a
loss of aversive memory 13 days after pneumonia induction and this loss
remained 50 days later.
Conclusions: Our study demonstrates the acute inflammatory response
to P. aeruginosa lung infection and indicates that possibly this pneumonia
model can cause irreversible cognitive impairment. Our results reveal a
possible experimental model for the study of encephalopathy associated
with systemic inflammation.
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Background: Morbidities associated with severe sepsis are serious
problems for surviving patients, such as cognitive impairment and
immunosuppression. The immunosuppression predisposes the patients to
a second infection, which generally is fatal. Several studies have been
made to understand the mediators involved with this immunosuppression
associated with sepsis. Some data from the literature show that caspase-1
promotes activation of cytokines, such as IL-1b, and actions are inhibited
by caspase-12. This study proposes to analyze the role of inflammatory
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caspases in immunosuppression and cognitive damage associated with a
two-hit model of sepsis.
Materials and methods: We submitted Swiss animals to the model of
two hits of infection. The first hit was the CLP model and the second hit
was intratracheal instillation of Pseudomonas aeruginosa. We analyze the
mortality rate and the inflammatory profile of the animals submitted to
the CLP model and the two-hit sepsis model. The cognition of the
animals was tested by the passive avoidance test 15 and 21 days after
the CLP and 21 days until 96 days after the two-hit sepsis model.
Results: First we characterize the model and we observed a 30% survival
rate of the CLP group in comparison with a 100% survival rate in the SHAM
group. The high mortality of the CLP group was associated with
hypoglycemia in the first 72 hours after the infection, increased neutrophil
accumulation in the peritoneal cavity 6 and 24 hours after the CLP and an
increase of inflammatory cytokines 6 hours after the CLP, such as CCL2, IL-1b
and IL-10. The CLP group had a cognitive impairment 15 days after the CLP,
but the memory was recovered 21 days after the infection. The CLP group
was more susceptible to P. aeruginosa infection 21 days after the CLP, when
we compare with the SHAM group. The CLP + P. aeruginosa group had a
low count of neutrophils in BAL when compared with the SHAM +
P. aeruginosa group. We observed a decrease in caspase-1 expression and
an increased expression of caspase-12 in the lungs of the CLP +
P. aeruginosa group. When we look to cognition, both the SHAM +
P. aeruginosa and CLP + P. aeruginosa groups had cognitive impairment
21 days after the infection, and the cognitive impairment remained until
96 days in the SHAM + P. aeruginosa group after the infection, but the
CLP + P. aeruginosa recovered the memory 96 days after the infection.
Conclusions: Our preliminary results suggest that the immunosuppression
associated with the CLP model (first hit) led to more susceptibility for
survivor animals, which succumbed to a pneumonia model (second hit). We
observed the involvement of inflammatory caspases in this immuno-
suppression phenomenon with a decrease of caspase-1 and an increase in
caspase-12 expression. When we observed the cognitive function, we
observed that the animals submitted to CLP had a cognitive impairment
15 days after the infection and the infection with P. aeruginosa induced a
cognitive impairment until 96 days in both in groups. However, further
studies should be made to confirm these results.
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Background: Sepsis is a major disease entity with important clinical
implications. Critical illness survivors present long-term cognitive
impairment, including problems with memory and learning. Chemokines
are important to the recruitment of leukocytes to infectious tissue, but a
few studies described the role of the CC-chemokine receptor 2 (CCL2) in
the cognitive process. In this study, we analyze the involvement of CCR2
in the physiopathology of sepsis, especially in development of cognitive
dysfunction.
Materials and methods: The CCR2-deficient mice (CCR2-/-) were
submitted to a CLP model and we analyzed the survival rate, the severity
score of the animals during 144 hours and 15 days after the CLP, and we
analyzed the memory of the animals. To analyze the contextual memory,
the mice were submitted to the open field method and the water maze
procedure. To evaluate the aversive memory, the passive avoidance test
was performed.
Results: First, we observed that the CLP group had cognitive impairment,
but the CCR2-/- group submitted to CLP had more severe cognitive
impairment in comparison with the WT-CLP group. Interesting, the
CCR2-/- Sham group presented cognitive impairment, suggesting that
CCR2 is important to the physiological process of cognition. We then
submitted CCR2-/- naive mice to water maze and passive avoidance tests.
We found that CCR2-/- naive mice have an impairment of aversive and
contextual memory. The cognitive impairment was associated with a
decrease of BDNF expression in the hippocampus. When we analyze the
expression of b-amyloid protein in the brain of CCR2-/- naive mice, we
observed the increased in b-amyloid protein expression in the cortex and
hippocampus of these animals, accompanied by increased cell
proliferation in the dentate girus, and increased caspase-3 and caspase-12
expression in the hippocampus and cortex. We did not observe a
difference in the numbers of neurons in the brain from CCR2-/- naïve
mice, as well the numbers of microglial cells. But, surprisingly, there was
an increase of astrocytes in the hippocampus of CCR2-/- mice.
Conclusions: CCR2 is involved with the physiology of cognition, with the
important role arising in the amyloid accumulation in the brain and
induction of the caspase-3 pathway.
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Background: Nitrones are a class of molecules whose main effect on
biological systems is their antioxidant action. Some studies showed a
neuroprotective effect in ischemia models and neurodegenerative
diseases. Those diseases presented an inflammatory profile that leads the
production of reactive oxygen species. This characteristic can generate
brain injuries, which can affect areas related to memory consolidation.
Sepsis is a pathology that forms an inflammatory response, which causes
encephalopathy creating cognitive impairment. Therefore, the present
study has the aim to evaluate the effect of the compound NXY-059 on the
cognitive impairment caused by encephalopathy like sepsis.
Materials and methods: For the assays, mice Swiss Webster male (22 to
28 g, n = 15 per group) were submitted to the CLP method and treated
with antibiotics (10 mg/kg, i.p.) for three consecutive days (6, 24 and
48 hours) and with NXY-059 (50 mg/kg, i.p.) for five consecutive days (6,
24, 48, 72 and 96 hours after the surgery). At 24 and 48 hours, a gravity
score was made to determine the level of sepsis and the percent of
survival was assessed until 144 hours. After 4 hours fast, the glucose
levels were also measured 24 and 48 hours after CLP performance. The
cognitive impairment was evaluated through the open field method on
the 15th (training) and 16th (test) day after the surgery.
Results: Our results show that treatment with NXY-059 did not offer a
protective effect on mortality and the animals developed moderated
sepsis according to the gravity score at 24 hours (4 to 6). At 48 hours, the
animals recovered for slight sepsis (2 to 3). The glucose levels were
slightly restored at 48 hours for the animals treated with the compound.
In the cognitive impairment analysis, we observed a as reduction (P <
0.05) in the numbers of crossing and rearings for the animals treated
with NXY-059 when compared with animals treated with vehicle (saline).
Conclusions: According to these results, we can suggest that treatment
with NXY-059 offered protection against cognitive impairment generated
by sepsis.
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Background: Recently it was shown that a significant proportion of
sepsis survivors can develop a transitory or permanent cognitive
impairment. Statins have the ability to block the cascade of cholesterol
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formation by acting on HMG-CoA reductase, reducing the synthesis of
endogenous cholesterol. Recently it has been observed that statins have
anti-inflammatory properties preventing brain dysfunction in malaria
models, reducing the production of brain cytokines, oxidative stress and
alterations in the blood-brain barrier. The aim of the present study was to
evaluate the ability of statins to reduce neuroinflammation and protect
septic animals from neurocognitive damage.
Materials and methods: Feces were extracted (5 mg/g b.w.) from the
large intestine of SW mice and diluted in saline, centrifuged and the
supernatant collected and injected into the animals (n = 5 to 8/group).
Control animals received 0.5 ml saline. Animals were treated at 6, 24 and
48 hours after sepsis induction with imipenem (30 mg/kg b.w., 0.2 ml s.c.)
and 1.0 ml saline (s.c.). Statins (Ator and Sinv) were administrated 1 hour
before and 6, 24 and 48 hours after the infection (20 mg/kg b.w., p.o.).
Mortality was observed for 96 hours and a score of severity evaluated.
The inflammatory profile and oxidative damage was determined at 6 and
24 hours. In addition, mice brains were evaluated for microglial activation
and BBB dysfunction. After 15 days we analyzed the cognitive damage
using the inhibitory avoidance task and Morris water maze.
Results: No significant difference in survival was observed comparing
septic animals treated with antibiotics plus atorvastatin or simvastatin
(56%; 53%) with septic animals with only antibiotics (37%). We observed
lower levels of proinflammatory cytokines (IL-1, IL-6) and chemokines (KC
and MCP-1) when comparing statin-treated animals and nontreated. We
also observed a decreased in the oxidative damage in brains 6 hours
after sepsis in the treated groups. Finally, statin treatment was able to
protect septic animals from cognitive damage including avoidance and
spatial memory, both affected in untreated infected mice.
Conclusions: We can conclude that statins protected septic animals from
cognitive damage, reducing neuroinflammation, and adjuvant therapies
with statins can be interesting targets for future clinical trials focused on
the prevention of long-term cognitive decline in sepsis.
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Background: Sepsis occurs as a result of a systemic inflammatory response
to an infection. In this context, homeostasis of biological systems depends
on regulatory mechanisms to modulate the amplitude of the immune
response to stimuli, such as infection, preventing damage resulting from this
imbalance of immune response. The exacerbated immune response can
cause serious tissue or systemic damage, as occurs in autoimmune and
chronic inflammatory diseases. The main aim of our study is to investigate
the effect of dasatinib in polymicrobial sepsis.
Materials and methods: Swiss mice were subjected to cecal ligation and
puncture and treated with dasatinib 1, 5 and 10 mg/kg 30 minutes before
and 6 and 24 hours after the surgery. Survival rate and clinical signs were
assayed; cell accumulation, bacterial load were measured in peritoneal
lavage and inflammatory mediators were measured in plasma.
Results: Animals receiving dasatinib 5 and 10 mg/kg showed the worst
clinical score and an increased mortality rate. Animals receiving dasatinib
1 mg/kg showed an increase in survival, a decrease in clinical score, in
cell migration, in colony-forming units and cytokine production.
Conclusions: Dasatinib has a dual effect in polymicrobial sepsis, where
higher doses had deleterious effects but lower doses had beneficial
effects, probably because lower doses may downregulate the immune
response, avoiding extensive tissue damage.
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Background: Sepsis is a major cause of death in veterinary medicine, as
in the human field, but there are no survival data described for this
syndrome in the veterinary clinical field. This aspect challenges
experimental medicine, may alter the baseline data to be applied in the
human setting and could explain in part why most results obtained from
laboratory research are not completely useful in the human clinical field.
The purpose of this prospective observational study was to investigate
the 24-hour and 30-day survival from severe sepsis and septic shock in
canine septic patients that were approached with the Surviving Sepsis
Campaign (SSC) bundles.
Materials and methods: Nineteen client-owned puppies with naturally
acquired parvovirus haemorrhagic gastroenteritis were classified as severe
sepsis and septic shock patients and received medical care according to
the guidelines proposed by the SSC. Subsequently, the 24-hour and
30-day survival was evaluated for each case. The results were statistically
analysed by Fisher’s exact test at a significance level of 5%.
Results: Fifteen patients (78.9%) were admitted to the emergency
department and classified as severe sepsis subjects. The mortality rate in
the severe sepsis group was 33.33% (five animals), of which four animals
died in the first 24 hours of admission and the other on the following
day. Four dogs (21.1%) were classified as septic shock patients. The
mortality rate in the septic shock group was 100%, of which two animals
died in the first 24 hours of admission and two on the day after (Table 1).
Conclusions: The observation of clinical outcomes in this clinical canine
sepsis model showed that the majority of deaths in both severe sepsis
and septic shock occur within the first 24 hours. However, after 30 days
there is a significant difference between both groups, showing no
survival in septic shock animals. Therefore, this preliminary study suggests
a new veterinary database to be applied for future human research.
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Table 1(abstract P110) Severe sepsis and septic shock animals classified as nonsurvivors and survivors 24 hours and
30 days after admission
Classification Total Nonsurvivors 24 hours Survivors 24 hours P Nonsurvivors 30 days Survivors 30 days P
Severe sepsis 14 4 (26.7%) 11 (73.3%) 0.557 5 (33.3%) 10 (66.7%) 0.033
Septic shock 4 2 (50.0%) 2 (50.0%) 4 (100.0%) 0 (0.0%)
Total 19 6 (31.6%) 13 (68.4%) 9 (47.4%) 10 (52.6%)
P, significance value of Fisher’s exact test.
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Background: Pseudomonas aeruginosa is a Gram-negative bacterium
regarded as an opportunistic pathogen. It infects immunocompromised
patients, and is the second leading cause of nosocomial diseases. This
bacterium has numerous virulence factors, adapts quickly to new
environments, and requires a few nutrients to survive. All of these
mechanisms will generate a host response. The fastest immune response is
neutrophil recruitment, followed by phagocytosis and degranulation. There
is another mechanism to fight bacteria called NET formation, which is the
formation of a neutrophil extracellular network. NET is formed through a
process called NETosis where the release of the cell nuclear material can
hold and destroy pathogens. The nuclear receptor peroxisome proliferator-
activated receptor PPARg, besides lipid and glucose metabolism, is
involved in the inflammatory response modulation, being considered a
potential target for the study of new therapies for inflammatory and
infectious diseases. We therefore aim to investigate the involvement of
PPARg in lung injury caused by P. aeruginosa using an agonist of this
receptor, rosiglitazone.
Materials and methods: For this purpose, Swiss mice were instilled
intratracheally with bacteria and treated with rosiglitazone 5 hours after
the operation. We analysed clinical signs using 10 physical parameters,
cellularity and DNA measurement to assess NET formation.
Results: We found that the animals stimulated with Pseudomonas showed
an increase in inflammatory parameters, while the animals treated with
rosiglitazone showed improvement in clinical signs and increased NET
formation.
Conclusions: We can conclude that rosiglitazone has an anti-
inflammatory role during lung infection, suggesting that PPARg activation
may improve the host defense against bacteria.
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